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“Not everything that can be counted counts, 





History of the Nijmegen Health Area project 
The roots of the Nijmegen Health Area project (NHA) go back to the end of the 
1970s, when Dr. Ferd Sturmans, head of the Institute of Social Medicine of 
Nijmegen University, took the initiative of conducting a general population 
survey on the need for health care. As this need is determined by a multitude of 
factors, the project was organised on a multi-disciplinary basis, not just for the 
assessment of somatic, psychiatric and psychosocial problems, but also with an 
eye on the medical, sociological and psychological background of healthcare 
consumption. To account for the complex topics to be surveyed, a number of 
university departments were invited to participate. After a period of preparatory 
talks, the sociology and psychiatry departments of Nijmegen University agreed 
to take part. The survey focused on the distribution of somatic complaints, 
psychosocial problems, and psychiatric symptoms, and also on the resulting 
illness behaviour and the attitude of patients to their need for care. As far as the 
psychiatric part of the survey was concerned, the data collection was carried out 
in 1983 by means of the PSE-9. The Prevention Foundation provided the 
resources for the Nijmegen Health Area 1 (NHA-1) project. The results of this 
first NHA project, and especially the psychiatric data, came to the attention of 
the Ministry of Health, Welfare and Sport, and played an essential role in the 
New Report on Public Health, which was released in 1984. 
In the early 1990s, Dr. Paul Hodiamont, who had been responsible for the 
psychiatric part of the NHA-1, was approached by a representative of the same 
ministry, who suggested a replication of the psychiatric part of the NHA-1 
project by the original research team in order to generate evidence on secular 
trends in the distribution of psychiatric disorders. The Institute of Social 
Medicine was willing to provide the organisational framework, and the Institute 
of Psychiatry was equally willing on condition that a supplementary research 
theme concerning the chronic use of benzodiazepines was incorporated into the 
study design. In order to meet this requirement, the co-operation of regional 
general practitioners (GP) was essential. Consequently, the Department of 
General Practice of Nijmegen University was invited to participate in the study, 
and the respondents were recruited randomly from the GPs’ patient registers. 
This recruitment method brought about two consequences, the first of which 
was advantageous and the second disadvantageous: the first was the 
possibility of creating a list of high-risk indicators for psychiatric disorders; the 
second was that the medical ethics committee judged that the epidemiological 
part of the study was no longer an open field survey in the general population, 
but a patient-oriented study. As a result, a detailed letter for obtaining informed 
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consent had to be drawn up, which had a discouraging effect on potential 
survey subjects.  
The data for the Nijmegen Health Area-2 project (NHA-2) was collected from 
September 1997 to January 1998. The Prevention Foundation and the Ministry 
of Health, Welfare and Sport provided the resources for the data collection for 
the NHA-2 project. 
At the same time, the Trimbos Institute (Netherlands Institute of Mental Health 
and Addiction) was given a government grant for the NEMESIS study, a 
longitudinal study on psychiatric morbidity, health service use, and need for 
care in the general population. An advisory committee chaired by Dr. Harry 
Rooijmans was formed to monitor the progress toward the separate goals of, 
and also the cooperation between, the two studies. The main differences 
between the NHA-2 and the NEMESIS were as follows: although both were 
epidemiological general population studies, the former was regional and cross-
sectional, and repeated (after 14 years), and carried out with the Schedules for 
Clinical Assessment in Neuropsychiatry (SCAN), an observer-based interview, 
whereas the latter was national and longitudinal and was carried out with the 
Composite International Diagnostic Interview (CIDI), a respondent-based 
instrument. Furthermore, the NEMESIS, which is more or less a replication of 
the National Comorbidity Study carried out in the USA a few years ago, 
determined psychiatric morbidity over a more limited diagnostic range than that 




This thesis uses descriptive epidemiological data to focus on some aspects of 
the reliability and validity of psychiatric diagnoses, with the objective of 
improving the quality of the diagnostic process, and through this, to enhance the 
quality of future epidemiological information. It will do so by investigating the 
correlation between relevant variables and the results of an international 
standardised clinical psychiatric interview, in particular version 2.1 of the SCAN 
(SCAN-2.1). The data were collected as part of a repeated cross-sectional 




After this introduction, in part one, we will elaborate on the theory and essential 
characteristics of epidemiology (see chapter 2) and on the principles of the 
diagnostic process and the psychometric parameters of various diagnostic 
procedures (see chapter 3). We will conclude part one in chapter 4 with the 
research questions addressed in this thesis. 
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In part two, which is on epidemiologic outcomes, we will present a model for 
mapping and monitoring epidemiologic data. First, in chapter 5 we will present 
an example of monitoring, since this was the initial motivation for performing the 
NHA-2 study. This monitoring example is illustrated by a comparison of the 
prevalence and distribution data generated by the PSE-9 in the NHA-1 study, 
with the similar data from the NHA-2 study. In chapter 6, the design, methods, 
and results of the NHA-2 study will be presented as an example of psychiatric 
mapping in which the contemporary clinical interview SCAN-2.1 was used as 
the interview instrument. The results from this study will be placed in both a 
national and an international perspective. 
In part three on diagnostics in epidemiology, the diagnostic process used in the 
SCAN-2.1 will be evaluated from different points of view. In chapter 7 we will 
present data on the psychometric properties of the SCAN-2.1, the central 
clinical diagnostic instrument we used in the NHA-2 study. Subsequently, in 
chapter 8, we will address in greater depth the process of clinical decision-
making implemented in the SCAN-2.1. Finally, in chapter 9, we will elaborate on 
the SCAN-2.1 data through a comparison of the two currently most frequently 
used psychiatric diagnostic instruments, the SCAN-2.1 and the CIDI-2.1.  
In part four we will summarise the research results, follow these with a general 
discussion, and finally, set out the implications of our results for future research 







2.1 Definition and background 
According to the Dictionary of Epidemiology (Last 1995), today epidemiology is 
defined as “the study of the distribution and determinants of health-related 
states or events in specified populations and the application of this study to 
control health problems”. ‘Study’ encompasses surveillance, observation, 
hypothesis testing, analytic research, and experiments. ‘Distribution’ refers to 
analysis by time, place, and classes of affected people. ‘Determinants’ are all 
the physical, biological, social, cultural, and behavioural factors that influence 
health. ‘Health-related states and events’ include causes of death, diseases, 
behaviour, reactions to preventive regimens, and provision and use of health 
services. ‘Specified populations’ are those groups of people with identifiable 
characteristics. ‘Application to control health problems’ makes explicit the 
objectiveof epidemiology: to promote, protect, and restore health. The concepts, 
principles, research strategies, and methods of psychiatric epidemiology are 
those of general epidemiology, adapted for the study of psychiatric 
disturbances, manifest in both behaviour and mental life (Anthony et al. 1995). 
Epidemiology offers some of the best available research strategies for 
addressing critical questions in different areas of interest. First, it serves 
(mental) health care, as it attempts to answer questions concerning the nature, 
aetiology, and course of (psychiatric) disorders in order to improve treatment 
potential, prevention and planning. Furthermore, epidemiological evidence is 
indispensable for ethical, well-planned, well-considered, and financially sound 
political decisions in a broad range of policy-making areas. These include the 
planning and financing of (mental) health care facilities, disaster management, 
and penitentiary services. 
There have been many definitions of epidemiology (Fleming & Hsieh 2002; 
Hodiamont 1996; Kluiter & Ormel 1999). In the course of time the definition has 
been broadened from concern with communicable disease epidemics to take in 
all phenomena related to health in populations. The word epidemiology is 
derived from the Greek: ‘έπί’ (‘epi’), ‘δήµος’ (‘demos’), and ‘λόγος’ (‘logos’), 
which mean ‘upon’, ‘people’, and ‘knowledge’, respectively. Thus epidemiology 
originally meant ‘the knowledge of what comes upon the people’. The ancient 
Greeks believed that plagues and other disasters (epidemics) were visited upon 
them by the gods or by destiny. The history of epidemiology that followed this 
initial conviction has been marked by dramatic transitions in thinking in 
response to new public health challenges and/or scientific breakthroughs 
(Susser & Susser 1996a; Susser & Susser 1996b). In the early nineteenth 
century, the industrial revolution brought about the Sanitary Era, with its focus 
mainly on societal factors and the theory of “miasma”, a kind of polluting vapour 
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that emerged from the build-up of putrefying waste. Notwithstanding its evident 
success, sanitary epidemiology provided insufficient explanations as to how 
societal factors led to disease in individuals. It was not until 1854 that John 
Snow, a London medical doctor, systematically searched for the cause of a 
cholera epidemic in London (Bynum 1994; Vinten-Johansen et al. 2003). He 
identified the cause of the epidemic (not of the disease), and this made him the 
founding father of modern epidemiology. Intrigued by the clinical aspects of the 
cholera cases, he left the hospital, systematically visited the inhabitants of the 
afflicted Soho area, gathered information on their daily lives (observations) and 
in doing so, discovered what he never would have been able to if he had stayed 
at his desk: the casualties were mainly dependent on the Broadway pump for 
their water supply. He also concluded from his observations that the disease 
barely affected the employees of the local brewery, who were supplied with free 
beer. The pump was closed down and the epidemic ceased - a first act of 
political decision-making based on epidemiological evidence from geographic 
mapping. Although the exact aetiology of the disease was still unknown, the 
reason for which it was so specifically localised was discovered, and effective 
measures could be taken to stop this sneaky killer in its tracks. 
At about the same time, the epidemiological method was successfully applied in 
psychiatry as well. Valdemar Steenberg, a Danish doctor working in a venereal 
clinic in Copenhagen, visited his colleague at the St. Hans Psychiatric Institute 
in the Danish capital. During the visit he recognised several patients with 
dementia paralytica (DP), whom he had treated for syphilis years before 
(Strömgren 1970). The epidemiological link between syphilis and DP was 
obvious to him, and he wrote a thesis on the subject. Some years later, Dr. 
Steenberg changed posts and started working at a peripheral hospital, where 
the prevalence rate of DP was much lower than in psychiatric in-patients in 
Copenhagen, where it was 45%. Those of his patients who did have the 
disease had all spent at least some time in the capital, at that time a centre of 
culture, pleasure and, as it seemed, venereal disease. A few decades later, at 
the end of the 19th century, Mattauschek and Pilcz, two Austrian army doctors, 
elaborated on these results and conducted a longitudinal survey up to 1911 on 
officers who had been infected with syphilis between 1880 an 1890. They 
discovered that, although syphilis was more or less endemic in the Austrian 
army, only 5% of the carriers developed DP. On analysing the difference 
between the groups without and with DP, it turned out that the former had had 
malaria fever soon after their syphilitic infection, in contrast to the officers who 
developed DP. Furthermore, they observed that in many tropical countries 
syphilis and malaria were endemic, whereas DP was practically unknown. They 
concluded that malarial fever probably had a preventive effect on the 
development of DP. Eventually, this led to the malarial treatments for which 
Wagner von Jauregg, as the first researcher in a psychiatric area, was awarded 
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the Nobel Prize in Physiology or Medicine in 1927 “for his discovery of the 
therapeutic value of malaria inoculation in the treatment of dementia paralytica” 
(Nobelprize.org). 
Both case histories illustrate the importance of mapping, of drawing a detailed 
picture of the circumstances of a disease, as a basic tool for the epidemiological 
analysis of health-related problems. Repeated mapping, or monitoring, is 
gaining interest in the (mental) health care. That is so because this technique 
reveals fluctuations in disease frequencies in the population, facilitating the 
search for underlying causes and providing the rationale for preventive actions 
and facility planning, among other measures. 
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2.2 (Meta-)theoretical aspects 
2.2.1 Causality: the ultimate goal 
Common to all sciences are four general goals: understanding, prediction, 
control and systematisation. Moreover, the goal of understanding has two 
components, description and explanation. To achieve understanding, two basic 
types of observation are carried out: on the one hand, naturalistic observation, 
to describe phenomena, and on the other, experimental observation, to explain 
phenomena. These are central to descriptive research and explanatory or 
experimental research (Gould 2002). In epidemiology, these research 
objectives are pursued by means of three research strategies, each with its 
specific leading question. Descriptively, the question is, “what condition occurs 
in whom, where and when?”. Analytically, (explanationwise) the question is, 
“why does the condition occur?”. Both research strategies are means to the end 
of achieving control over diseases and disorders. Experimentally, the question 
is “what can be done to prevent or heal the condition?”. All three strategies are 
illustrated by the example of DP as described above. 
The foundation upon which science seeks to achieve these goals is comprised 
of a number of assumptions, notably with respect to reality and determinism.  
When it comes to reality, scientists assume that objects and events have an 
existence external to and independent of man. In psychiatric epidemiology, 
constructs, such as schizophrenia, are, for the sake of convenience, given the 
status of facts. The true status of such constructs is, however, a complicated 
and controversial issue in psychiatry that deserves a review in its own right. We 
shall discuss this topic in chapter 3.  
Determinism refers to the belief that the occurrence of an event or a behaviour 
is determined by (or dependent on) antecedent events. Because a phenomenon 
could have many, or only obscure, antecedents we might not currently know 
every, or even any, of its determinants, but that does not preclude the eventual 
discovery of all the causal factors. Schizophrenia, again, is an example of a 
mental disorder for which the causes have remained obscure for a long time. 
Now, however, we are gradually learning more about its biological and 
environmental determinants. Unravelling causality is the nec plus ultra of 
(psychiatric) epidemiology, since it offers the best chance of treating or 
preventing disorders effectively.  
Mapping provides essential information about the who, where and when of the 
disorder in question and is an indispensable first step in the search for causality 
(Susser et al. 2002).  
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2.2.2 Concepts of causality  
Basically, in epidemiological research studies the how is studied of the 
association of variables with one another (Kluiter & Ormel 1999). Generally 
speaking, reported statistical associations, such as those disclosed in mapping 
studies, can be explained as either artificial, indirect, or causal (aetiological) 
(Lilienfeld & Lilienfeld 1992). Epidemiology primarily aims at the clarification of 
the nature, the direction, and the power of causal relations. Causal relations in 
general medicine, let alone in psychiatry, can not be proven, but at best only be 
made plausible on the basis of circumstantial evidence (Kluiter & Ormel 1999). 
A strict time sequence (Y follows X) is necessary but not sufficient to verify a 
causal relation. Reactive change (when X changes, Y changes too) is a 
powerful indication, but difficult to assess in psychiatry. Furthermore, in 
psychiatry disorders are seldom assumed to be initiated by a single cause, 
which makes the recognition of causality even more difficult. From this 
perspective, Rothman (1986) developed the notions of sufficient and 
component cause, whereby the latter is a necessary but not sufficient condition 
in the explanation of the occurrence of a disease, whereas a sufficient cause is 
a unique constellation of component causes that inevitably leads to the onset of 
a disease. 
The underlying influences on the incidence or duration of diseases are called 
determinants. A determinant has such an effect because either it is a 
component cause (or factor) of the disease itself, or it has an influence on one 
or more component causes (in which case it is referred to as an indicator). In 
the example of DP, living in an urban environment is an indicator, whereas 
having unprotected sex with prostitutes is a factor for contracting syphilis. Some 
indicators, however, do not have fixed meanings under all circumstances; in fact 
the contribution of some indicators depends on how they are interpreted in a 
socio-cultural context. A social indicator, which is more widespread in the 
population, is often more widely accepted and results in a lower stress level 
than an indicator that occurs incidentally. Murphy et al. (2003), reporting on the 
Stirling County study, concluded that “it was only when smoking was becoming 
non-normative that a strong and positive association with depression 
appeared”. Similarly, there is quite a difference between being an atheist in a 
large city and being an atheist in a small religious village. 
A second and more qualitative, aetiological approach to causal factors is based 
on a differentiation between the predisposing, facilitating, precipitating, and 
perpetuating qualities (Hodiamont 1999). These qualities are not mutually 
exclusive, so that factors can be attributed to more than one of them. 
Predisposing factors are factors that increase the probability of an individual’s 
contracting a certain disorder. These vulnerability factors are by definition 
component, but they are rarely sufficient. In Snow’s example of the Soho 
cholera epidemic, living in the densely populated Broadway area is a 
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predisposing factor. Facilitating factors augment or abate the risk of onset of 
diseases, but differ from the former in that they are variable in character, and 
intervention is possible. In the cholera story, the poor, often open, sewer system 
and lack of hygiene (failure to boil water before it is drunk) are facilitating 
factors. A precipitating factor is related to the actual onset of a disease. When 
this factor is more important than others for the actual disease, it may be a 
component factor. An illustration is the drinking of unboiled water from the 
Broadway pump. Finally, perpetuating factors maintain the expression of the 
disease, e.g. the passage of contaminated faeces through the open sewer 
system of the Soho area, which polluted the Broadway water supply. 
Perpetuating factors can have either facilitating or precipitating potential or 
neither of them, in that they do not have the quality needed to influence the 
actual onset of the disease. 
Currently, the approach to causality is incorporated into the diathesis-stress 
model (Butcher et al. 2007; Ingram & Luxton 2005; Kluiter & Ormel 1999; Meehl 
1962; Zubin & Spring 1977). In these models, a predisposition to developing a 
disorder is termed a diathesis. It can derive from biological, psychosocial, 
and/or sociocultural causal factors, and the different viewpoints tend to 
emphasise the importance of different kinds of diatheses. Many mental 
disorders are believed to develop as the result of some kind of stressor or 
precipitating event that acts on a person who has a diathesis or vulnerability for 
that disorder. Stress, the response of a person to demands he or she perceives 
as exceeding his or her personal resources, usually occurs when that person 
experiences chronic or episodic events that are undesirable. Factors 
contributing to the development of a diathesis are themselves sometimes highly 
potent stressors (Brown & Harris 1978). There are several different ways that 
researchers have proposed in which a diathesis and stress can combine to 
produce a disorder. In the so-called additive model, the diathesis and the stress 
summate. The greater the underlying vulnerability, the less stress is needed to 
trigger the behaviour/disorder. Conversely, when there is a smaller genetic or 
early-life contribution, greater life stress is required to produce the particular 
result. In what is called an interactive model, a certain level of diathesis must be 
present before stress can have an effect. Thus someone with no diathesis will 
never develop the disorder no matter how much stress he or she experiences, 
whereas someone with a diathesis will be increasingly likely to develop the 
disorder with increasing stress. In terms of Rothman’s causality model, the 
predisposition to vulnerability comprises the compilation of component causes 
that increase the risk of occurrence of a psychiatric disorder, either permanently 
or over a prolonged period, without being sufficient to actually elicit the disorder. 
An extra component cause (the stressor) is needed to trigger the onset of the 
disease. In the additive model, the stressor itself can be a factor that is sufficient 
to cause a disease. Even in healthy persons, for example, the cholera bacillus 
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itself can provoke the disease if it is sufficiently concentrated. Since the late 
1980s, attention has been focused on the concept of protective factors, which 
modify a person’s response to environmental stressors, making it less likely that 
someone with a certain diathesis will experience the adverse consequences of 
stressors (Rutter 1985). Protective factors, however, do not necessarily arise 
from positive experiences. Sometimes exposure to stressful experiences that 
are dealt with successfully can promote a sense of self-esteem that serves as a 
protective factor. Thus, paradoxically, some stressors promote effective coping. 
This “inoculation” effect is more likely to occur with moderate than with mild 
stressors (Rutter 1987). Protective factors sometimes lead to resilience – the 
ability to adapt successfully to even very difficult circumstances.  
 
2.2.3 Levels of causation 
The “level of causation” concept facilitates the specification of causes at 
different levels of organisation. Shortly after the Second World War, Von 
Bertalanffy (a biologist) introduced his general systems theory (Romme et al. 
1981). This framework, an organisation of hierarchically ordered systems, 
created the possibility of integrating information from many different scientific 
areas. In general, there are seven system levels which can be used as a 
reference for measurement: the societal level, the group/community level, the 
individual level, the organ level, the tissue level, the cellular level, and the 
genetic level.  
In the nineteenth century, in the Sanitary Era, when a social transformation 
(illustrated by industrialisation, amongst others ways) was associated with an 
accumulation of decaying waste resulting in polluting vapours, the societal level 
prevailed with its “miasma” paradigm. At the turn of the nineteenth century, the 
new science of microbiology heralded the Infectious Disease Era, which 
replenished the social process of infectious disease transmission with 
explanations of diseases on a more individual level on the basis of the “germ” 
paradigm. In the 1950s, the next shift was stimulated by the rapidly changing 
health profile of the western world. Thanks to antibiotics, infections were cured 
on an individual level and diseases were brought under control on a societal 
level, so that non-infectious, chronic disorders such as cardiovascular diseases 
and cancer became more apparent. It was not until after the Second World War 
that it was verified that smoking was a risk factor for lung cancer, which 
announced the Chronic Disease Era with its “risk factor” paradigm, which in turn 
signified a return of the societal level.  
Today we think scientifically not only about individual risk factors, but also about 
the influence of society and the group (like the family and other social 
subgroups with their role patterns), and of tissue, cell and gene. Although efforts 
are increasingly being made to unravel psychiatric disorders on the basis of 
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integrated disparate reference levels, including, in particular, genetic and tissue 
levels (Susser et al. 2002), for psychiatry the societal, community and individual 
level are still the most prevalent.  
 
As this thesis concentrates on psychiatry in its present-day state, in which 
societal and individual causal levels feature prominently, a few words on these 
levels of measurement are in place. A study that is based on a single level of 
causation has shortcomings that can be overcome by research on other levels.  
As far as the individual level is concerned, there are three important limitations 
(Susser et al. 2002). First, when a factor (like hygiene in developed countries) is 
generally present in the study population, its influence cannot be adequately 
studied because of its lack of variation. Data on the impact of this ubiquitous 
factor are speculative, although it may be involved, for example, in the 
predisposition to, or precipitation of, a disease, and its removal may have an 
enormous effect on risk modification. Second, quite often, the prevalence of a 
specific risk factor on the individual level is influenced by societal change. 
Consequently, an explanation on the societal level is indispensable to an 
understanding of many changes in disease prevalence. For example, the 
reason for the increase in the prevalence rate of allergic reactions of individuals, 
found in many studies, is still not traceable and might be linked to an increase in 
the standard of hygiene or of sterility (these being societal factors) in developed 
countries. Finally, as mentioned in the previous paragraph, the attribution, and 
consequently the significance, of a risk factor on the individual level can be 
influenced by the socio-cultural context of a subpopulation, making the societal 
level necessary for an adequate appreciation. In conclusion, to understand a 
sufficient cause, usually the individual approach per se is not satisfactory, as 
the hygiene hypothesis shows in the example of the growing allergic 
constitution. All in all, it may even be this common risk factor that carries the 
greatest implication for disease prevention, although its contribution is 
undetectable in a pure individual design. 
The societal level mainly helps to clarify determinants (factors and indicators) 
that are invariant within a population (not visible at the individual level) and also 
determinants in contexts and relations surrounding individuals. The distinction 
between the individual and the societal level is primarily a matter of magnitude, 
and consequently arbitrary (Susser et al. 2002). By definition, a society may 
constitute any combination of individuals who are connected in some 
meaningful way, from families to nations, the Roman Catholic Church and even 
the common denominator of developed countries. Each community or society 
has its particular attributes, which shape the experiences of people living in it. 
Although social factors appear to be remote from the occurrence of specific 
diseases in individuals, they are of great significance as causal determinants. 
While (specific) risk factor investigation can provide a more proximal cause 
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mechanism, research into societal factors may be more likely to indicate distal 
causes, which may lead to effective intervention strategies. For example, Snow, 
in his search for the cause of cholera, was not aware of the proximal, biological 
cause, but found a more distal cause on a communal level, which led him to the 
simple but effective solution of closing down the Broadway water pump. 
With current research, including increasingly complex statistical processing of a 
growing number of determinants, it is not possible to accurately measure all 
important influences at all causation levels and consequently a fully 
comprehensive understanding of disease causality is still far away. Even at the 
individual and the societal level, a fully comprehensive measurement of 
important factors is still overly ambitious. Nevertheless, the object of this thesis 
is to contribute to the cumulative evidence that clears a path toward insight into 
the causal process. 
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2.3 Operational aspects 
2.3.1 Choice of determinants 
Mapping is increasingly used to examine the causes of mental disorders 
(Susser et al. 2002). The result of mapping concerns the correlation of 
quantitative frequency data with qualitative distribution characteristics 
(Anderson 1999). In epidemiological terms, the questions to answer are: what 
are the prevalence rates (quantitative data) and what is their distribution 
(qualitative characteristics). The latter, or the determinants, can be factors that 
are directly involved in, and that influence, the quantitative phenomenon, or 
indicators that simply point toward an indistinct, indirect relation. In the DP 
example, living in an urban environment is an indicator, namely a higher risk of 
contracting syphilis, and syphilis itself is a factor in the development of DP. 
Of the many qualitative determinants at hand for making the diathesis-stress 
model operational, a selection of sociodemographic characteristics, coping 
styles, life events and other stressors is commonly used (Aalto-Setala et al. 
2002b; Brugha et al. 2004; Brugha et al. 2005; Fryers et al. 2005; Roca et al. 
1999; Roca-Bennasar et al. 2001; Wang 2005). The choice of the most 
meaningful determinants is still subject to trial and error, as the following two 
examples illustrate: (1) By way of operationalising the vulnerability/protecting 
factors, Aalto et al. (2002b) used trait anxiety, defence styles, self-esteem, life 
events and somatic symptoms, and found trait anxiety an important risk factor 
for mental distress, while gender differences suggested differences in coping; 
(2) Several research groups (Brugha et al. 2004; Selten et al. 2005; Selten & 
Cantor-Graae 2005) found that ethnicity as a factor is strongly associated with a 
higher prevalence rate of psychosis. But Brugha et al. established that the 
corresponding and underlying risk factors were socio-economic status (as 
measured by unemployment, poverty and lower social class), and social 
support and roles (represented by lone-parent status, low perceived social 
support, and having a small primary social support group). It should be noted, 
however, that none of these can be said to be a sufficient cause; until the 
causal correlation is clarified, it is better to talk about determinants. 
The abundant array of determinants (amongst them the ones used by Aalto-
Setala and Brugha in the aforementioned examples), which are by no means 
exhaustive, can be classified as in Table 2.3.1, in which the diathesis–stress 
model is related to the causal level of explanation. The vulnerability and 
protective traits are relatively stable factors, whereas stressors are more 
changeable over time. 
 
We chose our determinants with the objective of investigating whether the more 
or less consistent relationship that has been found between psychiatric disorder 
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and sociodemographic characteristics (Dohrenwend & Dohrenwend 1974; 




An example of sorting determinants into the diathesis-stress model and 









Individual (low) trait anxiety life events 
 coping styles somatic symptoms 
 self-esteem state anxiety 
 marital status changing social roles 
 social embedding lone parenthood 
 socio-economic status loneliness / social deprivation 
 education advanced age 
 gender declining vitality 
 chronic (somatic) disease drug prescription 
Societal/  ethnic composition  diminished social support 
communal primary groups poverty 
 social class unemployment 
 economic growth/prosperity multiple roles 
 social cohesion (imminent) natural disasters 
 level of local services 
(water, health care, etc.) 
population density (urbanisation) 




The history of psychiatric epidemiology, especially its designs, has been 
described in terms of generations (Anthony et al. 1995; Dohrenwend 1990; 
Dohrenwend & Dohrenwend 1982). Crucial to the typology of psychiatric 
epidemiological research designs are (1) the specificity of the 
psychopathological measurement used, (2) the quality of the sample, (3) the 
level of structure of the measurement, and (4) whether the score is observer- 
(objective) or respondent- (subjective) based. In other words, the research 
questions are: what can be said about whom?, what is the reliability of the 
information?, and what is its clinical validity? 
With the first generation designs, basically retrospective, administrative, clinical 
treatment statistics were used to study the association of sociodemographic 
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variables with (more or less) specific mental disorders. Hence, the sample was 
restricted to persons referred for treatment (2), and the assessment of 
psychopathology, based on the disease modeli used by the clinician (1 and 4) in 
a free-ranging diagnostic conversation (3), was not carried out with a reliable 
and standardised instrument. As a result, the data could not be generalised to 
the open population and were of limited value for policy decisions. The second 
generation designs sought to estimate the prevalence rate of general distress 
(1) in a sample of the open population (2), typically without much attention to 
specific psychiatric disorders (1), partially because a clear and reliable 
diagnostic categorical system was lacking. In that era, the data concerned the 
population as a whole, providing a basis for conclusions supporting policy 
decisions. But the outcome measure of general distress, mostly found by 
means of questionnaires (3), was based on the illness modeli of (subjectively) 
perceived morbidity (4), which brought about a very high prevalence rate of 
general distress. From the viewpoint of clinical relevance (as part of the disease 
model), the prevalence figures seemed to be excessively high. The third 
generation design combined the field survey approach (2) with standardised 
diagnostic instruments (3) and the intentional focus on specific disorders (1). In 
respect of the source of the information (4), two traditions co-exist, the 
clinical/objective SCAN/PSE tradition and the respondent-based/subjective 
CIDI-DIS tradition. In short, the development of psychiatric epidemiology is 
characterised by a generalisation from the population sample in the 
denominator and also by a far-reaching specification of the disorders in the 
numerator of the epidemiological fraction. So that policy makers are provided 
with accurate data, the contemporary objective is to search for standardised 
instruments that are able to measure psychiatric disorders as reliably and 
categorically as possible. This process of specifying mental disorders will be 
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3 Diagnostics in psychiatry 
3.1 Definition and background 
Diagnosis is conceptualised as the identification of a disease, disorder, 
syndrome, condition, etc. Etymologically the term diagnosis is derived from the 
Greek word διάγιγνώσκω, which literally means to know through. This meaning 
has evaluated into two distinguishable connotations. First, when a diagnostician 
“looks through” a patient, he or she knows and understands all signs and 
symptoms in a persons individual context, leading to potential treatment 
strategies. Second, when a phenomenon is known through, two aspects of it 
are understood: the fact that a combination of certain signs and symptoms form 
a syndrome, and that this syndrome can be distinguished from other 
syndromes, which makes possible categorisation. This duality illustrates the 
fundamental polarity that bedevils all diagnostic systems, namely the polarity 
between the idiographic and the nomothetic point of view, given that an 
individual can be studied from each of them. In the context of the former, a 
patient is regarded as a unique subject, and any evaluation that ignores 
uniqueness will deplete the information required for individualised treatment. 
The latter refers to the way in which a subject is considered to resemble other 
people and to be governed by universal laws. In practice, no clinician can 
function solely at either pole. Although the assessment may be totally 
individualised, every patient has some characteristics in common with others. 
On the other hand, a comprehensive treatment plan demands more than a 
mere description for a stereotypic tag. Whereas idiographic diagnosis is highly 
useful for treatment planning, nomothetic or categorical diagnosis is highly 
useful for summary communication and prediction. It follows that the two 
approaches complement one another (Nurcombe & Gallagher 1986).   
 
3.1.1 The idiographic approach to patients 
In principle, medical doctors busy themselves with the treatment of individual ill 
persons and seek to explore their specific illness in depth. They seldom ask 
themselves what illness really is (Semple et al. 2005). For psychiatrists this 
question is more germane, for several reasons. More than with other illnesses, 
the diagnosis of psychiatric disorders is dependent on subjective experiences 
rather than on objective abnormalities, and in the diagnostic process, value 
judgements play an important role. Furthermore, psychiatric disorders may have 
social and legal implications that add to the burden of morbidity. 
In the English literature, a meaningful distinction is made between illness, 
disease and sickness, with reference to subjective experience, the professional 
point of view and treatment, and social and legal implications, respectively. 
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Patients generally present complaining of or suffering from signs or symptoms 
(illness), a phenomenon called illness behaviour, related to the lay experience 
of being ill. Disease encompasses either a specific tissue lesion or a 
characteristic constellation of signs and symptoms, as diagnosed on the basis 
of clinical (professional) judgement, whereas sickness has to do with the social 
deficit consequent on symptoms. Each of these entities can exist without the 
















A patient with an asymptomatic form of cancer has a disease, does not feel ill, 
nor is he sick (see area [1] in Figure 3.1.1). Patients can experience symptoms, 
but may act as healthy persons, for example by not consulting a doctor [2]. 
Some patients may behave as if they were sick, for instance by simulating a 
disease without having an objective disorder or a subjective feeling of illness, 
and claim an entitlement pursuant to the Sickness Benefits Act [3]. Someone 
with chronic fatigue syndrome may experience himself as being ill (subjective) 
and try to qualify for a sickness benefit. This subjective experience, however, 
may not be acknowledged by the medical profession as (part of) an established 
syndrome, which is a formal criterion for granting a sickness benefit [4]. In [5] 
the patient has a specified disorder, behaves like someone with that disorder 
(for example, receives wages from her employer in accordance with the 
Sickness Benefits Act), but does not feel ill. Some patients feel ill and really 
have a specified disorder, but tend to act as if nothing were wrong [6]. Finally, 
[7] is the model patient, who experiences the illness (subjective), has a lesion 
as determined by medical criteria (objective), and behaves accordingly (sick 
role). 
It should be pointed out in passing that individuals need not be sick in order to 
show illness behaviour, and even illness behaviour alone can be pathological. 










attending doctor has the authority to grant a patient a sick role, and this role 
brings about two rights (a) and two obligations (b): a1) the right of exemption for 
the patient from his or her normal duties and a2) the right that the sick person is 
not held responsible for his or her sickness; b1) the obligation for the patient to 
seek medical professional help and b2) the obligation to comply with treatment 
in order to get well.  
Consequently, not only do doctors treat signs and symptoms; they also 
legitimise the social implications of disease. It follows that they serve a dual 
function: that of medical practitioners and that of social gatekeepers.  
To sum up, the psychiatrist, like other doctors, by way of achieving the goals of 
communication, prediction and control of treatment planning, has to fulfil the 
interactive roles of medical practitioner and social agent, with diagnosis as his 
or her indispensable tool.  
 
3.1.2 The nomothetic or classificatory approach to patients  
The act of classifying can be looked upon as a cognitive coping strategy: it 
enhances the chances of survival by reducing the chaos of incoming 
information to easily digestible, meaningful bits. Classification systems provide 
a fundamental reference frame in all sciences, “containing the concepts upon 
which theory is based and influencing what can and can not be seen” 
(Bogenschutz & Nurnberg 2000). The classification of diseases, or nosology, 
has always been an integral part of medicine. 
Nosology is the process by which medically relevant phenomena are sorted into 
categories in accordance with certain established criteria, for one or more 
purposes. Diagnoses are the primary categories of interest, referring to various 
concepts, ranging from a consistent cluster of signs and symptoms (syndrome) 
to the effects of a specified aetiological agent.  
Classification is necessary to provide a conceptual framework within which to 
place what is observed, to enable efficient communication about the conditions 
of illness, to predict outcomes, to guide general treatment decisions, and to 
keep records. These purposes can be summarised as communication, control, 
and comprehension. Psychometrically, they are substantiated by the 
procedures for establishing validity. 
Communication involves the use of names of categories as standard shorthand 
ways of summarising a great deal of information. For communication to be 
effective, there must be a high level of agreement among the users of a 
classification system. Control of disorders refers to the application of knowledge 
about their course with or without intervention, prevention or treatment, and is 
best supported by high predictability. Comprehension concerns more 
fundamental aspects of disorders, such as the process(es) involved in their 
origin, development and maintenance, and requires a high level of convergent 
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and discriminant validity (Zimmerman & Spitzer 2005). Medical classifications 
are relatively open systems of hypothetical constructs subject to falsification and 
further scientific inquiry. Meaningful research questions can be asked about 
them, which in turn influences the systems themselves.  
Despite its essential similarity to classification in the rest of medicine, 
psychiatric classification is often held as less ‘medical’ or scientific than it is in 
other branches of medicine, because mental disorders are generally of a 
typological nature, with less emphasis on clear boundaries than on the core of 
each disorder. Frantic attempts to correct this deprecatory judgement resulted 
in a paradigmatic shift from interpretative to empirically-based approaches, 
embodied, for example, in the Diagnostic Statistical Manual of Mental Disorders 
III (DSM-III) and its successors.  
Attempts, as in this thesis, to adequately classify mental disorders are at least 
as old as recorded history. They reflect the ideas of a particular epoch on the 
criteria and purposes of the classification of abnormal behaviour characterised 
by deviance, distress, dysfunction, and/or danger. Menninger compiled a 
compendium of these kinds of classification from ancient times to the modern 
era (Menninger 1963). From the many topics relevant to these classifications, 
we will elaborate on the meta-theoretical positions of nominalism versus those 
of realism, and of empiricism versus those of rationalism, on the theory of 
classification, and on the operational aspect of the increasing complexity of 
classification systems.  
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3.2 Meta-theoretical aspects 
Although of major importance, the ontological status of diagnostic categories is 
hardly ever discussed in psychiatry. The choice is between realism and 
nominalism. Realism assumes that an entity exists independently of its being 
named. Nominalism asserts that an entity has no reality independent of its 
name; diagnostic categories are cultural constructs, not independently existing 
entities. Since Plato, there has been an ongoing controversy between these two 
points of view. This centuries-old discussion is still recognisable, for example, in 
current policy-making papers on the financing of mental health care systems. 
Some of the authors of these papers consider psychiatric diagnoses as 
professional labels for problems of living (Kuypers et al. 2002), and for others 
they serve as real anchor points for reimbursement (managed care) (Maylath et 
al. 2006; Rushton et al. 2002). Whatever the results of this polemic, 
psychiatrists, in their roles as clinicians, social agents and scientists, must 
realise that patients fitting a certain type of diagnosis may be very different from 
one another in other relevant respects, that the social consequences of 
belonging to a diagnostic category are hardly evidence-based, that the general 
public tends to reify diagnostic categories, and finally, that diagnostic categories 
are in fact man-made typologies.  
In the approach to acquiring medical knowledge, there is an epistemological 
debate about which of two philosophical schools should predominate: 
empiricism, which stresses experience, or rationalism, which assigns primacy to 
reason. The debate can be traced back to classical Greece. In that epoch, both 
Hippocrates and Plato created a system for classifying disorders. Hippocrates 
developed a system based primarily on empirical observation, whereas Plato’s 
system was rooted in rational idealism. On the island of Kos, the Hippocratic 
School taught an individualised kind of medicine in which the patient was the 
primary focus of attention. On Knidos, from which Kos could be seen and which 
was located on the mainland of Asia Minor, the Platonic endeavours were first 
and foremost aimed at the elaboration of a nosology (Lindeboom 1971).  
After the Middle Ages, in which classification was predominantly a religious 
matter (punishment for sin or a test of faith), the Renaissance, and especially 
the Enlightenment, brought a revival of the scientific leitmotiv. Refinement of 
technical equipment (e.g., the microscope) and the growing independence of 
medicine from church and state gave rise to the practice of systematic 
observations and planned experiments, leading to the descriptive era. Thomas 
Sydenham, and later Carolus Linneaus and François Boisser de Sauvages, 
attempted to apply the taxonomic methods of biology to medical and psychiatric 
illnesses, with categories based on observed signs and symptoms. At the end 
of the 19th century, the apex of empiricist nosology was reached by Kraepelin, 
who conceived a classification system for psychoses based on extensive 
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observations in the newly established asylums. On the basis of his experiences 
with neurotic patients, Freud, on the other hand, developed a (psychodynamic) 
theory that guided his observations and interventions and that dominated the 
field of psychiatry for several decades. The influential psychiatric methodologist 
and philosopher Jaspers, a contemporary of Freud, summarised this approach 
aptly, as follows: 
 
“Die Wirklichkeit wird durch die Brille der Theorie gesehen. Es ist 
daher ständig unsere Aufgabe, von Theoretische Vorurteilen, die 
jederzeits in uns wirksam sind, absehen zu lernen uns zu üben, rein 
die Befunde aufzufassen.” (Jaspers 1973).  
(Reality is always viewed through the prism of theory. It is therefore 
our unceasing responsibility to find a way of resisting the influence of 
theoretical preconceptions, which are always active within us, and 
of applying ourselves to the understanding of observations in their 
untainted form.) 
 
Even though it eventually became obvious that both empiricism and rationalism 
were needed for adequate classification, Jaspers’ call for unbiased observations 
was interpreted in terms of a kind of superficial empiricism in the Anglo-Saxon 
countries. In other words, his phenomenological, or in-depth, version of 
empiricism according to which only beliefs about one’s own sensory experience 
are directly corroborated was generalised to the idea that beliefs about what we 
perceive in the physical environment should be directly confirmed by 
experience. As empiricism re-emerged in the 1950s under the influence of 
biological and epidemiological tendencies, it therefore took the form of 
superficial or neo-Kraepelinian empiricism, which was incorporated into what is 
now known as the DSM tradition. From a rationalistic point of view, however, 
the DSM-III and its successors are handicapped by the lack of an underlying 
theory, notably about aetiology. 
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3.3 Theoretical aspects 
3.3.1 Categories versus dimensions 
Classifications can be made in terms of categories or dimensions. In medicine 
(and consequently in psychiatry) the categorical model is traditionally preferred 
because practically, it implies that a certain disorder is either present or not 
present, and hence that a treatment should or should not be considered. If a 
diagnosis has been made for a patient, this means that his or her health differs 
qualitatively from a conception of a health norm. In a pure categorical system, 
all diagnostic criteria are necessary and sufficient to make a diagnosis. Patients 
with a given diagnosis are considered to be a homogeneous group in this 
respect.  
The categorical model, however, is increasingly being criticised. According to 
Craddock & Owen (2005) for example, the distinction between bipolar affective 
disorder and schizophrenia made by Kraepelin and accepted to the point where 
it is enshrined in current classifications, is now reaching the end of its useful life. 
On the basis of a review of the evidence from both epidemiological and 
molecular genetics research, they concluded that psychiatry would be better 
served if a spectrum or a dimension of functional psychoses were 
conceptualised. In such a dimensional model of classification there are no 
categories; individuals are described in quantitative terms along continuous 
factors that have a (more or less normal) distribution throughout the population. 
Because the dimensions are continuous, various intermediate measures 
between the two poles of the dimensions can be expressed quantitatively. In a 
multidimensional classification, individuals can be characterised by their 
position along a limited number of dimensions. Examples are the two-
dimensional system for depression and anxiety proposed by Goldberg and 
Huxley (1992) and the three-dimensional model for generalised anxiety, phobic 
anxiety and depression put forward by Ormel et al. (1995). 
Be this as it may, pathology in a dimensional system represents a statistical 
deviation from a quantitatively defined norm. Dimensional approaches are found 
in the DSM-IV with reference to axes II (personality disorders) and V (social 
functioning). Both the categorical and the dimensional model have advantages 
and disadvantages: the categorical model is informative as far as treatment and 
prognosis are concerned, whereas the dimensional model is better suited for 
shedding light on the overlap of syndromes and facilitating aetiological 
research.   
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3.3.2 Classification versus typology 
The fundamental elements of any classification are its commitments to theory, 
basic units and the criteria for ordering these basic units into a classification. In 
biological classification, for example, evolution supplies the theoretical 
orientation. Here, the goal is to make the basic units of classification identical to 
the basic units of biological evolution. Medical classification or nosology aims at 
predicting the maximum possible number of relevant facts about diseases. 
Psychiatric classifications ideally consist of mutually exclusive and jointly 
exhaustive hypothetical disorders (diagnostic categories) and also rules for 
making the diagnosis for each category. In a traditional system of classification, 
categories are defined by a number of individually necessary and jointly 
sufficient (or monothetic and conjunctive) criteria. So that they can be applied 
unambiguously, these criteria should be defined as operationally as possible, 
i.e. as measurable variables. Once the rules defining the category are applied to 
a case – a process called diagnostic classification, or in short, diagnosis – it can 
be determined whether or not this case belongs to a given category. Thus the 
boundaries of the categories are rigorously defined and individuals within such 
a category are homogenous with respect to the defining characteristics of the 
category. To meet the demand for mutual exclusiveness of the categories, 
larger categories of a superordinate level of abstraction are indicated, 
analogous to the genera, families, etc. in the classification of biological species, 
and a hierarchy is then imposed on the system. This kind of hierarchical 
categorical system works to the extent that the relevant classes have such a 
structure. Unfortunately, like many common object categories, most psychiatric 
illnesses do not have clear defining features. Consequently, modern psychiatric 
classifications have been based on typology. One or more, but not all (polythetic 
and disjunctive) features have to be present for membership of a category. 
Typology has been called ‘the opposite of true classification’ because it puts 
similar things together, rather than separating different things from one another 
(Bogenschutz & Nurnberg 2000). The typological view permits the existence of 
borderline and heterogeneous cases within a given category. Typal categories 
have clearly defined centres, but their boundaries are fuzzy. As far as hierarchy 
is concerned, it is not necessary for members of a subset to have all of the 
characteristics of the more inclusive set. The recession of the hierarchical 
approach in the transition from the DSM-II to the DSM-III and its successors has 
inevitably led to an increase in the prevalence rate of comorbid psychiatric 
disorders (Kessler et al. 1997).  
Because the prototypal model, to a greater extent than the categorical model, is 
widely regarded as resembling the way in which clinicians conceive of and 
actually use diagnostic categories in psychiatry, the DSM model in force is 
basically designed as a prototypal model. This fact has also led to a 
specification of former, more global categories, resulting in more explicit 
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separate diagnostic categories such as sleep disorders, somatoform disorders, 
and dissociative states, so that borders between categories are possibly 
emphasised where they should not exist.  
 
3.3.3 Classification – its recent history 
The demands of the authorities for statistical (census) data created the need for 
a classification of mental disorders in the 19th century. In the course of the 
1800s, the number of categories was increased from one (“idiocy/insanity”) to 
seven in 1880 (DSM IV 1994). In 1883 Kraepelin published his Kompendium 
der Psychiatrie, in which he first presented his nosology or classification of 
disorders, dividing mental illnesses into exogenous, treatable disorders, and 
endogenous, incurable disorders (Kraepelin 2007). He continued to refine his 
classification, issuing nine revisions of his psychiatry textbook, which grew into 
several volumes. In the sixth edition (1899), he first made the distinction 
between manic-depressive psychosis and dementia praecox, now called 
schizophrenia. His classification of mental disorders served as the foundation 
for the versions of the DSM and the International Classification of Diseases 
(ICD), used by psychiatrists today. 
Between 1920 and 1940, health economics, the increasing role of government 
in healthcare, and the military greatly facilitated the development of an 
unambiguous taxonomy of diseases, including mental diseases. The first 
international classification of mental diseases appeared in the sixth edition of 
the ICD (1948), published by the WHO. Because the mental diseases section of 
the ICD-6 was not found to be satisfactory in the United States, in 1951 its 
Public Health Service commissioned a committee to draw up an alternative to 
the mental diseases section contained in ICD-6, which resulted in the DSM-I in 
1952. Despite its significant impact and influence on American psychiatric 
literature, the DSM-I was not universally accepted as an official nomenclature. 
Although the WHO promoted an international effort to develop a system of 
classification for mental diseases which would improve the ICD-6 section and 
meet the requirements of all member nations, the two classification systems 
have co-existed and been developed side by side ever since. In ICD-8, 
individual syndromes and diseases are collected in homogeneous categories 
and organised in a mutually exclusive, hierarchical fashion. At the same time 
(1968), the new diagnostic manual, i.e. the DSM-II, was published, which was 
compatible with the list of mental diseases in ICD-8 but adapted for use in the 
United States. The DSM II was adopted by the American Psychiatric 
Association and officially accepted nationwide. The ICD-9 and the DSM-III were 
introduced in the early 1980s. The latter, which was published in 1980, brought 
in significant methodological innovations, such as a diagnostic algorithm based 
on clear defined criteria with rules for inclusion and exclusion, the system of the 
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multi-axial classification and the declared neutral attitude regarding the 
explicative theories, making it exclusively descriptive. 
Subsequent sharpening of the diagnostic criteria led to the publication of the 
DSM-III-R (1987) and the DSM-IV (1994), parallel to the WHO publication of the 
ICD-10 in 1992. Their respective nosographies have become more 
homogeneous and, consequently, more comparable.  
At present the ICD-10 is widely used in Europe. In the United States, however, 
the changeover to the ICD-10 was complicated by the fact that the ICD-9-CM 
(Clinical Modification) was part of the hospital billing system. The U.S. National 
Center for Health Statistics has set a deadline, as recommended by the 
National Committee on Vital and Health Statistics, for the adoption of the 
current revision of ICD-10-CM, which was pre-released in autumn 2003. 
Parallel to this evolution, modern psychopharmacology and genetic research 
continue the search for the core of psychopathological processes with ever-
more powerful investigational instruments.  
 
3.3.4 Classification – advantages and disadvantages 
Given the potential clues for treatment offered by a diagnostic classification, we 
must not forget that assigning patients to diagnostic categories has limitations 
and potential ill effects.   
Attitudes to psychiatric classification have undergone a revolution in the past 
few decades. From the 1950s to the 1970s, psychiatric diagnoses were held in 
low esteem and some of the rationales of this judgement can still be heard 
today. Psychiatric diagnoses were, and sometimes still are, considered a very 
inadequate means of conveying what the clinician believes to be the essence of 
a patient’s misery. Also, many psychiatric diagnoses have pejorative 
connotations, which might prejudice the attitude of other people to the patient 
and so the attitude of the patient to him- or herself. Furthermore, attaching a 
name to a condition may give rise to a spurious sense of understanding; some 
clinicians reify a diagnostic concept and treat the disease instead of trying to 
relieve their patients’ burden. The greatest danger posed by classifications is 
the potential reification of hypothetical approaches, arbitrary categorisation and 
the dulling of reflection, all of which have created a need for regular revisions 
underpinned by field trials (Lemperiere 1995). Furthermore, before the 1980s, 
the reliability of psychiatric classification was known to be low (Beck 1962; Ward 
et al. 1962a), and, as confirmed by the US-UK study, key diagnostic terms like 
schizophrenia had different meanings in different parts of the world (Andreasen 
1989).  
In the 1980s the attitude towards psychiatric classification changed radically. 
This shift might be partially explained by the rise of the biologically (at the 
expense of the sociologically) oriented approach to deviant behaviour, and 
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partially by the attempts of psychiatry to improve the scientific foundation of its 
classification systems. On balance, this resulted in the development and 
worldwide acceptance of the DSM-III and its successors. 
This remarkable change of attitude towards classification reflects the transition 
from emphasis on the shortcomings to emphasis on the strengths of the 
classificatory system. These strengths and shortcomings are intrinsically related 
to the essential purpose of classification: to distinguish between characteristics 
of patients. Every patient possesses characteristics of three kinds (Kendell 
1975b; Kendell 1993): 
- those, he/she shares with all other patients; 
- those, he/she shares with some other patients, but not all; 
- those which are unique to him/her. 
In so far as the first of these three categories is dominant, classification is 
pointless, since it results in just a single category. To the extent that the third 
category is dominant, classification is impossible, as every category contains 
just one individual. As soon as one begins to recognise features that apply to 
some patients but not to all, and to distinguish those that are important from 
those that are not, one is classifying them. If we want to use different treatment 
strategies with maximum efficacy, we have no alternative but to distinguish 
between one type of patient and another. A distinction between different kinds 
of mental disorders, consequently, is inevitable in any situation in which groups 
of patients need to be considered. As classifications of mental disorders are still 
largely based on differences in symptomatology rather than on differences in 
aetiology, we must try to improve the classification systems we possess. A 
future classification should be more transparent, stable, and valid (Kendell 
1993). 
Another important but often disregarded question we would like to put is 
whether a classification system can be used for the general population or is it 
meant only for clinical (sub)groups. This question has to do with the basic 
problem of defining ‘caseness’. After all, traditional psychiatric classifications 
are based on symptoms of patients encountered in psychiatric hospitals, and 
one may ask whether these symptoms are representative of individuals in the 
general population.  
 
3.3.5 The psychopathological spectrum 
As mentioned previously, the central pillar of epidemiology is the condition, 
which has to be defined unambiguously in a case definition. This central 
question of ‘what is a case’ (diagnosis) is as old as mankind. As a major need 
even in ancient medical practice, case definition has undergone transitions from 
simplicity, resulting in a dichotomy (healthy and ill or believer and doomed) to a 
system in which biological, psychological, sociological, religious and political 
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screening filters, under the influence of technical refinement and treatment 
potential, play a role, that has resulted in a set of hundreds of more or less 
distinguishable disease entities. This situation has of course given rise to the 
phenomenon of more than one diagnosis for a given person at a given time 
(comorbidity) (First 2002). 
The art of healing (and consequently of diagnosis) is one of the oldest 
intellectual attainments of human beings and it arose from human limitations, 
need, self-protection, and the urge to help one’s fellow human being (Magner 
1992). The ancient Greeks established intellectual traditions that provided the 
foundations of Western philosophy, science and empirical medicine. In contrast, 
for example, to the ancient Indian, Chinese, and Egyptian civilisations, the 
Greeks managed to separate medicine from religion and placed disease on a 
far more rational basis. For more than one thousand years after this period, no 
important new insights into medicine were developed, and the 
psychopathological spectrum remained restricted to the major entities of 
psychosis and depression. In the Middle Ages, these were perceived as a 
punishment for sin or a test of faith and diagnosis was therefore predominantly 
a religious matter. The Renaissance, and especially the era of enlightenment, 
brought about veritable revolutions in the understanding of the origin of 
diseases, but this did not result in an adjustment of the psychopathological 
spectrum. It was not until the mid-19th century, with the development of 
pharmacology, cell pathology and bacteriology (Pasteur), that organic 
syndromes were added to the psychopathological spectrum, with dementia 
paralytica as the most elaborate example. Under the influence of 
psychoanalysis, this was followed at the beginning of the 20th century by a 
broadening of the scope to include neurotic and reactive states. 
In the last decades of the 20th century, the spectrum was updated with case 
definitions of dissociative states, various sleep disorders and somatoform 
disorders.  
This expansion of the range of psychopathology can be logically explained in 
terms of the shift of emphasis in the diagnostic process. Formerly, the use of 
specific diagnoses had been exclusively dependent on the clinical impressions 
of authorities in the clinical field (face validity). This practice changed in the last 
decades of the 20th century, since in response to the demand for transparency 
and public accountability, there was a requirement for diagnoses to be defined 
as operationally as possible, i.e. they were to be measurable. 
Another explanation for the extension of psychopathology is that the clinical 
view is not unambiguous. In the 1950s, making a specific diagnosis was the 
domain of a clinical specialist, with his or her high-powered credentials, but 
narrow view. In addition, these specialists worked almost exclusively with in-
patients. Today, general practitioners are the gatekeepers of specialised 
(mental) health care, and the vast majority of psychiatrists work with out-
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patients. Both of these factors have resulted in a different frame of reference 
from that of the clinical psychiatrist of the 1950s. The GP now sees a different 
category of patients, who present sub-clinical manifestations or precursors of 
the “real” diseases, and he or she applies correspondingly different professional 
standards in dealing with them. The above-mentioned requirement for 
transparency and public accountability also resulted in an emphasis on 
prevention and primary care when possible, whereby the importance of 
extending the scope of what is defined as ‘not normal’ was stressed. 
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3.4 Operational aspects 
3.4.1 Operational methods of diagnosis 
In practice, disease categories are inseparable from the means of diagnosing 
them, and the diagnostic algorithm should reflect the ‘true’ structure of the 
disorder as much as possible. The optimal diagnostic algorithm would be 
achieved through the use of an infallible criterion that is pathognomonic for the 
disorder in question. Down’s syndrome, for instance, can be diagnosed 
unequivocally by a karyotypal demonstration of the presence of all or part of an 
extra 21st chromosome (trisomy 21). Unfortunately, in psychiatry, there are 
hardly any true gold standards. Consequently, categorical diagnoses 
concerning mental disorders are made with the aid of a number of diagnostic 
criteria, each of which is thought to be correlated with the disorder, but none of 
which is necessary or sufficient to conclude that the individual in question has 
the disorder. The diagnostic algorithm in psychiatry proceeds from signs and 
symptoms through syndromes to disorders and diseases. Signs and symptoms 
are the basic units and syndromes are sets of symptoms that co-occur at a 
greater than chance frequency. A disorder is the manifestation of the 
conjunction of a syndrome with a clinical course, although the underlying 
causes remain obscure. In psychopathology, the term disease is reserved for 
situations in which signs and symptoms, pathology, underlying causes, and 
their connections are known. Progress in understanding pathology is like an 
archaeological process in that the ‘digging’ proceeds from the superficial signs 
and symptoms to the underlying disease. A precise understanding of syndrome 
and pathology course furthers the discovery of mechanisms and causes. The 
separation of Down’s syndrome from the more general category of mental 
deficiency, for instance, facilitated Lejeune’s discovery of the underlying 
aetiology – trisomy 21 (Lejeune et al. 1959). This kind of constructive distinction 
is difficult to make in psychiatry because of the prototypal character of the 
categorical system, in which similarities are looked for instead of differences. 
Until the 1950s, the most widely used method in the process of diagnosis was 
the free-ranging interview, like the classical psychiatric examination. This 
method is prone to a number of typical errors (De Bruyn et al. 2003; Kreitman et 
al. 1961; Kreitman 1961), of which two examples follow: first, although people 
(whether of not professionals) are able to adequately estimate the difference 
between certain (psycho)physical stimuli (McDowell & Newell 1996), in general, 
they perform poorly when it comes to assessing, considering, or revising their 
estimations; second, in the daily judgements that people make, often they do 
not use reason in strict accordance with logic, or else they leave relevant 
information out, or make use of irrelevant information. Even when someone has 
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all the relevant information that is available, the process of modification of 
estimations in the light of the new material does not proceed optimally.  
It is for these reasons that the information gathered with the free-ranging 
interview, though clinically relevant, is too much influenced by subjective factors 
and therefore uncommunicable. This fact limits scientific usefulness, which is 
unacceptable to the psychiatrist-epidemiologist, about whom Cooper said that 
he or she should choose (diagnostic) variables that are not only clinically, but 
also scientifically, relevant (Cooper 1979). Diagnostic instruments in psychiatry 
ought to be diagnostic algorithms that have been constructed in such a way that 
they are transparently operational. The recognition of the aforementioned 
shortcomings, together with the improved classification systems, encouraged 
the development of a diagnostic instrument with better psychometric properties, 
without detriment to the clinical perspective. 
 
3.4.2 Diagnostic instruments 
With a view to making the process of classifying mental disorders operational, 
various instruments have been designed in the past few decades. The two most 
important general diagnostic instruments today are the Schedules for Clinical 
Assessment in Neuropsychiatry (SCAN) (Janca et al. 1994; Wing et al. 1990; 
Wing 1996), which includes the tenth version of the Present State Examination 
(PSE-10), and the Composite International Diagnostic Interview (CIDI) (Robins 
et al. 1988), the successor to the Diagnostic Interview Schedule (DIS). In 
contrast to their predecessors, both the PSE-10 and the CIDI can be used for a 
diagnostic classification with reference to the DSM-IV and ICD-10; a computer 
programme generates diagnoses from the item scores, in a consistent way. 
The two essential differences between the SCAN (and the PSE), on the one 
hand, and the CIDI (and the DIS), on the other, are the semi-structured 
character, including clinical judgments, and the bottom-up approach of the 
SCAN/PSE versus the fully standardised character without clinical judgment 
and the top-down approach of the CIDI/DIS (Ustun & Tien 1995). In the 
SCAN/PSE tradition, the interviewer keeps asking questions about a specific 
symptom until he or she is satisfied with the answer as to its presence or 
absence and its severity, without consideration of a possible diagnosis. Only a 
trained clinician can perform this kind of ‘cross-examination’, and he or she 
does so on the basis of an extensive manual, in which the psychopathological 
concepts are clarified and criteria are defined for the presence of symptoms. 
These criteria rest on three underlying notions about psychiatric symptoms: the 
patient is suffering from the symptom; the severity of the symptom is not 
proportionate to the circumstances in which it occurs, and the patient is not in 
control of his or her symptom, i.e. she is not able to put it out of her mind. 
Fundamental for the SCAN/PSE tradition, consequently, is the symptom-based 
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approach, which corresponds to the definition formulated by Leighton: 
Behaviour of Psychiatric Interest’, (which) can be seen as a set of basic units 
out of which the recognised syndromes are assembled, much as the notes of 
the music scale are combined to make melodies (Leighton 1979). In contrast to 
the SCAN/PSE, clinical experience is not necessary to administer the CIDI/DIS. 
Clinical judgment in the CIDI/DIS is replaced by questions concerning help-
seeking behaviour of the patient, medication and hindrance. Furthermore, the 
CIDI/DIS checks for the presence or absence of syndromes as a whole (as 
classified by the DSM or ICD system), while the SCAN/PSE checks for each 
individual symptom. These differences favour the CIDI interview in that it is less 
expensive than the SCAN interview, and consequently the CIDI is the 
epidemiological instrument of choice for large general population surveys. 
As low-cost alternatives for interviews, there are numerous self-administered 
questionnaires, for example the well-known General Health Questionnaire 
(Furer et al. 1995b; Goldberg & Williams 1988; Koeter & Ormel 1991b). 
Although questionnaires result in an assessment of severity, albeit rough, and in 
a limited diagnostic domain with certain questionnaires, they can not be used to 
establish signs and symptoms and syndromes, let alone a diagnosis. Some 
questionnaires approximate caseness, for example when a cut-off point is used. 
Each approach has its pros and cons. Symptom-based instruments, such as the 
SCAN/PSE, have two advantages: their nature is such that they can survive 
changes in diagnostic classifications, and they are quite comparable to the 
clinical process(es) involved in diagnosis-making, in that they compensate for 
the patient’s lack of illness awareness. A disadvantage is that the interview is 
costly, since it can be performed only by well-trained professionals and 
clinicians and it is time-consuming (on average it takes about 90 minutes to 
administer). Diagnostic instruments for epidemiologic surveys, like the CIDI/DIS, 
have the advantage that they are suitable for use in large-scale surveys since 
they are cost-effective. The cost saving arises from the fact that lay interviewers 
are used and these instruments take on average only about 60 minutes to 
administer. There are two disadvantages to these fully standardised 
approaches: first, not all positive ratings necessarily denote the presence of a 
clinical symptom, but rather the subjective experience of a malaise, and second, 
there is a risk of false negatives with respect to symptom identification because 
of their top-down structure, or the subject’s lack of illness awareness. In large-
scale surveys, when underlying relations are investigated, false positives and 
negatives can be seen as noise, on the assumption that there is no biasing 
systematic effect. Finally, a major disadvantage of general questionnaires is 
that a diagnosis can not be made on the basis of the results obtained from 
them. Their strength lies in the fact that they can be used as a convenient and 
cheap means of screening people at risk from mental disorders in general 
population surveys. 
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3.5 Psychometric evaluation of diagnostic procedures 
The main question before us now is, do current standardised psychiatric 
instruments successfully reflect an explicit and accepted definition of mental ill 
health. The issue here is validity: the assessment of whether a measurement 
really measures what it is supposed to. This matter is particularly important, as 
in real life, people have a personal stake in the estimation of their mental health. 
Someone who is learning to shoot must first learn to hit the centre of the target, 
and then learn to do this consistently. This metaphor is analogous to the 
situation regarding the validity and reliability of a diagnostic procedure or 
diagnostic measurement (McDowell & Newell 1996). The consistency (or 
reliability) of a diagnostic procedure can be compared to the closeness of 
successive shots to one other in the target area. Validity can be likened to the 
target that is being aimed at – the closeness of the shots to bull’s eye. Ideally 
the shots should cluster in the centre of the target (reliable and valid), but for a 
marksman who is consistently off target they would cluster at a distance from 
the centre (reliable but not valid). 
A third psychometric quality of instruments is their responsiveness or sensitivity 
to changes in the state of the subjects of interest, described as “an instrument’s 
ability to detect clinically important changes in patient status” (Deyo & Patrick 
1989). The SCAN/PSE is based on an assessment of the clinical relevance of 
symptoms. Since the SCAN/PSE is relatively independent of the classification 
system in use, it can be expected to incorporate this capability. Since 
measurement of change (from 1983 to 1997) was one of the goals of this study, 
we will elaborate on this item. 
 
3.5.1 Assessment of validity 
Validity of measurement is an even greater concern than reliability of 
measurement. After all, what is the good of being consistently wrong? (Gould 
2002; McDowell & Newell 1996) Health and illness are complex phenomena 
that are not directly accessible to measurement. All health measurement 
instruments can be looked upon as indicators of hypothetical health constructs 
embedded in a theoretical network of other health-related constructs (König-
Zahn et al. 1993). In other words, as Carmines and Zeller stated (1979), 
(health) measurement is a process of linking unobservable theoretical concepts 
to empirical indicators. According to a broad definition (McDowell & Newell 
1996), validity describes the range of interpretations that can be appropriately 
put on a measurement score: what can we conclude about a person with a 
particular score on a measurement instrument? This general definition has 
advantages and disadvantages as compared with the commonly used more 
specific definition of validity as the extent to which an instrument measures what 
it is intended to measure. The broad definition may stimulate a search for 
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interpretations of an indicator outside the intended scope of the instrument, 
which may lead to questions about alternative possibilities, and hence to the 
discovery of links between constructs that were previously thought to be 
independent. It may also yield valuable insights into the scope of instruments. 
Dementia screening tests, for instance, are valid in that they succeed in their 
purpose of identifying cognitive impairments, but they also appear to detect 
people with little education, which suggests that the tests are a less specific 
indicator of cognitive functioning. The validity of an instrument should always be 
measured against its purpose (Carmines & Zeller 1979). If we want to know the 
prevalence of treatable diseases, we should use instruments that were devised 
from a clinical perspective; however, a questionnaire that is internally valid 
might generate results that at first glance are similar to those obtained from 
such instruments. A disadvantage of broadening the definition of validity is that 
that could give rise to carelessness in defining the precise purpose of a 
measurement. Because of this, much time has been wasted, for example, on 
speculation about what certain psychological well-being scales are actually 
supposed to measure. This pitfall can best be avoided through closely linking 
the validation process to a conceptual formulation of the aims of measurement 
and also linking such a formulation to other, related concepts so that the 
possibility of alternative interpretations of scores can be taken into account.  
The three most frequently used methods of validity testing, i.e. construct, 
criterion, and content validity, will be discussed briefly. Face validity is not 
considered by most experts as a true type of validity. In the case of a measuring 
instrument, most authorities in the field view it instead as giving a first 
impression of the comprehensibility, the clarity and the appropriateness of the 
questions of the instrument. 
 
3.5.1.1 Construct validity 
The crucial feature of scientific research is the measurement of abstract 
concepts (constructs) and their relationships to other abstract concepts. From 
this perspective, validity can be described as the degree to which the score 
obtained from an instrument, which is an empirical indicator for a theoretical 
concept, actually represents the concept of interest. In fact, of all three types of 
validity, construct validity is all-embracing and the most complex, and is 
therefore a never-ending process. With construct validity, two different types of 
testing are conducted – convergent and discriminant validity testing. The first 
tests whether the outcomes of the instrument under study are highly correlated 
with measured values of indicators of equal usefulness for the same health 
construct. In contrast, the second tests whether there is a low correlation with 
measured values of indicators used for different health constructs. 
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3.5.1.2 Criterion validity 
Criterion validity asks whether the measure compares well with external 
standard measures (so-called gold standards). There are two subtypes of 
criterion measures, the predictive and the concurrent measure. The first asks 
whether the test accurately predicts behaviour in the true situation, e.g. does 
the ability to learn new or uncommon words predict the ability to learn foreign 
languages at school? The validity coefficient is a measure of the relationship 
between scores on the prediction test and on actual performance in the criterion 
situation (Gould 2002). The second type, concurrent validity, measures the 
correlation between the test under study and another assessment of the 
situation carried out at the same time, e.g. the correlation of a new test of 
depression and a well-known valid assessment tool, i.e. a gold standard.  
 
3.5.1.3 Content validity 
With content validity the key question is, how representative are the test items 
of the content of the health construct. There are two standards by which content 
validity is assessed: the representativeness of the collection of items chosen 
and the type of test construction used to measure the concept. Content validity 
is considered to be less objective than criterion validity. There is no specific 
statistical means of testing content validity, and so reason or else a consensus 
among experts must be relied on as regards the representativeness of the 
content. 
 
3.5.2 Assessment of reliability 
Reliability is defined as the consistency or stability of the measurement process 
across time, respondents or observers (Gould 2002), and should not be 
confused with a term like trustworthiness. Although consistency of 
measurement describes the phenomenon in a more unambiguous way, 
reliability is the most widely accepted term, and consequently is used here. 
There are many sources of measurement error, and, put simply, each measure 
is the summation of the true score, the constant (or systematic) error, and the 
variable (or random) error. Systematic errors (or biases) are more a validity then 
a reliability issue, and are therefore generally considered in the context of 
validity testing. 
Random errors are inaccuracies that may, in equal measure, lead to an over- or 
underestimation. Random error is formally defined as the proportion of 
observed variation in scores that is equally distributed over the low and the high 
side of the true score. It may be due to inattention or fatigue on the part of the 
rater or mechanical inaccuracy of the test instrument. McDowell and Newell 
(1996) cite three different types of reliability testing. The first type tests whether 
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different raters assessing the same respondent obtain the same result (inter-
rater agreement). Such agreement often leads to an overestimation of reliability, 
for example when one person performs the interview and also does the scoring, 
while a second person only rates the answers to the questions put in the 
interview. In this case, the differences in interview techniques are eliminated. 
This disadvantage can be overcome by a second type of testing, namely having 
the respondent re-interviewed after a brief interval by each of the raters 
separately. In this test-retest procedure, reliability is underestimated as there is 
a difference in time between the two interviews. Moreover, the respondent 
might react differently during the second interview, resulting in a lower reliability 
score, if only because the same test is being performed twice. The same 
applies to the third type of test, the intra-rater reliability test, which assesses 
whether the same result is obtained when the same rater makes a second 
assessment of the same respondent (McDowell & Newell 1996).  
Gould (2002) adds more sophisticated techniques to the aforementioned tests, 
such as the alternate-forms technique (calculation of the correlation between 
two successive measures on two different, but equivalent, versions of the same 
test) and the split-half technique (calculation of the correlation between two 
simultaneously obtained measures from equivalent halves of a single test). 
Combinations of the aforementioned techniques are often used in testing the 
reliability of new interviews and questionnaires.  
Kendell addresses three methodological principles for improving reliability 
(Kendell 1993):  
 
1. structured and standardised instruments should be used; 
2. all symptoms and signs that are determined should be well defined in such a 
way that the rater understands the definitions;  
3. any algorithms that are used should be transparent and unambiguous.  
 
It goes without saying that the way in which an instrument is presented or used 
is crucially important to its reliability. When interviewers perform a semi-
structured interview, as in our study for example, they should be experienced 
not only in interview techniques, but also in the psychopathology to be 
determined.  
Another way, in fact the most commonly used way, of improving reliability is to 
create a high internal consistency among the set of items to be measured. Such 
consistency is a powerful property that manifests itself in increased repeatability 
and consequently increased reliability. But as this factor often reduces the 
scope of an instrument, it mostly improves reliability at the cost of a decreased 
clinical validity and also of a lower content validity. Hence there is an equilibrium 
between validity and reliability; to be valid, a measurement must be highly 
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reliable, but too high a reliability score as a result of an extremely high internal 
consistency, on the contrary, might compromise the validity. 
 
3.5.3 Sensitivity to change 
Sensitivity to change (or responsiveness) refers to the change scores obtained 
with a health status instrument, as if it were a screening test for the detection of 
true change, e.g. in the measurement of responsiveness to a certain 
treatment(Deyo et al. 1991; Deyo & Inui 1984; Deyo & Patrick 1989; Fitzpatrick 
et al. 1998). Guyatt (1989) defined responsiveness as the ability of an 
instrument to detect clinically important change. In a strict sense, this procedure 
is meant to measure the sensitivity to change over time in a specified group or 
cohort. Generally speaking, scale data are preferred over ordinal data, and both 
are preferred over frequency data because of their greater precision of 
measurement and hence sensitivity (Gould 2002). From this point of view, 
caseness as a measurement result from the SCAN/PSE is not a sensitive 
measure for assessing change, as it is binominal in character. On the other 
hand, in many psychiatric epidemiological studies, measurement of caseness 
has been used in the general population, with frequency data as a result. 
Together with the large numbers of respondents, this approach generates 
sufficient power for analysis.  
Finally, it is important to realise that most diagnostic instruments (like the SCAN 
and the CIDI) measure over a 1-month reference period for most disorders, but 
not for example, for somatisation and disorders related to substance use, which 
require a much longer reference period. Consequently, in this regard, sensitivity 
to change for the two last-named disorders is different from what it is for, for 
instance, depressive disorder, especially when the time interval between the 
two surveys is relatively short in relation to the reference period. This means 
that a protracted interval in a repeated cross-sectional survey conduces to a 




In this study, the Nijmegen Health Area 2 project (NHA-2), we chose to use the 
SCAN-2.1 as an instrument in the PSE tradition for the following reasons: first, 
we believed it would enhance the comparison with the data obtained in the first 
project, in 1983; second, it fulfilled the requirement that the psychiatrist-
epidemiologist should choose his or her instruments and variables not only for 
their clinical, but also for their scientific, usefulness (Cooper 1979). 
Furthermore, since in real life people have a personal stake in the estimation of 
their health, the SCAN/PSE, with its observer-based approach, provided us with 
a professionally oriented assessment. referral 
The SCAN-2.1 covers almost the total psychopathological spectrum and its 
psychometric properties are highly acceptable (Andrews et al. 1995; Tomov & 
Nikolov 1990), as will also be proved in this thesis. Finally, in the Netherlands 
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4 Research objectives 
4.1 Introduction: case finding and case identification 
To summarise the theoretical background of chapters 2 and 3, although the 
application of epidemiological methods in psychiatry is a relatively recent 
development, it is of scientific importance in exploring the prevalence rate and 
distribution of psychiatric disorders, improving etiological understanding and 
enhancing treatment, prevention and planning in psychiatry. Whatever the 
objective, it is essential that prevalence rates should be not only reliable, but 
also valid; in other words, prevalence rates must be clinically relevant. 
Psychiatric epidemiology turns around the question of what condition occurs in 
whom, where and when. If this question is to be answered properly, the whole 
complex of case definition, case identification and case finding has to be taken 
into account. In the previous chapters, we discussed in detail the various 
aspects of the principles that subtend these phenomena. The following 
definitions apply in the rest of this thesis:  
• case definition: the theoretical concept underlying ‘what is a case’, based 
on the presence of a specified set of signs and symptoms. Case definitions 
are ordered in a classification system, on the one hand by describing the 
boundaries of each case and thus the distinctness of each case with respect 
to all the others, and on the other hand, by sorting cases into categories 
through matching characteristics; 
• case identification: the operationalisation of a theoretical diagnostic 
concept or classification system on the basis of a detailed description; 
• case finding: the application of case identification in a population study. 
 
Epidemiology can contribute to improved communication, control, and 
comprehension only if case definition is valid and unambiguous, if case 
identification is based on clinical relevancy and if the process of case finding is 
reliable and valid. Notwithstanding, reliability and validity in psychiatric case 
finding have been and still are called into question. Prevalence rates are often 
not as important or clinically relevant as they seem to be at first glance. 
Although questionnaires and fully standardised interview instruments are 
frequently used for case detection in general population surveys, questions can 
be raised about their clinical validity. On the other hand, clinical interview 
instruments are time-consuming and expensive when used on a large scale and 
are often said to lack reliability, although the results of several studies challenge 
this claim.  
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4.2 Descriptive epidemiology, i.e. case finding: the 
prevalence and distribution of identified cases 
Many of the subjects raised in the preceding theoretical chapters have played a 
role in the decisions taken with reference to the design of both the Nijmegen 
Health Area-1 (NHA-1) and the NHA-2 study. Both of these are descriptive 
epidemiological case finding studies in the general population of the Dutch 
Health Area of Nijmegen and they are harnessed to one another in a repeated 
cross-sectional design. In deciding upon the interview instrument to be used in 
these studies, sitting on the shoulders of Jaspers, we followed the empirically 
based, phenomenological clinical tradition. This states that observations should 
be unbiased, which calls for a theory-free, bottom-up approach to the 
assessment of symptoms, rather than the assessment of symptoms within the 
framework of a specific psychiatric syndrome or classification system. Because 
the ninth version of the Present State Examination interview (PSE-9) had been 
used for the NHA-1, for the NHA-2 it was decided to use the Schedules for 
Clinical Assessment in Neuropsychiatry (SCAN-2.1), as the latter instrument is 
the successor to the PSE-9 and contains the PSE-10 interview. The use of the 
SCAN-2.1 gave us the opportunity to convert the scores of the latter so that it 
fitted into the format of the PSE-9 interview algorithm. This conversion made 
possible a meaningful comparison between the years 1983 and 1997 with 
reference to the PSE-9 data, as an example of monitoring (see chapter 5), in 
addition to the comparison with reference to the more general GHQ data (see 
chapter 11.1). 
Thanks to its bottom-up approach to the evaluation of psychiatric signs and 
symptoms, the SCAN-2.1 made it possible to assess the supplemental 
epidemiological value of three additional diagnostic categories relatively newly 
determined in the general population: dissociative disorders, sleep disorders 
and somatoform disorders (see chapter 6). 
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4.3 Diagnostics: case identification 
As the WHO had recently designed the SCAN-2.1, we had to establish the 
psychometric properties of the SCAN interview instrument before using it in our 
field study (see chapter 7).  
One of the advantages of the SCAN-2.1 is that in addition to the registration of 
the absence of a sign or symptom (“0”), the scoring algorithm allows a clinical 
interpretation of each sign or symptom that is present; specifically, a sub-clinical 
presence can be scored as “1” and a clinical presence as “2” or “3”. The 
qualification sub-clinical (“1”) in particular made it possible to study the 
properties of the SCAN-2.1 with respect to clinical decision-making (see chapter 
8).  
Finally, sound policy-making must be based on reliable and valid data. 
Increasingly, transparency and accountability are required in the framework of 
the evidence-based approach. We therefore have to know what the 
epidemiological data actually add to the existing body of knowledge and 
whether they really reflect the extent of the presence of the clinically relevant 
psychiatric disorders in the general population. Since a number of surveys 
generate quite different prevalence rates, the results of the CIDI and the SCAN, 
these being the major representatives of the two psychiatric interview traditions, 
were directly compared with one another (see chapter 9). 
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4.4 Research questions 
This thesis uses descriptive epidemiological data generated by the SCAN-2.1 
by way of focusing on the relevance of clinical judgement in psychiatric 
diagnoses, the objective being to improve the quality of the diagnostic process 
and consequently of the quality of epidemiological data.  
 
 
Part II: Descriptive epidemiology, i.e. case finding: the prevalence and 
distribution of identified cases 
In chapter 5 (monitoring) the primary question that we address is whether the 
prevalence rate of neurotic and functional psychotic disorders and their 
distribution changed over the period 1983 to 1997. In this chapter, we set out to 
answer the following, more specific questions: 
 
1. What were the prevalence and distribution of psychiatric disorders in 1983 
and 1997? 
2. What were the shifts in psychiatric prevalence and its socio-demographic 
distribution between 1983 and 1997?  
3. If there was a shift, how could it be explained in terms of time trends (age, 
cohort and period effects)? 
In chapter 6 the NHA-2 project of 1997 is described as an example of mapping. 
In this chapter, we attempted to answer these questions:  
1. What were the prevalence rate and the distribution of the total range of 
psychiatric monomorbid and comorbid disorders in 1997? 
2. What is the additional value of the three diagnostic categories, which can be 
regarded as an expansion of the diagnostic range determined in the general 
population with DSM-IV en SCAN-2.1? 
 
 
Part III: Diagnostics: case identification 
In chapter 7 the psychometric properties of the SCAN-2.1 are described. The 
specific questions requiring an answer are: 
1. Can the semi-structured, clinically oriented SCAN-2.1 interview be reliably 
applied in a stratified sample of the open population? 
2. What is the validity of the SCAN-2.1 diagnoses, given the standard score of 
experienced clinical psychiatrists?  
To make clinical judgement operational, it is important to recognize the aspects 
of signs and symptoms that should be clinically assessed in the process of case 
identification. In chapter 8, the following questions about clinical decision-
making in SCAN-2.1 are answered:  
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1. Does clinical judgement, as operationalised in the SCAN-2.1, make a 
difference?  
2. What is the effect of the scores for the sub-clinical items (illness but not 
disease) upon the prevalence rates? 
In order to improve our understanding of the common finding that fully 
structured interviews in the general population consistently give rise to 
discrepant findings in comparison with clinically oriented psychiatric diagnostic 
interviews, in chapter 9 we report the outcome of a direct comparison of the 
results of the SCAN with the results obtained with the CIDI. We set out to 
answer the following questions: 
1. In what respects do results obtained with the SCAN-2.1 and the CIDI agree 
and differ with reference to the same subjects, chosen from the open 
population?  
2. What is the influence of clinical judgement in this regard? 
 
Part IV: Discussion and conclusions 
In chapter 10 we summarise and discuss the epidemiological outcomes and the 
results with respect to the use of clinical judgement in interview instruments. 







5 Monitoring: Psychiatric disorders in a Dutch 
health area – a repeated cross-sectional 
survey with the PSE 
5.1 Introduction 
Time and again it has been suggested that the prevalence rate of psychiatric 
disorders is rising owing to the noxious factors that characterise the way of life 
in modern society. Many aspects of contemporary life, such as increasing 
urbanism, mounting bureaucratisation and governmental regulation, and the 
rapidity of social change in the spheres of family life and work, are viewed as 
creating psychological difficulties for people. There is also evidence to the 
contrary. For example, in spite of the numerous social changes in Stirling 
County between 1952 and 1970, Murphy et al. (1984) found a stable point 
prevalence rate of depression and anxiety disorders. Likewise, Nandi et al. 
(2000) reported an unchanged overall level of psychiatric morbidity over twenty 
years in a rural Indian community, but an interesting alteration of the morbidity 
pattern: the rates of anxiety, phobia and hysteria had fallen dramatically and 
those of depression and mania had risen significantly. In London, Bebbington et 
al. (1981; 1997) even found slightly lower rates than those they had determined 
in the 1980s. On the other hand, there was a rise in 1-year psychiatric 
prevalence rate from 20% to 28% between the two waves of the 
Epidemiological Catchment Area (ECA) cohort study in the USA (Regier et al. 
1998). The diagnostic validity of the latter results has been questioned as they 
were generated by lay interviewers administering fully structured diagnostic 
instruments instead of by experienced clinicians using a semi-structured 
interview (Cooper & Singh 2000). Some feel that self-report interviews capture a 
wider range of trivial or less severe symptoms and disorders than a psychiatrist 
would, and that the high estimates of prevalence rates are biased (Eaton et al. 
2000; Frances 1998). 
Studies on the question of whether psychiatric prevalence is declining, stable, 
or increasing are fraught with methodological difficulties. While a prospective 
cohort study has the obvious advantage of consistency as far as the population, 
the diagnostic system, and the measuring instruments are concerned, secular 
population changes cannot be examined adequately that way, because the 
cohort ages over time. A repeated cross-sectional survey, on the other hand, 
does offer that possibility, but with the disadvantage of a relative incomparability 
of the study populations, the diagnostic systems, and the measuring 
instruments. Because of these difficulties, there are few studies that compare 
community psychiatric surveys carried out in the same area at different points in 
time.  
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Despite the widely differing reports of psychiatric prevalence rates, a more or 
less consistent relationship has been found between psychiatric disorder and 
sociodemographic characteristics (Dohrenwend & Dohrenwend 1974; Surtees 
et al. 1983). In their review, the last-named authors reported a higher 
prevalence rate for females, urban people, the elderly, the poorly educated, the 
unemployed, and divorced and widowed persons. This finding may reflect a 
higher degree of exposure and/or vulnerability to the stresses of everyday life. 
Consistent with Rothman’s definitions on sufficient and component cause (see 
chapter 2 on epidemiology), vulnerability can be described as the existence of a 
(group of) component cause(s) that increase the risk of a disease manifestation 
but that by itself is not sufficient to do so. Vulnerability increases the risk that 
another component cause, normally not powerful enough to elicit the disease, 
will do so. This is called the eliciting factor in the vulnerability-stress model, the 
equivalent of the precipitating factor of the aetiological approach. 
 
At the end of the 1970s a research project was started to determine any change 
in psychiatric prevalence rates over a 14-year period, and to test the hypothesis 
of a consistent association between demographic characteristics and 
psychopathology. This was done by means of a repeated cross-sectional 
survey in the Nijmegen Health Area (NHA) in the Netherlands, in which a semi-
structured psychiatric instrument administered by clinically experienced 
interviewers was used.  
In a previous paper, Hodiamont et al. (1987) described a community study of 
psychiatric disorders among 18 to 64 year olds that was performed 1983. The 
investigators used the General Health Questionnaire (GHQ) and the ninth 
version of the Present State Examination (PSE-9), which were combined in a 
two-phase design, the object having been to estimate the prevalence rate of 
psychiatric disorders. The relationship between the PSE-9 caseness and the 
GHQ score was expressed in a logistic regression model that yielded a 7.3% (± 
1.9%)ii point-prevalence of the PSE cases. There was no significant difference 
between males and females. Higher case rates were found in the age range of 
55-59 years, among divorced and widowed persons, for lower educational and 
occupational levels, the unemployed, the chronically ill, the work-disabled and 
city dwellers. The study added further evidence to a growing body of 
epidemiological data, suggesting similar figures and patterns of psychiatric 
disorder in populations in industrialised countries (Bebbington et al. 1981; 
Henderson et al. 1979; Lehtinen et al. 1990; Vazquez-Barquero 1990). 
However, it raised new questions about age-specific risks and the magnitude of 
the difference in case rates between urban and rural inhabitants of this rather 
densely populated region (Hodiamont et al. 1992). 
The objectives of the 1997 survey were to compare the case rates and their 
distribution in 1983 and 1997, to explore the impact of urbanisation on these 
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findings, and to explore possible time trends in terms of cohort, period, 
and age effects on psychiatric prevalence. Because the foremost concern was 





5.2.1 The sample  
In 1983, a random sample of 4,500 persons was drawn from the population of 
all adults in the NHA (over 250,000 people, aged 18-64). Persons who had 
been admitted to institutions or hospitals or who did not have a sufficient 
command of the Dutch language were not interviewed. The area was divided 
into two parts: Nijmegen, and the remaining 29 communities. A total of 10 
communities were selected from the second stratum without replacement. They 
were drawn one at a time and the chance of selection was proportional to the 
size of the community. Each of these 10 communities supplied a systematic 
sample of 280 people and Nijmegen supplied 1,700 people. In this way an 
equal proportion of individuals from Nijmegen and the other communities in the 
sample was obtained. The distribution by gender, age and marital status of the 
3,245 subjects in phase 1 (T1) corresponded to the population distribution 
according to the 1982 census data (CBS).   
In 1997, again, a random sample of 4,517 persons was drawn from the 
population of all non-institutionalised Dutch-speaking adults in the NHA (over 
325,000, aged 18-74; nearly 295,000 aged 18-64), which consisted of the city of 
Nijmegen and the surrounding communities (SC). In order to gain easy access 
to medical data, 32 general practitioners (GPs) were recruited, 11 working in the 
city of Nijmegen and 21 in the surrounding communities. They all met the 
following criteria: they had worked in the same practice within the NHA for at 
least 2 years, and they had been supported by an operational automated 
information system for patient data for at least 1 year. Since virtually every 
inhabitant of the Netherlands is registered in a general practice, the degree of 
this registration is equivalent to that of the registry offices (Boerma et al. 1993). 
An age- and gender-stratified sample of 150 persons from each practice were 
sent a letter by their GP asking for their informed consent to take part in the 
survey. The total sample of 4,517 persons agreed well with reference to the 
population distribution for age and gender according to the 1997 CBS data. 
After two rounds of reminders, 2,049 persons consented, 1,975 explicitly 
refused, and no answer was received from 493. An interview was conducted 
with 1,813 persons in T1, 1,617 of whom were aged 18-64 years (the survey 
sample reported on in this chapter).  
To establish whether a bias had affected the response, data on gender, age, 
degree of urbanisation and the prescription of psychotropic medication (as a 
parameter of mental illness) were used to test whether the survey sample was 
an adequate representation of the general population. Census data on other 
sociodemographic and economic characteristics are not regularly registered in 
the Netherlands. 
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No significant difference in GP prescription of psychotropic medication was 
found between the survey sample and the general population, so that selection 
bias with respect to psychiatric disorders was unlikely. Females and rural 
dwellers were overrepresented in both survey samples (1983 and 1997), and 
the elderly only in 1997 (Table 5.2.1). Adjustments for these differences were 
made in the statistical analyses. Like the 1983 results, the 1997 results may 




Because the clinical instruments that were available at the time, i.e. the PSE-9 
(Wing 1974) and version 2.1 of the Schedules for Clinical Assessment in 
Neuropsychiatry (SCAN-2.1) (Wing et al. 1990), are extensive and expensive 
interviews, a two-phase strategy was adopted (Duncan-Jones 1979; Henderson 
et al. 1979; Williams et al. 1980) both in 1983 and in 1997, in which the 30-item 
General Health Questionnaire (GHQ) (Goldberg 1972; Goldberg 1978; Koeter & 
Ormel 1991b) was used to screen in T1, and the PSE-9 and the SCAN-2.1 were 
administered respectively to determine the existence of psychiatric cases and to 
specify these cases in phase 2 (T2). 
In 1983 one out of eight subjects was randomly selected from the T1 survey 
sample and invited to enter T2, while in 1997 one out of four subjects was 
randomly selected from the T1 survey sample. In both cases, predominantly 
those persons with a low score on the GHQ-30 were selected. The two random 
sub-samples were supplemented in 1983 by the T1 subjects who had a GHQ-
30 score of at least 10 and in 1997 by the T1 subjects who had a GHQ-30 score 
of at least 4. This was done in order to get sufficient data for the estimation of 
the logistic model and, subsequently, the psychiatric prevalence rate.   
This approach led, in 1983, to 3,232 completed GHQs and 486 PSE-9 
interviews. In 1997, 1,605 subjects completed the GHQ and 707 were 
interviewed with the SCAN-2.1. 
 
5.2.3 The general interview 
The T1 interview with the survey sample covered sociodemographic 
characteristics, and contained questionnaires on social support, coping 
behaviour, life events, chronic disease, psychiatric history, quality of life, 
political and religious convictions, and also the GHQ.  
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Table 5.2.1 
Comparison of the data from the 1983 and 1997 survey samples (NHA-1 
and NHA-2) with CBS data for degree of urbanisation, gender, and age, 
and representativeness of the 1997 survey sample for psychotropic 
medication prescription with reference to GP practices.  
  1983 1997 
  Survey 
sample 
N = 3,245 
 
Population 








N = 294,782 
χ² 
  % %  % %  
Urbanisation Nijmegen 33.6 39.1 p < .001 29.2 34.3 p < .001 
 Surrounding 
communities 
66.4 60.9 70.8 65.7 
Gender Males 48.7 50.5 
p = .037 
44.3 50.4 
p < .001 
 Females 51.3 49.5 55.7 49.6 
Age  18-19 5.2 5.9 
p < .001 
1.5 3.6 
p < .001 
(years) 20-24 14.7 15.3 5.9 11.1 
 25-29 15.5 14.7 9.2 13.2 
 30-34 14.9 14.0 13.2 13.3 
 35-39 12.7 11.5 14.0 12.5 
 40-44 10.3 9.3 11.5 11.8 
 45-49 6.9 8.5 9.3 11.7 
 50-54 7.6 7.8 8.5 8.7 
 55-59 7.4 7.1 7.8 7.5 
 60-64 4.9 5.9 7.1 6.7 
Prescriptions 
 





N = 80,315 
 
Antidepressants   3.4 3.4 .98 (NS) 
Benzodiazepines    10.3 9.5 .21 (NS) 
Antipsychotics    0.4 0.8 .07 (NS) 
Analgesics    10.3 9.6 .33 (NS) 
Other psychotropic drugs   2.7 2.7 .88 (NS) 
 
 
Consistent with our NHA-1 report (Hodiamont et al. 1987), the discussion on the 
comparison is confined to gender, age, marital status, highest completed 
education level, employment status, and degree of urbanisation.  
For the statistical analyses, the degree of urbanisation was reduced to two 
categories: Nijmegen (large city) and the SC in the health area. 
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5.2.4 The measurement of psychiatric disorder  
The SCAN-2.1 is a semi-structured, clinical psychiatric interview. It includes the 
tenth version of the Present State Examination (PSE-10), the successor to the 
PSE-9, developed by the WHO (Wing 1996). As in the NHA-1, a one-month 
reference period was chosen for the current psychiatric state.  
Because of their common roots and design, it is possible to convert the PSE-10 
scores into the PSE-9 scores. In co-operation with Fokko Nienhuis of the WHO-
SCAN Collaborating Centre in Groningen, an automated program for generating 
the PSE-9 output from the SCAN 2.1 data was developed. Of the 140 PSE-9 
items, 97 were identical to the items of the PSE-10, so that the item scores 
could be converted linearly. For example, zero and subliminal ratings of 
depressed mood in the PSE-10 were converted into a zero score in the PSE-9, 
whereas clinically significant (2) and severe (3) ratings were converted into 
scores of 1 and 2, respectively, for the PSE-9. A total of 37 composite PSE-9 
items were broken up into single PSE-10 items. For instance, the scores of the 
nine items on specific phobia in the PSE-10 covering the sole composite item of 
the PSE-9 on this pathology were converted into the latter on the basis of their 
clinical significance. Only sixiii of the 140 PSE-9 items were not integrated into 
PSE-10, three of which were not included in CATEGO-4, the algorithm program 
for the PSE-9, and one of which was irrelevant to the diagnostic process, and 
consequently their scores could not be converted. The two remaining items 
were not included in the PSE-10 as they yielded no relevant information when 
the PSE-9 was administered. After the conversion, the same CATEGO-4 
program that was used in 1983 was used to classify the 1997 data in terms of 
the Index of Definition (ID, with eight levels based on the presence of 
discriminating symptoms, key combinations of symptoms and the total number 
of symptoms present) and tentative psychiatric diagnoses based on the ICD-9. 
A tentative psychiatric diagnosis was calculated at or above ID level 5 
(threshold or caseness level). 
In view of the clinical nature of the PSE and the SCAN, physicians, 
psychologists, and psychiatric nurses were selected for their psychiatric 
experience as interviewers. All interviewers participated in a 1-week training 
course given by Professor Frans Verhey Sr. (Maastricht) in 1983 and Professor 
Rob Giel and Fokko Nienhuis of the WHO-SCAN collaborating centre 
(Groningen) in 1997. Booster sessions were given to enhance their expertise. 
The reliability of the PSE-9 and the SCAN-2.1 turned out to be satisfactory 
(Duine et al. 1985a; Rijnders et al. 2000).  
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5.2.5 Analyses  
The SAS version 8 package was used for all analyses. 
The relation between the GHQ score and the PSE caseness was expressed in 
a logistic regression model. In this model, the logit of an individual's caseness 
probability is expressed as a linear function of the GHQ score:  
 
  log p/1-p = α + (β x GHQ score),  
 
where p is the probability that a certain GHQ score corresponds to a PSE case 
and α and β are parameters estimated from the outcome of the T2 interviews 
(Henderson et al. 1979; Hodiamont & Veling 1984).  
All sociodemographic variables were tested to determine whether they had a 
significant impact on the logistic regression model. Since only the two degrees 
of urbanisation resulted in significantly different models, different parameters for 
Nijmegen and the surrounding communities were used. The 1983 data were re-
analysed in this respect.  
The prevalence rate of the PSE cases was estimated on the basis of the 
regression equation and the distribution of GHQ scores from the first phase of 
the study in which the sample had participated. To estimate the 95% two-sided 
confidence intervals, the logistic model was integrated into a bootstrap 
procedure, a re-sampling technique with duplication (Dunn et al. 1999; Efron & 
Tibshirani 1993). On the assumption of a normal distribution of the estimated 
prevalence rate, it was tested whether any two subgroups differed in respect of 
case rates. Because of the nominal character of the variables, in this way the 
case rates of each pair of subgroups was tested for significance with a Kruskal 
Wallis test.  
The prevalence rates of the ID levels and of the tentative diagnoses were 
calculated in two steps. In the first step, the prevalence rate was estimated 
separately for two strata of the PSE subjects in T2: for those subjects with GHQ 
scores of < 10 and for those with GHQ scores of ≥ 10. In the second step, the 
mean of the two prevalence rates was calculated by weighing on the basis of 
the proportional size of the two strata as they occurred in T1. For the 
differences between the survey sample and the general population with respect 





5.3 Results  
5.3.1 Sociodemographic shifts  
The NHA population, apart from having aged markedly, grew in 14 years by 
almost 20%, mainly (91%) on account of newly built areas in the small towns 
and villages of the SC, while the population of Nijmegen hardly changed.  
From the data (e.g., Table 5.2.1 and Table 5.3.5), it is clear that the 
sociodemographic profile of the population altered markedly after 1983. With 
regard to marital status, for example, an increase in the number of single, 
divorced and cohabiting persons was observed. The number of persons 
remunerated for their work grew substantially, unemployment fell, and the 
percentage of full-time housewives was halved. On the other hand, the 
percentage of chronically ill or work-disabled persons remained generally 
unaltered. The mean highest completed level of education increased, which 
resulted in a smaller contribution by persons who had only a primary school 
education. Overall, the contribution of persons to the lowest levels of the various 
socioeconomic classes appeared to have decreased. 
 
5.3.2 GHQ data  
Table 5.3.1 shows the distributions of GHQ-30 scores by gender, degree of 
urbanisation (Nijmegen and SC), and year of survey (the NHA-1, 1983; the 
NHA-2, 1997). In both surveys, females scored higher than males and 
Nijmegen subjects scored higher than those of the SC. The mean scores show 
a significant increase over time, most markedly for females in the city of 
Nijmegen (+2.7, p < 0.001). While the differences between Nijmegen and the 
SC were minimal in 1983, in 1997 the score for Nijmegen was significantly 
higher than the mean score for the SC.  
The increase concerned especially the items on social dysfunction. Items on 
social interaction in particular were scored worse (for instance, ‘finding it easy to 
get on with other people’; ‘able to feel warmth and affection for those close to 
you’). On the other hand, items on socio-economic prospects (for instance, 
‘hopeful about your own future’; ‘finding that life is a constant struggle’) were 
scored unchanged or even better.  
In short, although the socio-economic status of the population improved, judging 
by the aforementioned shift from 1983 to 1997, its health status in terms of 
GHQ scores worsened. 
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Table 5.3.1  
Frequency distribution* of GHQ-30 scores by gender, degree of 
urbanisation and year of survey  
 Males Females 
 Nijmegen SC Nijmegen SC 
 1983 
N = 512 
1997 




N = 519 
1983 
N = 571 
1997 




N = 619 
GHQ-score % % % % % % % % 
0 – 2 62.6 54.2 64.7 63.2 59.9 45.2 63.3 55.8 
3 – 5 18.4 18.1 17.5 14.8 18.5 18.8 18.1 14.9 
6 – 7 5.7 5.0 5.9 6.1 7.0 6.1 6.1 5.0 
8 – 9 2.5 3.8 4.4 4.1 4.9 6.1 4.1 6.3 
≥ 10 10.8 18.9 7.4 11.8 9.8 23.9 8.4 18.1 
Mean 
score 
3.2 5.2 2.9 3.6 3.4 6.1 3.0 4.7 
S.D.† 2.1 3.8 1.9 2.9 2.1 4.0 2.0 3.5 
* Adjusted for age 
† Standard deviation 
 
 
5.3.3 Relationship between GHQ and the PSE  
On the basis of the T2 interviews, maximum-likelihood estimates were obtained 
for the parameters in the logistic regression equation, which applied to all of the 
demographic variables except degree of urbanisation (see Figure 5.3.1).  
The relationship between the GHQ and the PSE manifested itself in quite 
different curves for Nijmegen (N’n) and the SC respectively in 1983, whereas 
the shape and course of both curves looked quite alike in 1997. 
The higher GHQ scores are associated with a higher probability of caseness in 
1983 than in 1997, while the lower GHQ scores show a higher probability of 




Probability of PSE-caseness by GHQ-score in Nijmegen (N’n) and the SC, 
1983 and 1997 
 
                 Figure 5.3.1 
5.3.4 PSE data  
ID level 
The percentages of the various PSE-ID levels in the NHA-1 and the NHA-2 are 
presented in Table 5.3.2.  
With respect to 1983, the number of persons with symptoms at or above 
threshold level (ID≥5) increased. Contrary to our expectations, this also applied 
to the number of persons without psychiatric symptoms (ID level = 1). Thus, the 
1997 ID levels were percentually higher for the extremes than was the case in 
1983 (p = 0.010). This held even after adjustment for the significant effect (p = 
0.003) of degree of urbanisation. 
The prevalence rates of CATEGO classes and corresponding tentative ICD 
diagnoses presented in Table 5.3.3 show a two to five times higher level in 
Nijmegen than in the SC (p = 0.011). The prevalence rate of psychotic states 
found in the NHA-2 was more than twice that in the NHA-1 for both Nijmegen 
and the SC, whereas for neurotic states, a difference was found for the SC only. 




Prevalence* of PSE-ID levels in the NHA-1 and the NHA-2 by degree of 
urbanisation 
 Nijmegen SC 
 1983 
N = 1083 
1997 
N = 464 
1983 
N = 2149 
1997 
N=1138 
ID-level % % % % 
1 No PSE symptoms 25.6 ± 2.4 † 47.6 ± 7.4 33.1 ± 2.7 47.6± 6.0 




59.8 ± 0.6 34.9 ± 3.5 62.2 ± 0.6 43.7 ± 1.9 3 
4 
      
5 Symptoms at 
threshold level 
9.6 ± 1.2 10.3 ± 0.5 3.8 ± 2.2 5.2 ± 1.8 




5.0 ± 1.8 7.3 ± 3.4 1.0 ± 1.1 3.5 ± 2.4 7 
8 
* Adjusted for gender and age 




The overall prevalence rate of PSE cases in the population of the NHA as a 
whole was 11.9% (±2.7%)iv in 1997, significantly higher than the prevalence 
rate of 7.8% (±2.3%), which was found in 1983 (p < 0.001). The prevalence rate 
of depression and anxiety disorders for the health area as a whole, was also 
significantly different between1997 (9.7% ±2.9%) and 1983 (7.7% ±2.2%, Table 
5.3.3; p < 0.01). 
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Table 5.3.3 
Prevalence* of PSE-CATEGO classes (with the ICD equivalents) in the 
NHA-1 and the NHA-2 by degree of urbanisation 







N = 1083 
1997 
N = 464 
1983 
N = 2149 
1997 
N = 1138 
   % % % % 
Schizophrenic psychoses S 295.3 
1.7 ± 0.6 † 3.7 ± 0.7 0.3 ± 0.3 0.7 ± 0.2 
Paranoid states P 297.9 
Manic and mixed  
affective psychoses 
M 296.1,3 
Depressive psychoses D 296.2 
12.7 ± 2.2 13.9 ± 3.2 4.4 ± 3.0 7.5 ± 3.9 
Inhibited depressions R 296.2 or 
300.4 
Neurotic depressions N 300.4 
Anxiety neuroses A 300.0,2 
*  Adjusted for age and gender  
†  95%= confidence interval 
 
 
5.3.5 The relation between PSE data and sociodemographic 
variables 
Urbanisation 
The resulting prevalence rates for degree of urbanisation and gender are 
presented in Table 5.3.4. 
The increase in case rates turned out to be smaller for Nijmegen (from 12.8 
±5.3 to 18.0 ±6.4) than for the SC (from 4.5 ±1.4 to 8.8 ±2.5). Although there 
was still a substantial difference in psychiatric prevalence rate between city and 
rural dwellers, there was a tendency for the surrounding communities to catch 
up in terms of psychiatric caseness. In terms of diagnoses, there was a two-fold 
increase in the prevalence rate of psychotic disorders, both in Nijmegen and in 
the SC. For neurotic disorders, however, a more or less stable situation was 
found in Nijmegen, in contrast to a near doubling in the SC. 
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Table 5.3.4 
Prevalence rates in the NHA-1 and the NHA-2 by degree of urbanisation 
and gender 
 1983 1997 
Nijmegen 12.8 ± 5.3 † 18.0 ± 6.3 
SC 4.5 ± 1.4 8.8 ± 2.5 
   Males  7.5 ± 2.2 10.8 ± 2.7 
Females 8.0 ± 2.3 13.1 ± 2.8 




In contrast to the similar PSE case rates for males (7.5 ± 2.2%) and females 
(7.8 ± 2.3) in 1983, the rates in 1997 differed significantly for males (10.8 ± 
2.7%) and females (13.1 ± 2.8%, p<0.001). 
 
Age  
Our conclusion in 1983 that ‘for both sexes the case prevalence rate more or 
less increases with age up to about age 60’ should be readjusted. Table  shows 
a higher rate for persons aged 45 years and older, but no clear pattern for the 
younger age groups. In contrast to our findings in 1983, when most cases were 
found in the 55- to 64-year-old age group, caseness in 1997 peaked in the 45- 
to 54-year-old age group for both sexes, most strikingly in the SC. In addition, a 
lower case rate was found for females aged 55-64 from the SC in 1997 than in 
1983.   
 
Marital status  
The 1983 finding of a significantly higher case rate for divorced females than for 
females married or living with others was confirmed in 1997. The tendency for 
single males to be at high risk from psychiatric caseness turned out to be 




A significant difference in the rates of disorder was found when the 
unemployed, chronically ill and work-disabled were compared with all other 
categories, irrespective of gender, degree of urbanisation, and year of inquiry (p 
< 0.05). The only deviation from the general increase in case rates for all 
employment statuses over time (most markedly for chronically ill, male, urban 
dwellers; p = 0.024) was the significant decrease in chronically ill, male, rural 
dwellers (p = 0 .018). 
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Level of education 
There was a trend towards an inverse relationship between case rate and 
education level, which reached significance in the SC (p < 0.05). For female city 
dwellers with the lowest levels of education, the rise in the prevalence rate of 
the PSE caseness from 1983 to 1997 was significantly greater than for most 
other categories.   
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Table 5.3.5  
Sociodemographic distribution of PSE caseness (Males) 
  Males 
  Nijmegen (N’n) SC 
  1983 
N = 512 
1997 
N = 191 
1983 
N = 1060 
1997 
N = 519 
  N % N % N % N % 
Age group 18-24 115 12.9 16 18.9 198 3.4 b 28 5.6 b* 
 25-34 158 10.3 44 16.1 338 3.1 b d 93 6.2 b d 
 35-44 108 13.8 64 15.9 254 4.7 151 7.8 
 45-54 62 12.1 41 18.0 156 5.3 a 144 10.2 a 
 55-64 69 16.2 26 17.7 114 6.9 c 103 8.0 c 
Marital  Single 65 14.4 42 19.2 21 2.4 28 10.2 
status Living with parents  58 10.9 5 15.9 206 3.2 b 32 6.8 b 
 Living with partner 73 12.6 38 14.6 54 6.4 35 9.0 
 Married 296 12.2 93 16.6 760 4.3 b 401 7.4 b 
 Divorced 15 13.9 12 14.1 14 13.1 a 22 11.4 a 
 Widowed 5 29.6 1 12.4 5 3.2 1 3.5 
Employment Full-time employed 259 10.3 b d 132 14.4 bd 746 2.8 f 419 7.2 f 
status Part-time employed 31 9.8 b 23 13.6 b 42 1.0 f 25 7.8 f 
 Retired 20 10.6 b 3 15.4 b 11 1.2 f 14 10.3 f 
 Chronically ill/ 
unable to work 
42 22.3 a 5 49.4 a * 79 19.3 e 33 12.9 e * 
 Unemployed 68 16.8 c 11 30.2 c 110 6.5 f 12 11.9 f 
 School or college student 87 13.2 b 12 20.9 b 70 1.6 f 12 7.3 f 
 Householder 1 6.1 -- -- -- -- 1 3.0 
 Others without an occupation 4 8.5 5 22.4 2 25.0 2 11.4 
Level of  University 68 9.6 43 16.8 69 1.1 36 8.5 
education Higher vocational education 97 9.9 33 15.5 189 2.5 b 95 7.3 b 
 Upper-stream sec. education 64 14.0 35 17.0 56 2.6 36 5.0 
 Lower-stream sec. & post-
sec. lower vocational 
education 
49 12.0 23 15.0 142 4.2 124 7.9 
 Lower-stream sec. education 34 14.3 14 17.2 67 3.8 51 8.2 
 Continued primary education 119 13.4 33 18.6 348 4.4 137 8.6 
 No education or only primary 
education 
81 15.8 10 19.0 189 7.8 a 40 10.9 a 
In some subgroups, due to missing data the cumulative N was lower than the N of the 
survey sample stated in the title of the table. 
 
Age group 
SC males: Kruskal-Wallis  .01 < p < .05; Scheffé (.05)  a - b and c - d 
* significant difference between the year pairs (p < .05) 
Marital status  
SC males: Kruskal-Wallis  .001 < p < .01; Scheffé (.05)  a - b  
Employment status 
N’n males: Kruskal-Wallis p < .001; Scheffé (.05)  a - b and c - d 
SC males: Kruskal-Wallis p < .001; Scheffé (.05)  e - f 
Level of education  
SC males: Kruskal-Wallis .01 < p < .05; Scheffé (.05) a - b 
* significant difference between the year pairs (p < .05) 
83 
Table 5.3.5 (continued) 
Sociodemographic distribution of PSE caseness (Females) 
  Females 
  Nijmegen (N’n) SC 
  1983 
N = 571 
1997 
N = 276 
1983 
N = 1089 
1997 
N = 619 
  N % N % N % N % 
Age group 18-24 135 12.2 29 16.9 194 3.4 f 47 6.4 f 
 25-34 146 12.0 86 18.2 339 3.8 136 11.6 * 
 35-44 113 12.6 80 17.3 267 4.4 166 8.8 
 45-54 87 14.0 53 21.6 165 5.6 e 154 13.0 e 
 55-64 90 15.6 28 22.8 124 8.4 116 7.4 * 
Marital  Single 72 11.0 d 49 16.7 d 29 6.4 16 4.6 
status Living with parents  42 13.3 3 20.8 120 2.8 f h 24 9.4 f 
 Living with partner 86 11.5 d 93 17.4 d 41 4.9 49 8.7 
 Married 322 12.9 d 106 19.8 d 839 4.3 f 495 10.4 f 
 Divorced 30 22.0 c 22 26.0 c 27 13.5 e 18 13.5 e 
 Widowed 19 16.5 2 20.9 33 13.2 g 17 8.9 
Employment 
status 
Full-time employed 87 11.9h 101 14.4h 187 2.6 j 102 10.0 j * 
Part-time employed 118 11.2 94 18.6 211 4.4 258 9.3 
 Retired 2 7.2 2 8.3 1 0.5 6 5.6 
 Chronically ill/ unable to work 8 17.7 g 7 31.7 g 13 5.9 i 12 23.0 I 
 Unemployed 24 12.8 10 32.3 29 9.7 9 16.9 
 School or college student 72 12.6 15 16.7 45 3.8 j 18 7.0 j 
 Householder 257 14.2 34 26.6 * 602 5.2 j 190 10.3 j 
 Others without an occupation 3 23.7 12 16.3 1 0.3 25 9.6 
Level of 
education 
University 33 14.3 68 15.2 27 3.4 9 9.2 
Higher vocational education 101 10.2 82 14.6 136 1.6 d 96 7.5 d 
 Upper-stream sec. education 65 11.7 35 17.0 57 2.9 55 11.3 
 Lower-stream sec. & post-
sec. lower vocational 
education 
74 13.1 12 24.2 167 3.4 169 8.2 
 Lower-stream sec. education 57 12.0 23 19.5 122 2.2 113 11.2 * 
 Continued primary education 104 13.7 40 25.8 * 322 5.4 143 11.8 
 No education or only primary 
education 
137 15.4 16 32.0 * 258 7.9 c 33 12.2 c 
In some subgroups, due to missing data the cumulative N was lower than the N of the 
survey sample stated in the title of the table. 
Age group 
SC females: Kruskal-Wallis  .01 < p < .05; Scheffé (.05) e - f 
* significant difference between the year pairs (p < .05) 
Marital status  
N’n females: Kruskal-Wallis p < .001; Scheffé (.05)  c - d  
SC females: Kruskal-Wallis .001 < p < .01; Scheffé (.05)   e - f and g - h 
Employment status 
N’n females: Kruskal-Wallis p < .001; Scheffé (.05)  g - h 
SC females: Kruskal-Wallis .001 < p < .01; Scheffé (.05) i - j 
* significant difference between the year pairs (p <. 05) 
Level of education  
SC females: Kruskal-Wallis .001< p < .01; Scheffé (.05) c - d 
* significant difference between the year pairs (p < .05) 
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5.4 Discussion  
As stated in the introduction, the objectives of this monitoring study were to 
compare the case rates and their distributions in 1983 and 1997, to identify 
the influence of urbanisation on the changes in prevalence rates and 
distribution, and to explore possible cohort, period, and age effects on the 
prevalence rate of PSE cases. 
 
5.4.1 Study limitations 
The NHA studies used a cross-sectional design and this had an advantage and 
a disadvantage: the advantage was the possibility of examining secular 
population changes, and the disadvantage concerned potential limitations with 
regard to the comparability of the study populations and the compatibility of the 
measuring instruments and the diagnostic system used.  
At first sight, the notable non-response in 1997 appears to call into question the 
assumption of a representative survey sample and limit the comparability of the 
results for 1983 and 1997. Potential subjects seemed to be deterred by the 
exhaustive information campaign deemed necessary for informed consent by 
the medical ethics committee. On the other hand, this sampling design, in which 
GP practices were used, enabled us to check for selectivity by means of 
psychotropic medication. There was no evidence of a selection bias in the 
sense of patients with psychiatric morbidity (medicated) being overrepresented 
in the sample. We therefore assume that for 1997 too, the sample was a fair 
representation of the general population.   
So that limitations would be reduced with regard to differences between 
interview instruments and diagnostic systems used in 1983 and 1997, the NHA-
2 instrument, i.e. the SCAN-2.1/PSE-10, was deliberately chosen on the basis 
of its suitability as the successor of the the PSE-9 used in the NHA-1, which 
made possible a WHO-approved conversion of the NHA-2 scores into the NHA-
1 format. In this way the data from the NHA-1 and the NHA-2 could be 
compared properly.  
 
5.4.2 Prevalence rates, GHQ – PSE relationship 
Table 5.3.1 shows that the number of persons with a GHQ-score ≥ 10 
underwent a two-fold increase from 1983 to 1997. Since Figure 5.3.1 shows a 
lower associated rate of caseness for the higher GHQ-scores for 1997 than for 
1983, it can be concluded that in 1997 more subjects reported a substantial 
feeling of decreased well-being without an underlying formal psychiatric 
disorder than in 1983. 
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In the 14-year interval between the two studies, newly built areas in the small 
towns and villages of the SC were partially populated as a result of migration 
from the city of Nijmegen. Such a population shift offers an explanation of the 
relative similarity of the course and shape of the curves representing the GHQ – 
PSE relationship for Nijmegen and the SC in 1997 in comparison with 1983.  
 
5.4.3 Prevalence rates, the PSE-caseness 
The increase in the prevalence rates of the PSE-ID levels 5 through 8 from 
1983 to 1997 could have been expected from the distribution of the GHQ-
scores, and is consistent with the view that after conversion the SCAN-2.1 
adequately detects PSE-cases. For the lower PSE-ID score range however, in 
1997 the prevalence rate of level 1 was higher, while levels 2 through 4 were 
lower than in 1983. Although the SCAN is sensitive to PSE-9 caseness, its 
scoring algorithm might also help to explain this discrepancy. In contrast to the 
PSE-9, the SCAN can be used to score signs and symptoms that are present, 
but at a sub-clinical level (score 1). In the more common neurotic sections this 
feature might result in the absence of mild symptoms when the SCAN scores 
are converted to PSE-9 scores.   
Through logistic regression, the one-month prevalence rate of neurotic and 
functional psychotic caseness, which was rated by means of a clinical semi-
structured psychiatric interview after screening with the aid of a questionnaire, 
was estimated at 7.8 ± 2.3% (after reanalysis) in 1983 and 11.9 ± 2.7% in 1997, 
in representative samples of a Dutch general population, aged 18-64 years. 
Consequently, the prevalence rate of psychiatric disorder had risen by about 
50% for the NHA as a whole. The mathematical explanation of this 
phenomenon is as follows: 
On the one hand, in 1997, a low GHQ-score was associated with a higher 
probability of caseness than in 1983 (see Figure 5.3.1). This concerned the 
majority of the 1997 subjects (Table 5.2.1). On the other hand, despite the fact 
that for high GHQ-scores the probability of caseness slightly waned in 1997 in 
comparison with 1983, this subgroup had its boosting effect on caseness since 
its size more than doubled over the years (Table 5.3.1). 
 
To put the prevalence rates in perspective, they should be compared with rates 
from other surveys conducted analogously. In the 1980s, the Dutch PSE-9 case 
rates (ID ≥ 5: 7.8%) (Hodiamont et al. 1987) were compared and contrasted 
with those for Canberra (ID ≥ 5: 9.1%) (Henderson et al. 1979) and Camberwell 
(ID ≥ 5: 10.9%) (Bebbington et al. 1981), and the Dutch rates were found to be 
the lowest. This finding still applies in comparison with prevalence estimates 
from other surveys done in the 1980s using the same instruments in Finland 
and Spain (Vazquez-Barquero 1990). Our estimate of 11.9% for 1997 fits in 
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better with the overall pattern of psychiatric disorder in western industrialised 
countries. Whereas our prevalence rate increased by more than 50% in 14 
years, Bebbington et al. (1981; 1997), using more or less the same design and 
instruments as those used in the NHA study, reported a more or less stable 
one-month prevalence rate over about the same period (10.9% and 9.8%, 
respectively). Kessler et al. (2005c) recently reported a stable psychiatric 12-
month prevalence rate over the period 1990 - 2003 (29.4% and 30.5%, 
respectively). These investigators compared data from the NCS study with 
findings from the NCS replication study. Nandi et al. (2000) reported the same 
effect on a rural Indian area from 1972 to 1992 (11.7% and 10.5%, 
respectively), and Merikangas et al. (2003) did so from their Zurich Cohort 
Study, conducted over a period of 20 years. They reported the prevalence rate 
of depressive and anxiety disorders to be 4.9%, 8.6%, 9.7%, and 7.7% in 1981, 
1986, 1988, and 1993 respectively. The latter investigation had the advantage 
of being prospective, and the disadvantage of being mainly based on a narrow 
age range, namely 19-20 year old in 1979.  
 
5.4.4 Sociodemographic shift and distribution of psychiatric 
disorders 
The sociodemographic profile of the population changed markedly after 1983. 
The NHA population, apart from having aged markedly, grew by almost 20% in 
14 years, mainly on account of the SC. Furthermore, there was an increase in 
divorced persons and singles, and a decrease in persons living with their 
parents. Thirdly, the mean highest completed level of education increased. 
Finally, as the percentage of persons remunerated for their work grew 
substantially, the percentage of full-time housewives was halved, and the 
percentage of chronically ill or unemployed persons decreased for males, but 
remained generally unaltered for females. When looking for explanations of the 
case-rate findings, It is important to reflect on these (major) changes at the 
societal level since societal interventions are potentially most powerful from the 
preventive point of view (Susser et al. 2002). 
Over time, our psychiatric case rates increased in all sociodemographic 
categories, but the increases were greater in the lower social classes. This 
latter finding may be an artefact created by the decreasing number of people in 
these classes, but there are other explanations.  
 
Despite the widely differing reports of psychiatric prevalence rates, a more or 
less consistent relationship has been found between psychiatric disorder and 
sociodemographic variables (Dohrenwend & Dohrenwend 1974; Surtees et al. 
1983). In their reviews, the last-named investigators reported a higher 
prevalence rate for females, urban dwellers, the elderly, the poorly educated, 
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the unemployed, and divorced and widowed persons (Fryers et al. 2003; Fryers 
et al. 2005).  
In the NHA-1 (1983), the assumption of a higher percentage of disorders among 
city dwellers, those who had lost a partner, poorly educated people, and the 
unemployed was confirmed. Only the gender difference was not substantiated. 
On the basis of the NHA-2 (1997) data, the aforementioned starting hypothesis 
was reconfirmed in all respects, including the higher case rate for females. 
Consequently, the former explanation that “role patterns in the Nijmegen Health 
Area may have changed in such a way that the inherent stress produced a 
similar amount of psychiatric disorder for the two sexes” (Hodiamont et al. 1987) 
can no longer be considered tenable.  
From 1983 to 1997 the prevalence rates for females increased to a greater 
extent than for males. From a societal point of view, this might be explained by 
the growing demand for well-educated employees in Western society. This 
factor has reinforced the assumption, generally accepted today, that all 
individuals should become part of the professional work force, which has 
stimulated females to catch up with males in respect of the highest education 
levels, this pressure having been significantly lower in 1983. In parallel, the 
work status of females changed from running a household to paid part-time 
employment. Simultaneously, an increasing percentage of females decided to 
cohabit (with or without children in the living unit) instead of living with their 
parents or on their own. Altogether these changes were tantamount to an 
increase in role stress, which constitutes a risk factor with reference to the 
burden side in the vulnerability-stress model. To a lesser degree the same 
dynamic applied to males, who took on increasing responsibilities on the 
domestic front in addition to their existing professional duties.  
Apart from role stress, possible explanations that have been suggested for the 
apparent association between gender and the prevalence rate of mental 
disorders are response bias and biological vulnerability. Gender did not have 
any effect on the GHQ-PSE model, so that response bias is an unlikely 
explanation for our data. If biological and/or hormonal vulnerability does indeed 
play a role in the higher rate of disorders among females, one might expect a 
reduction of this difference between males and females for the category of 
people over 55 years of age in comparison with younger persons. So far, there 
has been some evidence to this effect: for all persons over 55 years of age the 
prevalence rate is between 10.4% and 10.9%, while for persons 54 years and 




5.4.5 Influences of urbanisation 
As for the apparent influence of degree of urbanisation on the rate of psychiatric 
disorders in 1983 and 1997, it can be inferred from the parameters of the 
different logistic regression models that, for lower GHQ scores, people from the 
city of Nijmegen had a higher probability of PSE caseness than those from the 
SC. In the course of time, however, this difference tended to decline (see                  
Figure 5.3.1). This trend is especially true for the neurotic states, for which the 
SC subjects effectively caught up with the Nijmegen subjects through almost 
doubling the prevalence rate over the 14-year interval, whereas the prevalence 
rates for psychosis increased in both regions. 
A societal explanation might be that the newcomers moved into newly built 
areas, outside the old village centres with their sense of strong social 
coherence. This change would have increased the feeling of anonymity, 
resulting in a strongly diminished sense of social cohesion in comparison with 
their previous city life. The decline of social coherence might have resulted in an 
increased vulnerability (McConnell et al. 2002), more distinct in the SC than in 
Nijmegen. 
Another possible explanation is the difference in the sociodemographic shift 
between 1983 and 1997 in Nijmegen and in the SC. In the latter, people tended 
to a greater extent than city dwellers to remain locked into the lower socio-
economic classes (poor education, non-remunerated work, divorced or 
widowed). Kirkbride et al., in their study on psychotic syndromes (2006), 
concluded that “the incidence of all diagnoses was greater in Southeast London 
than Nottingham or Bristol after standardisation for age and gender. These 
differences remained after further adjustment for ethnicity, except for affective 
disorders. This suggests truly ‘psychotogenic’ effects of that environment or 
population stratification in terms of psychosis risk.”  
Altogether, these societal changes are likely to have contributed to an influence 
of urbanisation on the overall increase in the prevalence rate from 1983 to 
1997. 
 
5.4.6 Cohort, period, and age effects 
The high rates of disorder found in 1983 in the group aged 55-59 years 
persisted even after controls for marital status, employment status, and 
perceived morbidity had been introduced. This fact prompted Hodiamont et al. 
(1987) to speculate at the time that the experience of having lived in a war zone 
had had an effect on his cohort (a so-called cohort effect); after all, his 
population sample had been in their teens during the Second World War. If the 
war had played any role in the above-mentioned high rates, one would expect 
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to find a peak prevalence in the age range of 69-73 years in 1997, but this 
proved not to be the case.  
The increase in prevalence rate between 1983 and 1997 may have been 
caused by one or more, possibly cumulative, period effects. A first period 
effect was reported in the paper by Hodiamont at al. (2005), in which we 
explained that there had been an overall increase (from 19.0% in 1983 up to 
28.9% in 1997) in the GHQ-30 scores for Nijmegen and the SC over the 14-
year interval in question. This increase especially concerned the items on social 
dysfunction. Items on social interaction in particular were scored worse. On the 
other hand, items on socio-economic prospects were scored unchanged or 
even better. In short, although the socio-economic status of the population in 
the area as a whole improved, on the basis of the aforementioned shift in social 
interaction from 1983 to 1997, its health status in terms of GHQ scores actually 
worsened. These findings are supported by Verhaak et al. (2005), who reported 
on the same issues in a large-scale, national, Dutch replication study based on 
GP practices. Among other results, these researchers observed a national trend 
towards a substantial increase in mental health problems over a 14-year interval 
(1987 – 2001), the GHQ-12 having been used as a measuring instrument. In 
this study the GHQ score ≥ 2 rose from 16.8% in 1987 up to 22.8% in 2001, with 
females, people with a lower education level and widowed and divorced 
persons having significantly higher scores. These subjects presented an 
increase in family and relational problems, while material problems were less 
often reported. 
A second period effect for the area as a whole had to do with the above-
mentioned remarkable sociodemographic shift in the NHA over the relatively 
short 14-year interval (see 6.4.4). Verhaak et al. (2005) reported the same 
phenomenon nation-wide (See Verhaak Table 1). It may therefore be concluded 
that this shift is not just a coincidental regional finding. The assumption is that 
this upward sociodemographic shift results in changed social roles, with 
attendant increasing role stress, and increasing prevalence rates as a 
consequence. A third general period effect may be found in the policy of 
reducing the number of psychiatric hospital beds, resulting in a 12% decrease in 
admission days (Ypsilon 2001), under the influence of which the prevalence 
rates for psychosis increased in both Nijmegen and the SC. In contrast to the 
preceding, the prevalence rate of neurotic disorders in the SC nearly doubled 
in contrast to a more or less stable prevalence rate of these disorders in 
Nijmegen, which contributed to the higher overall prevalence rate for the NHA 
as a whole in 1997 (Table 5.3.3). A fourth (but regionally oriented) period effect 
is the aforementioned migration of city dwellers to the SC, who brought their 
neurotic burden in the form of a higher prevalence rate with them. A fifth 
explanation is a (geography-specific) period effect: the evacuation of many of 
the rural dwellers because of the high waters of the Rhine and the impending 
 
90 
inundation of their homes in the winters of 1993 and 1995. Some support for 
this hypothesis may be found in the fact that the prevalence rate of neurotic 
disorders in the communities adjoining the river was nearly 25% higher (p = .07) 
than in the inland communities. 
 
In this monitoring study, a clear age effect could not be proved. An age effect 
implies, after all, that the highest case rate should be consistently found in the 
same age group. Because most cases were found in the age range of 45-54 
years in 1997 (in contrast to 1983, when such cases massed in persons aged 
55-64 years), this condition was not borne out in a strict sense. However, the 
possibility that the expected age effect was obscured by the above-mentioned 
period effects can not be ruled out. The 45-54 yr age group may have been 
more prone to the various period effects, and may have reacted more morbidly 
in terms of neurotic symptoms than the resigned seniors.  
 
5.4.7 Conclusions 
All things considered, it can be concluded that, while the distribution of cases 
remained generally unaltered, the prevalence rate of psychiatric disorders rose 
substantially in the Nijmegen Health Area from 1983 to 1997. In sum, neither an 
age effect nor a cohort effect was found. However, striking period effects 
showed up. These concerned both the population as a whole – apparently 
because of overall changes in social roles and a modified health policy – and 
the rural communities, as a result of the sociodemographic shift due to the 
above-noted migration and of the imminent inundation of their homes and 
property.  
Despite the improved socio-economic conditions in the overall population 
surveyed, the increasing complexity of life, which has already been referred to, 
apparently took its toll, even among those best equipped to deal with the socio-
affective vicissitudes. This conclusion seems to contradict the general finding 
that upward mobility in society is associated with a better health status. This 
finding, however, concerns upward-moving individuals in rather steady social 
classes. In this study, an improvement in socio-economic conditions was found 
for the great majority of the population. An undesirable result of this socio-
economic improvement might be a destabilisation of social classes, manifesting 
itself in feelings of indistinctness and uncertainty among the members of these 
classes and a greater overall vulnerability to stress. 
These social changes, which Murphy et al. (1984) hypothesised were potentially 
harmful for mental health, were definitely extensive in the Nijmegen Health Area 
(Hodiamont et al. 2005) and the Netherlands as a whole (Verhaak et al. 2005), 
and probably were limited in other countries. Murphy et al. stated that the 
impersonalness and anonymity associated with increasing urbanism might be 
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destroying the resources that people use in order to achieve a sense of inner 
worth, that mounting bureaucratisation might be stifling autonomy and 
independence, and that the rapid pace of change in family life and work might 
be taxing the individual’s ability to adapt and maintain personality integration. In 
the same vein, Stevens (1999) pointed out the likelihood of a connection 
between various forms of psychopathology and Western society’s inability to 
satisfy the archetypal needs of the human species. He quoted John Bowlby, 
who had declared that “the further the rearing environment deviates from the 
environment of evolutionary adaptedness, the greater the likelihood of 
pathological development”. However, the question of whether psychiatric 
prevalence in general is rising, stable, or decreasing in Western countries, and 
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6 Mapping: The Nijmegen Health Area-2 project  
6.1 Introduction  
Descriptive epidemiology, and mapping in particular, are basic means of turning 
up leads through which patterns in the occurrence of disease can be disclosed 
(Hennekens & Burning 1987). Mapping provides essential information about the 
who, where and when of the disorders in question. It improves our 
understanding of the relationship between the disorder and biological, socio-
demographic, psychological and social characteristics. As a result, the aetiology 
of the pathological process becomes clearer (Lilienfeld & Lilienfeld 1992). 
Mapping is therefore an indispensable first step in the search for causality 
(Susser et al. 2002). This process is especially important as it is generally 
accepted in medicine that causal treatment, if available, is the best option.  
From the moment that Quality-Adjusted Life Years (QALYs) became a primary 
measure of disease burden, psychiatric disorders were ranked among the top 
five health problems of the Western World. Depression and anxiety disorders 
affect a sizeable portion of the population and often result in a substantial loss 
of quality of life for a prolonged period of time. Consequently, reducing the 
number of QALYs lost on account of psychiatric disorders is one of the main 
targets of health policy. Given the continuous need of health policy makers for 
information on how to achieve this goal most effectively, “the relevance of 
mapping psychiatric prevalence in the general population is undisputed” 
(Thornicroft & Tansella 2001).  
Our scores, when converted into the PSE-9 format, suggested a significant 
increase in psychiatric prevalence rates over time (see chapter 5 of this thesis 
and Hodiamont et al. [2005]). Findings of increased psychiatric prevalence rates 
are frequently criticised. Cooper & Singh (2000) reported that, apart from an 
increase in the prevalence rates of psychiatric disorders in the population over 
the previous 10 – 15 years, rates of psychiatric morbidity tended to inflate. This 
inflation might be due to the use of different time frames (lifetime instead of 1-
month prevalence rates), the employment of ‘non-clinical’, fully standardised 
instruments instead of clinical, semi-structured interview instruments (Brugha et 
al. 1999a), and the actual evolution of interview instruments, mostly resulting in 
a more extensive and a more sensitive successor. Another explanation for the 
rise in prevalence rates is the evolution of classification systems, which entails 
an expanded diagnostic range or more diagnostic subtypes (Batstra et al. 
2002).  
As the primary objectiveof the Nijmegen Health Area-2 (NHA-2) survey was to 
obtain data in the NHA for comparison with the NHA-1 data (see chapter 5), it 
was decided to use the 1997 state-of-the-art clinical instrument, the successor 
to the PSE-9, namely Schedules for Clinical Assessment in Neuropsychiatry 
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(SCAN-2.1), to map the psychiatric point (1-month) prevalence rate. This choice 
resulted in a number of qualitative advantages.  
First, the use of the SCAN-2.1 implied an assessment from the clinical 
viewpoint, whereas most other population studies employed a fully (and 
strictly) standardised instrument, which makes interviews conducted by lay 
interviewers suitable, for example the Composite International Diagnostic 
Interview (CIDI). To arrive at a valid clinical judgement, the SCAN interviewers 
must probe until they are satisfied with the information obtained, since it is the 
professional who must decide if symptom definitions are fulfilled. As a 
consequence, the subjective symptoms reported are weighted in the SCAN-2.1 
for their clinical relevance, possibly resulting in more moderate prevalence rates 
than those found in studies with lay interviewers (Brugha et al. 1999a; Brugha et 
al. 2001; Cooper & Singh 2000).  
Second, the SCAN-2.1 is the first (clinical) interview instrument that uses the 
integral DSM-IV classification system as a diagnostic reference (disorders 
usually first diagnosed in childhood being an exception). Use of the integral 
diagnostic reference creates the only opportunity to classify all disorders, which 
makes possible, on the one hand, a comparison with other recent field studies 
conducted with other instruments, and, on the other hand, the use of a more 
integral classification system with respect to the previous clinical interviews, 
which were based on a more limited diagnostic reference. the SCAN has been 
used before (Andrews et al. 1995; Brugha et al. 2001; Eaton et al. 2000), but 
never in a general population survey with the integral DSM-IV range. The NHA 
study is the first mapping in the general population to have adopted the full 
DSM-IV range of psychiatric disorders diagnosed on the basis of a direct clinical 
judgement. This approach is rarely used. Reasons for the rarity of use were 
given by Narrow et al. (2002), who stated: ’In large epidemiologic surveys, 
direct clinical judgement is rarely used because of the high cost of clinical time 
and the large number of subjects, so proxy measures are used.’ The use of the 
full DSM-IV range might lead to an increase in prevalence rates – indeed, on 
reflection, the real rates – in comparison with studies in which a partial range is 
used, which gives rise to artificially low prevalence rates. 
Third, the SCAN-2.1 is an extensive interview instrument, with over 1800 
questions, in comparison with the 140 questions of the PSE-9. Thanks to this 
comprehensive questioning, the SCAN-2.1 has the advantage of generating 
detailed, clinically relevant data, making possible precise classification on a 
subdiagnostic level. As a result, comorbidity can be expected to increase 
because of the more detailed classification of disorders. As the SCAN-2.1 is a 
semi-structured instrument that allows flexibility in accordance with the 
respondents’ actual situation, the duration of the interview (an average of 90 
minutes, with peaks of over 3 hours) appears not to bother the respondents, 
and it generates a reliable picture of the clinical psychiatric situation.  
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Finally, because the SCAN-2.1 is the first psychiatric diagnostic instrument into 
which the full diagnostic range of DSM-IV is incorporated, the opportunity is 
created to pay attention to the expansion of the full adult diagnostic range. 
Compared with the PSE-9, this means an extention of the diagnostic range 
to include diagnostic categories such as substance-related, somatoform, sleep, 
and dissociative disorders. Compared with the CIDI, which assesses the 
prevalence of almost all psychiatric disorders, the diagnostic extension 
concentrates on sleep disorders. In the international literature on epidemiologic 
studies in the general population, somatoform, dissociative, and sleep disorders 
are hardly, if ever, reported. In this study, in addition to the prevalence rate 
worked out on the basis of the full diagnostic range, we shall concentrate on 
three ‘newly’ determined categories in the general population (somatoform, 
sleep, and dissociative disorders) by identifying (1) the contribution of the 
separate prevalence rates for the three new categories to the overall prevalence 
rates; (2) their supplementary contribution to comorbidity; and (3) their 
contribution to possible changes in the stable pattern of prevalence distributions 
(Dohrenwend & Dohrenwend 1974).  
 
As argued before, any qualitative change in the diagnostic process has its 
influence on the quantitative diagnostic outcome, and consequently on the rate 
of the co-existence of diagnoses, i.e. comorbidity. Comorbidity itself is a major 
health issue, because, on the one hand, it points to the complexity of the 
underlying problems, and on the other, most interventions (medication, 
psychotherapy, etc.) are not comorbidity ‘proof’, in that they are focussed on the 
treatment of well-defined monomorbid disorders. Many definitions of 
comorbidity are at hand, each contributing to a wide range of prevalence rates, 
ranging from less than 1% to as high as 50% (van den Akker et al. 1996). The 
recession of the hierarchical approach in the transition from DSM-II to DSM-III 
and its successors has inevitably led to an increase in the prevalence rates of 
comorbid psychiatric disorders (Kessler et al. 1997; Pincus et al. 2004). 
In this study we shall use the definition of comorbidity adopted by Feinstein 
(1970): ‘any distinct additional entity that has existed or may occur during the 
clinical course of a patient who has the index disease under study’. However, 
we shall restrict comorbidity to formal psychiatric disorders in order to examine 
its prevalence rates and sociodemographic distribution in the general 
population, and to study the impact of the three newly determined categories on 
both of these phenomena. 
 
At the same time as the NHA-2 study was performed, the first wave of the 
NEMESIS study, a national survey on psychiatric morbidity, was carried out (Bijl 
et al. 1998) with a non-clinical, fully standardised, instrument (the CIDI-1.1) 
based on a narrower diagnostic range and derived from the DSM-III-R. The 
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opportunity to compare mutatis mutandis the non-clinical NEMESIS results with 
the clinical NHA-2 findings was an important reason for the Ministry of Health, 
Welfare, and Sport to support the NHA-2 study.  
In the Netherlands, the SCAN had never been used in a general population 
survey. Internationally, only a few studies are known in which the SCAN-1.0 had 
been used (McConnell et al. 2002; Roca et al. 1999). 
 
In this chapter, mapping is illustrated through reporting the epidemiological 
prevalence data and their distribution as found in the NHA-2 survey, carried out 
in 1997 with the SCAN-2.1 as a clinical interview instrument for the first time in 
a general population survey. The objective of the NHA-2 study, in addition to the 
comparison with the NHA-1 (see chapter 5), was to assess the following items 
with respect to the integral diagnostic reference of the DSM-IV: 
1. the prevalence rates of psychiatric disorders in the general population; 
2. the sociodemographic distribution of these disorders; 
3. the rate of comorbidity and its distribution with reference to gender, age 
and urbanisation; 
to study  
4. the influence of three newly determined diagnostic categories on 
prevalence, distribution and comorbidity; 
and to compare 
5. the NHA-2 data, with data from a contemporary epidemiological national 
survey in the Netherlands (NEMESIS) with respect to prevalence rates, 




6.2.1 History of the NHA-2 
In the early 1990s, Hodiamont, who had been responsible for the psychiatric 
part of the NHA-1, was approached by a representative of the Ministry of 
Health, Welfare and Sport, who suggested a replication of the psychiatric part of 
the NHA-1 project. Given that the primary objectiveof the 1997 survey (NHA-2) 
was to obtain (replication) data in the Nijmegen Health Area (NHA) for 
comparison with the 1983 NHA-1 data, the opportunity was seized to use an up-
to-date interview instrument with optimal possibilities for conversion of the 
scores to the 1983 format. The comparison of the NHA-1 and NHA-2 data with 
the use of the PSE-9 format was described in chapter 5. 
In this chapter, the 1997 data are presented with the aid of the data obtained 
with the interview instrument (SCAN-2.1) that was actually used, in order to 
describe the prevalence rates and distribution of psychiatric disorders in the 
general population.  
In addition to being used for the objectives mentioned above in this chapter and 
those stated in chapter 5, the data of the NHA-2 study were employed in six 
other studies. The purpose of one of these was to develop a list of High Risk 
Indicators (HRI) for psychiatric caseness for use in primary care practice 
(Roscam Abbing & Hodiamont 2000). A second study aimed at generating a 
screening list in primary care practice for the risk of future long-term use of 
benzodiazepines (Zandstra et al. 2002a; Zandstra et al. 2002b; Zandstra et al. 
2004). The object of the third study was to determine the relationships between 
social factors and depressive symptoms in the general population (Meertens et 
al. 2003; Meertens 2004). In the fourth study, Kooij et al. (2005) assessed the 
internal and external validity of attention-deficit hyperactivity disorder in a 
population-based sample of adults. The fifth study explored psychiatric 
comorbidity with a view to gaining a better insight into its magnitude, its 
distribution and its consequences for the general population and also into the 
differences between monomorbidity and comorbidity (Rijnders & Furer 2003). 
Finally, in the sixth study, which was explorative, the diagnosis and treatment of 
mental health problems in general practice were investigated (van Rijswijk et al. 
2000a; van Rijswijk et al. 2000b; van Rijswijk et al. 2005; van Rijswijk 2005). 
 
6.2.2 Study design 
Directly in line with the design of the NHA-1 study (1983), the NHA-2 study 
consisted of a two-stage (sampling), two-phase (interview) procedure (Duncan-
Jones 1979; Henderson et al. 1979; Hodiamont et al. 1987; Hodiamont & Veling 
1984). As far as the assessment of prevalence is concerned, the differences 
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between the first and the second study included an extension of the research 
domain and a refinement of the research method. In particular, the NHA-1 
domain was extended, which implied a widening of the diagnostic spectrum to 
include, for example, substance-related, somatoform, dissociative, and sleep 
disorders, and an increase in the age range up to 75 years. The refinement 
concerned mainly the screening instruments. 
 
6.2.3 Survey sample 
In order to gain easy access to the medical data needed for the additional 
projects, it was decided to use general practice registers for stage one. Since 
practically every inhabitant of the Netherlands is registered in a general 
practice, the degree of this registration is comparable to that of the registry 
offices (Boerma et al. 1993). We recruited 32 general practitioners (GPs), 11 
working in the city of Nijmegen and 21 in the surrounding communities. They all 
fulfilled the following criteria: they had worked in the same practice within the 
Nijmegen Health Area (NHA) for at least 2 years and had been supported by an 
operational, automated information system for patient data for at least the year 
preceding the study.  
The 32 GP registers contained information on 80,315 persons aged 18 to 75 
years, and a data set was constructed for all these persons, containing gender, 
age and prescription of psychotropic drugs. A random sample of 4,517 persons 
consisting of an equal number of subjects from each practice were sent a letter 
by their GP asking if they would give informed consent to take part in the survey 
(stage two). Those who consented were interviewed over a period extending 
from September 1997 to March 1998. 
 
6.2.4 Interviews 
The interviews were conducted in accordance with a two-phase design with the 
General Health Questionnaire 30 items (GHQ-30) as a screening list for 
psychiatric disturbance in phase one (T1) and the SCAN-2.1 psychiatric 
interview in phase two (T2). 
After informed consent was obtained from the respondents at stage two of the 
sampling, in T1, experienced interviewers from the Institute of Applied 
Sociology held a general interview with all subjects in the survey sample. In 
addition to the GHQ, which was used for screening in T1 (Furer et al. 1995a; 
Koeter & Ormel 1991a; Ormel et al. 1989), the interview included 
questionnaires about health measurement and health-related conceptsv and 
also addressed demographic characteristics. After completion of T1, the GPs, 
with the help of their automated system, filled out a questionnaire on the 
following: consultation frequency, GP psychiatric diagnosis and treatment (if 
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applicable), comorbidity data, some physical morbidity data, and the reason for 
the use of benzodiazepines. 
In T2, the respondents were interviewed with the SCAN-2.1, which includes the 
latest (tenth) version of the PSE (PSE-10), the successor to the PSE-9 (Wing et 
al. 1990; Wing 1996). The PSE-10 consists of two parts, the first dealing with 
anxiety, mood, and other neurotic manifestations and the second with psychotic 
and cognitive phenomena, and observation items on speech, behaviour, and 
affect. In this survey, the interview with the July 1997 version of the SCAN-2.1 
was used (Giel & Nienhuis 1997). 
Because the SCAN-2.1 requires clinically experienced trained interviewers and 
is time-consuming and consequently expensive, not all respondents in T1 were 
interviewed in T2. The number of respondents entering T2 was limited to a 
randomly assigned 25% portion of the survey sample, predominantly with a low 
score on the GHQ-30. To amplify for psychiatric caseness, the random sample 
was supplemented with all respondents who had a score of 4 or higher on the 
GHQ-30 in T1. The rationale for this selection was based, on the one hand, on 
the expectation that we would detect a sufficient number of cases to enter T2, 
and, on the other hand, on the requirement to include respondents with a low 
score, which is essential for analysing the full-scale GHQ-SCAN relationship. 
Consistent with the clinical, semi-structured nature of the SCAN-2.1, 30 
psychologists and psychiatric nurses were selected for their knowledge of 
psychopathology. Special sessions on psychiatric phenomenology were 
organised to optimize their actual clinical judgement. All interviewers 
participated in a 1-week training course on the use of the pencil-and-paper 
version of the SCAN, organised by the WHO-SCAN collaborating centre in 
Groningen. To assure data of good psychometric quality (see chapter 7), 
regular booster sessions with the interviewers were organised to improve their 
knowledge of psychopathology and interviewing techniques. Furthermore, a 
WHO-approved, computerised version of the SCAN-2.1 was introduced, 
including an algorithm for calculating DSM-IV diagnoses. During the fieldwork, 
problems encountered during the data checks were discussed with a 
psychiatrist (CR). Before the survey was conducted, a reliability study was 
carried out. The claim that clinical interviews are imperfect because of low 
interrater reliability and potential validity problems (Wittchen et al. 1999) has 
been rebutted for the PSE-9 (Duine et al. 1985b; Lesage et al. 1991; Wing et al. 
1977) and for the SCAN-2.1 (Andrews et al. 1995; Brugha et al. 1999b; Cheng 
et al. 2001; Rijnders et al. 2000; Tomov & Nikolov 1990). 
 
6.2.5 Analyses 
For all analyses, the Statistical Analyses for Social Sciences software package 
(SAS v8.2) was used. 
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For all SCAN data, DSM-IV diagnoses were computed by means of the SCAN-
2.1 algorithm. For the purpose of this survey, SCAN diagnoses were grouped 
on three levels: first, closely related diagnoses like single episode and recurrent 
depressive disorder were sorted into one diagnostic group (e.g., depressive 
disorder); then, associated diagnostic groups (e.g., depressive, dysthymic, and 
bipolar disorders) were classified into one diagnostic category (e.g., mood 
disorder), in accordance with the structure of DSM-IV; finally, the highest level 
of aggregation was represented by diagnostic caseness, defined as “the 
presence of at least one specific diagnosis”. 
 
The relationship between the GHQ and SCAN “caseness” was expressed in a 
logistic regression model in which the probability of an individual’s qualifying for 






where p indicates the probability that a certain GHQ score corresponds to 
SCAN-caseness, on the basis of the assessed α and β,which reflect the 
relationship between GHQ and the SCAN caseness as estimated from the 
outcome of all T2 interviews (Henderson et al. 1979; Hodiamont & Veling 1984). 
Because only 25% of the respondents with a GHQ score of less than 4 during 
their T1 interview were interviewed in T2, a weighting procedure was used for 
this group to restore the proportions initially present in the T1 group. Through 
substitution of the assessed probability for SCAN caseness for the GHQ score 
for all respondents in T1, the prevalence rate for the population was calculated.  
 
The prevalence rates for the diagnostic groups and categories were calculated 
through weighing the extent to which they occurred in the two GHQ classes with 
scores < 4 and ≥ 4 for T2 respondents. The weighting factors were determined 
by the ratio of the sizes of the two GHQ classes to one another in the first phase 
of the sample.  
So that the data for the general population could be interpreted, a post-
stratification weighting procedure was applied with the aid of 16 defined strata 
for gender, age (4), and urbanisation (2) on the basis of the 1997 census data 
(CBS 1997).  
To estimate the 95% two-sided confidence intervals for these weighted data, 
the logistic model was integrated into a bootstrap procedure, i.e. a re-sampling 
technique with duplication (Dunn et al. 1999; Efron & Tibshirani 1993).  
The significance of the difference in prevalence rates within sociodemographic 
distributions was tested in an ANOVA model. 
p(caseness)   =    1    
1+e 
-( α + β * GHQ) 
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6.3 Results 
6.3.1 Response and representativeness 
The response rate of the survey sample (T1) was 40.3% (N = 1,813). A total of 
440 subjects in the survey sample were randomly assigned to T2 (subgroup 1), 
supplemented by 509 subjects with a GHQ-30 score ≥ 4 (subgroup 2). Finally, 
767 subjects were interviewed in T2, the response rate being 81% in both 
subgroups. 
 
The impact of non-response was analysed with respect to the 
representativeness of general practices (stage 1 of the survey), 
sociodemographic variables, and psychotropic drug use as a measure of mental 
health (respondent-aligned, stage 2 of the survey). 
The general practices were representative of all Dutch general practices with 
regard to practice size, number of GPs working in the practice, GPs’ gender and 
year of registration, total working time of GPs and the percentage of practices 
with a pharmacy. The only significant difference was the higher number of 
practices with training facilities for GPs among the participating practices (χ² = 
5.6, p = .018). Since being a GP trainer was related to neither caseness nor 
GHQ score, it was not necessary to correct for this finding.  
Gender, age, and urbanisation (the city of Nijmegen versus the smaller 
surrounding communities) were used to test whether the survey sample was a 
good reflection of the general population (CBS 1997). Both the GP population 
and the GP sample proved to be good representations of the regional general 
population (Table 6.3.1). The significances found were a consequence of the 
larger numbers and are not relevant percentually.  
In the survey sample in T1, males and inhabitants of Nijmegen had a lower 
representation and younger persons were underrepresented. For all three 
sociodemographic variables, a correction was made for the analysis, in which 
the 1997 CBS census data were used. 
The existence of at least one prescription of psychotropic medication over the 
12-month period preceding the study was used as an indicator of mental illness. 
In epidemiological research into psychiatric prevalence, this can be regarded as 
an important representativeness indicator. No differences were found between 
the GP population and the samples with respect to any of the five medication 





Representativeness for gender, urbanisation, and age  








Sociodemographic  N=325,566 N = 80,315 N = 4,517 N = 1,813 
variable  % % χ²    ( p) % χ²    ( p) % χ²  ( p) 




44.7 19.8  
(< .001)  Female  50.1 50.7 51.4 55.3 
         









 Surrounding  
communities 
65.5 65.0 65.3 70.7 
         









 30 - 44 34.0 37.0 36.6 37.5 
 45 - 59 25.3 23.5 24.8 30.0 
 60 - 74 15.6 13.8 14.1 17.7 




Table 6.3.2  




GP sample Survey sample 
 N = 80,315 N = 4,517 N = 1,813 
Prescription % % χ² ( p) % χ² ( p) 
Antidepressants 3.4 3.0 2.0 NS 3.4 0.0 NS 
Benzodiazepines 9.5 8.7 3.0 NS (.08) 10.3 1.6 NS 
Antipsychotics 0.8 0.6 2.8 NS (.10) 0.4 3.3 NS (.07) 
Analgesics 9.6 9.6 0.0 NS 10.3 0.9 NS 
Other psychotropic drugs 2.7 2.7 0.0 NS 2.7 1.4 NS 




6.3.2 Psychiatric prevalence 
6.3.2.1 Prevalence: full diagnostic range 
In the logistic regression model, α was estimated at -2.52 and β at +0.16. After 
correction for gender, age and urbanisation, the 1-month overall prevalence rate 
of psychiatric morbidity in the Nijmegen Health Area turned out to be 17.6% (± 
2.6%). Variables such as gender, age, and urbanisation did not improve the 
model. 
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The prevalence rates for the respective diagnostic categories and groups are 
reported in Table 6.3.3. The four categories with the highest prevalence rates 
were sleep (4.8%), anxiety (4.6%), substance-related (4.0%), and mood 
disorders (3.8%). Substance abuse (3.2%), depression (2.7%), and phobic or 
panic disorders (2.6%) were the diagnostic groups most frequently found. 
 
6.3.2.2 Prevalence: influence of the three newly determined categories 
When the three newly determined diagnostic categories in the general 
population (sleep, dissociative, and somatoform disorders) were left out of the 
logistic regression model, α was estimated at -2.99 and β at +0.15. In 
comparison with the full diagnostic range, the prevalence rate of psychiatric 




Prevalence rates* of psychiatric disorders with reference to caseness, 
categories and groups 
 Prevalence  Prevalence 
Caseness 17.6 (± 2.6) †   
Psycho-organic disorder 0.3  Eating disorder 0.4 
Dementia 0.3  Anorexia Nervosa 0.1 
Other organic brain disorder 0.0  Other eating disorders 0.3 
Substance-related disorder 4.0  Somatoform disorder 2.8 
Dependence 0.9  Somatisation disorder 0.1 
Abuse 3.2  Pain disorder 1.2 
Psychotic disorder 0.5  Other somatoform disorder 1.5 
Schizophrenia 0.4  Dissociation disorder 1.4 
Delusional disorder, non-aff. psychosis 0.1  Sleep disorder 4.8 
Mood disorder 3.8  Dyssomnia 2.2 
Depression 2.7  Parasomnia 2.1 
Mania, hypomania, mixed disorder 0.3  Other sleep disorder 0.5 
Dysthymic disorder 1.9  Other psychiatric disorder 0.7 
Anxiety disorder 4.6    
Generalised anxiety disorder 0.3    
Phobic or panic disorder 2.6    
Obsessive-compulsive disorder 1.3    
Other anxiety disorders 0.6    
* after correction for gender, age, and urbanisation; due to comorbidity, cumulative 
percentages of diagnostic groups within a given category may exceed percentages 
for diagnostic categories 




6.3.3 Distribution of psychiatric disorders  
6.3.3.1 Distribution: full diagnostic range 
The sociodemographic distribution of psychiatric caseness is presented in Table 
6.3.4. The prevalence rate of caseness was significantly higher for females 
(19.1%) than for males (16.2%, Table 6.3.5). This also applied to subjects living 
in the city of Nijmegen (20.1%) in comparison with those resident in the 
surrounding communities (16.3%). Table 6.3.4 shows that the age group 45-54 
yrs (20.1%), divorced subjects (22.7%), unemployed subjects (29.5%) and 
chronically ill subjects (29.5%), and those in a lower education bracket (20.0%) 
had a higher caseness rate than the subjects in other sociodemographic 
subgroups. Apart from the age effect, this distribution agreed with the findings of 
Dohrenwend and Dohrenwend (1974). 
 
The distribution of diagnostic categories across gender, age, and urbanisation 
subgroups is presented in Table 6.3.5. The number of age groups was reduced 
to obtain sufficient power for the analysis of the more detailed diagnostic 
categories and groups.  
The rates for females were equal to or higher than those for males for all 
diagnostic categories and groups, except for substance-related disorders, for 
which the rate was significantly higher for males, mainly because of a difference 
in substance abuse rates. Mood disorders, in particular depression and 
dysthymia, were two to three times more common amongst females, while the 
prevalence rate of sleep disorders, a DSM category rarely assessed in the 
general population, was three to four times higher for females than for males.  
The prevalence rate of substance-related disorders decreased with increasing 
age, with a significantly lower rate of substance abuse for the oldest subjects. A 
tendency toward the highest rates for mood disorders was found in the age 
group 45-59 yrs, especially due to a significant contribution of depressive 
disorders, which was significantly lower in younger persons. The rates of sleep 
disorders were also lower for younger people.  
The prevalence rate of caseness for subjects living in the city of Nijmegen was 
higher than for those resident in the surrounding communities. Nearly all 
diagnoses, especially substance-related disorders and mood disorders, were 
more frequent in the city of Nijmegen than in the surrounding communities, 
except for somatoform disordersvi, for which the prevalence rate was higher in 




Sociodemographic distribution of psychiatric caseness  
 Total Males Females 
  Nijmegen SC * Nijmegen SC * 
 N % N % N % N % N % 
Caseness 1,799 17.6 214 18.8 589 14.8 311 21.3 685 17.8 
Age group (yrs)           
18-24 120 16.0 16 21.9 28 12.4 29 19.6 47 13.9 
25-34 359 18.4 44 18.5 93 13.2 86 20.9 136 20.4 
35-44 461 16.8 64 17.9 151 15.2 80 19.8 166 16.5 
45-54 391 20.1 a 41 20.7 144 18.1 53 25.3 153 20.0 
55-64 272 16.7 26 19.8 102 15.2 28 26.9 116 14.9 
≥ 65 194 14.7 b 23 14.9 70 12.7 35 17.6 66 15.2 
Marital status           
Single 141 19.8 41 22.2 33 20.8 48 19.1 19 14.9 
Living with parents 68 15.4 5 24.5 32 13.2 3 25.0 28 15.4 
Living with partner 214 18.2 35 17.9 39 17.0 84 20.1 56 16.5 
Married 1,209 17.2 117 18.1 454 14.4 124 22.6 514 18.2 
Divorced 88 22.7 11 15.2 24 20.6 31 27.3 22 22.2 
Widowed 77 16.9 5 14.2 6 19.3 21 16.3 45 17.2 
Employment status**           
Full-time employed 706 15.6 b d 130 16.2 384 14.4 92 16.2 100 18.7 
Part-time employed 378 18.0 b d 23 15.1 27 14.3 90 21.6 238 17.4 
Retired 189 14.8 b d 28 15.6 100 14.7 20 20.8 41 11.3 
Chronically ill/unable to work 74 29.5 a e 6 58.8 42 21.5 9 36.3 17 35.4 
Unemployed 40 29.5 c 10 35.0 12 20.3 9 39.5 9 25.6 
School or college student 60 17.8 b 12 24.6 14 15.4 13 19.3 21 14.6 
Householder 285 19.9 f -- -- 1 7.5 57 26.9 227 18.2 
Others without an occupation 59 17.4 b 5 25.7 7 16.4 19 16.0 28 17.1 
Educational level           
University 151 17.4 46 18.7 35 16.0 62 17.1 8 18.4 
Higher vocational education 314 15.3 36 16.8 97 14.0 82 16.8 99 14.7 
Upper-stream sec. education 162 17.9 36 19.5 40 10.9 35 21.7 51 19.7 
Lower-stream sec. & post-sec. 
lower vocational education 338 16.0 26 17.2 130 14.6 16 24.4 166 16.1 
Lower-stream sec. education 226 18.5 18 17.9 55 16.7 32 20.5 121 18.8 
Continued primary education 423 19.7 38 21.9 156 15.7 53 28.7 176 20.0 
No education or only primary 
education 
183 20.0 14 17.9 75 17.5 31 28.9 63 18.9 
* SC: surrounding communities 
** N = 6 missing  
Age group: Kruskal-Wallis    .0001 < p < .001; Scheffé (.05) a – b 
Marital status: Kruskal-Wallis  .001< p < .01; Scheffé, non-significant 
Employment status: Kruskal-Wallis  p < .0001; Scheffé (.05) a – b ,  c – d , and for females 
only e - f 
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Psychotic disorder 
     Schizophrenia  
Mood disorder 
     Depression  
Mania, hypomania, mixed disorder 
     Dysthymic disorder 
Anxiety disorder 
     Generalised anxiety disorder 
     Phobic or panic disorder 
     Obsessive-compulsive disorder 
     Other anxiety disorder 
Eating disorder 
     Anorexia Nervosa 
     Other eating disorder 
Somatoform disorder 
     Somatisation disorder 
     Pain disorder 
     Other somatoform disorder 
Dissociation disorder 
Sleep disorder 
     Dyssomnia 
     Parasomnia 
     Other sleep disorder 
Other psychiatric disorder 
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Legend to table 6.3.5 
* SC: surrounding communities 
a  after correction for gender, age, and urbanisation 
p:  Caseness: ANOVA: * = .01 < p ≤ .05; ** = .001 < p ≤ .01; *** = p ≤ .001,  
Scheffé (.05) b - c 
Categories and groups: χ2: * = .01 < p ≤ .05; ** = .001 < p ≤ .01; *** = p ≤ .001; for 
age: Scheffé (.05) d - e 
 
6.3.3.2 Distribution: influence of the three newly determined categories 
When the three newly determined categories were left out, the 
sociodemographic distribution of caseness was characterised by about the 
same pattern as the distribution of caseness for the full diagnostic range (Table 
6.3.6). At first sight, the geographical distribution of two of the three categories 
appears not to correspond to the findings of Dohrenwend and Dohrenwend, as 
the prevalence rates for somatoform disorders and sleep disorders were higher 
in the surrounding communities than in Nijmegen (Table 6.3.5). But when the 
hierarchical rules of DSM-IV were not applied, the regional distribution of the 
prevalence rates corresponded to its expected pattern of a higher rate in the city 
than in the surrounding communities (somatoform disorders 3.9% and 3.4%, 





Sociodemographic distribution of psychiatric caseness without the three 
newly determined categories  
 Total Males Females 
  Nijmegen SC* Nijmegen SC* 
 N % N % N % N % N % 
Caseness 1,799 11.9 214 12.9 589 9.8 311 14.8 685 12.0 
Age group (yrs)           
18-24 120 10.5 16 15.1 28 7.9 29 13.1 47 8.9 
25-34 359 12.4 44 12.2 93 8.5 86 14.4 136 13.9 
35-44 461 11.3 64 12.3 151 10.1 80 13.6 166 11.0 
45-54 391 14.4 a 41 14.4 144 12.4 53 17.8 153 15.2 
55-64 272 11.3 26 14.3 102 10.2 28 19.4 116 9.7 
≥ 65 194 9.8 b 23 10.0 70 8.4 35 12.0 66 10.0 
Marital status           
Single 141 13.2 41 15.0 33 14.0 48 12.6 19 9.5 
Living with parents 68 10.1 5 17.4 32 8.3 3 17.2 28 10.0 
Living with partner 214 12.3 35 11.9 39 11.6 84 13.8 56 10.1 
Married 1,209 11.7 117 12.7 454 9.5 124 15.9 514 12.3 
Divorced 88 15.6 11 9.8 24 14.6 31 19.3 22 15.3 
Widowed 77 11.2 5 8.9 6 12.5 21 11.1 45 11.3 
Employment status**           
Full-time 706 10.2 b 130 10.6 384 9.5 92 10.6 100 12.4 
Part-time 378 12.1 b 23 9.9 27 9.5 90 14.8 238 11.6 
Retired 189 10.0 b 28 10.6 100 10.0 20 14.5 41 7.2 
Chronically ill/unable to work 74 21.6 a c 6 47.3 42 14.9 9 29.1 17 25.2 
Unemployed 40 21.7 a 10 27.2 12 14.0 9 28.7 9 18.9 
School or college student 60 11.8 b 12 17.3 14 9.8 13 12.8 21 9.4 
Householder 285 13.7 d -- -- 1 4.8 57 19.3 227 12.3 
Others without an occupation 59 12.0 b 5 19.2 7 10.6 19 11.2 28 11.5 
Educational level           
University 151 11.5 46 12.7 35 10.6 62 11.2 8 11.8 
Higher vocational education 314 10.0 36 11.0 97 9.2 82 11.1 99 9.6 
Higher secondary education 162 12.0 36 13.3 40 7.0 35 14.5 51 13.3 
Lower-stream sec. & post-sec. 
lower vocational education 
338 10.7 26 11.2 130 9.7 16 18.1 166 10.7 
Lower-stream sec. education 226 12.6 18 12.5 55 10.9 32 14.5 121 12.9 
Continued primary education 423 13.6 38 15.9 156 10.6 53 20.8 176 13.7 
No education or only primary 
education 
183 13.6 14 12.9 75 11.8 31 20.8 63 12.4 
* SC: surrounding communities 
** N = 6 missing  
Age group: Kruskal-Wallis: .0001 < p< .001; Scheffé (.05) a – b 
Marital status: Kruskal-Wallis:  .001< p< .01; Scheffé, non-significant 
Employment status: Kruskal-Wallis:  p< .0001; Scheffé (.05) a – b  and for females  
only  c - d 
Educational level: Kruskal-Wallis:  .001< p< .01; Scheffé, non-significant 
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6.3.4 Psychiatric comorbidity 
6.3.4.1 Comorbidity: full diagnostic range 
Although DSM-IV includes a diagnostic hierarchy, one person can have more 
than one diagnosis. Of the total number of cases, 26.1% had more than one 
diagnosis (17.1% two, 4.1% three, and 4.9% four or more diagnoses - see 
Table 6.3.7). The comorbidity rates for females were higher than for males, 
which was significant for subjects with two diagnoses. For all numbers of 
diagnoses per subject, prevalence rates of comorbidity differed significantly for 
age and urbanisation. Comorbidity rates were higher for subjects aged 45 to 59 
years and subjects living in the city of Nijmegen. 
 
 
Table 6.3.7  
Distribution of diagnostic comorbidity across gender, age and 
urbanisation  
 Total Gender Age Urbanisation 






















Caseness 17.6 16.2 19.1 *** 17.1 17.2 20.1 a 15.5 b *** 20.1 16.3 *** 
             
1 diagnosis 13.0 12.3 13.8 ** 12.7 12.8 14.4 c 11.9 d *** 14.4 12.3 *** 
2 diagnoses 3.0 2.7 3.3 ** 2.7 2.9 3.6 c 2.7 d ** 3.6 2.7 *** 
3 diagnoses 0.7 0.6 0.8  0.5 0.7 1.0 0.6 * 1.1 0.5 *** 
4 diagnoses 0.9 0.7 1.0  0.6 0.8 1.3 0.8 * 1.3 0.6 *** 
Caseness: ANOVA: * = .01 < p ≤ .05; ** = .001 < p ≤ .01; *** = p ≤ .001,  
Scheffé (.05) a - b 
Number of diagnoses: χ2: * = .01 < p ≤ .05; ** = .001 < p ≤ .01; *** = p ≤ .001; for age: 
Scheffé (.05) c - d 
 
 
6.3.4.2 Comorbidity: influence of the three newly determined categories 
The cumulative prevalence rate of the three categories was 9% (Table 6.3.3), 
whereas their actual contribution to caseness was only 5.7% (17.6% and 11.9% 
with and without the three categories). This means that the comorbidity rate for 
the three newly determined categories themselves was 36.7% (Table 6.3.8), as 
against 26.1% for comorbidity for the full diagnostic range. As a result, of the 
total number of subjects who constituted a case when the three categories were 




Distribution of diagnostic comorbidity across gender, age and 
urbanisation, without the three newly determined categories  
 Total Gender Age Urbanisation 






















Caseness 11.9 10.8 13.0 *** 11.3 11.6 13.8 a 10.4 b *** 13.9 10.9 *** 
             
1 diagnosis 9.3 8.7 9.8 ** 9.0 9.1 10.3 c 8.4 d *** 10.3 8.7 *** 
2 diagnoses 1.6 1.4 1.8 ** 1.4 d 1.6 2.1 c 1.4 d ** 2.1 1.4 *** 
3 diagnoses 0.7 0.5 0.8  0.4 0.6 1.0 0.6 * 1.0 0.5 *** 
4 diagnoses 0.4 0.3 0.4  0.2 0.3 0.6 0.3 * 0.6 0.2 *** 
Caseness: ANOVA: * = .01 < p ≤ .05; ** = .001 < p ≤ .01; *** = p ≤ .001,  
Scheffé (.05) a - b 
Number of diagnoses per subject: χ2: * = .01 < p ≤ .05; ** = .001 < p ≤ .01; *** = p ≤ .001;  
for age: Scheffé (.05) c - d 
 
 
6.3.5 The NHA-2 and the NEMESIS 
The first wave of the Netherlands Mental Health Survey and Incidence Study 
(NEMESIS) was carried out in 1996 with the aid of the CIDI-1.1 (Bijl et al. 1998). 
A total of five main diagnostic categories were included in the psychiatric 
interview in the general population, aged 18 to 64 years.  
When the survey sample (with respect to age) and diagnostic range in the NHA-
2 were reduced to the extent adopted in the NEMESIS, the prevalence rate for 
the NHA-2 was 11.7% (±2.2%), which was substantially lower than the 16.5% 
(±0.4%) prevalence rate in the NEMESIS study (see Table 6.3.9). Yet the 
distribution of the prevalence rates by gender is comparable for the two studies, 
as in both the prevalence rates were higher for females for all diagnostic 
categories and groups, except for the substance use-related disorders.  
The most striking difference between the two studies from a diagnostic 
perspective (probably due to a difference in the clinical experience of the 
interviewers) was in the anxiety category, especially in the phobic groups. The 
prevalence rate for this category was twice as high in the NEMESIS study as in 
the NHA-2 (9.7% vs. 4.9%), the biggest difference occurring in the specific 
phobia group (5.5% vs. 0.8%). As the only exception, the prevalence rate of 
obsessive-compulsive disorder (OCD) in the NHA-2 was higher than in the 
NEMESIS study (1.4% vs. 0.3%).  
Another marked difference was found with regard to substance-related 
disorders, for which the prevalence rate in the NHA-2 was lower than in the 
NEMESIS (4.4% vs. 5.8%), and for males the rate of substance abuse was 
higher and that of dependence lower than in the NEMESIS.  
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The rate of psychotic disorders found in the NEMESIS study was lower than in 




Prevalence rates a in the NHA-2 and the NEMESIS study 
 NHA-2 NEMESIS 
 Male 
N = 710 
Female 
N = 895 
Total 
N = 1,605 
Male 
N = 3,777 
Female 
N = 3,299 
Total 
N = 7,076 
Caseness 10.7 12.7 11.7 15.9 17.0 16.5 
Substance use-related disorder 7.4 1.9 4.4 9.2 2.4 5.8 
     Dependence 1.0 1.0 1.0 5.1 1.4 3.3 
     Abuse  6.4 1.0 3.4 4.2 1.0 2.6 
Psychotic disorder 0.5 0.5 0.5 0.1 0.2 0.2 
     Schizophrenia 0.3 0.5 0.4 --- --- --- 
     Delusional disorder,  
     non-aff. psychosis 
0.2 0.0 0.1 --- --- --- 
Mood disorder 2.4 5.2 4.0 2.8 5.0 3.9 
     Depression 1.4 4.1 2.9 1.9 3.4 2.7 
     Mania, hypomania,  
     mixed disorder 
0.3 0.3 0.3 0.4 0.8 0.6 
     Dysthymic disorder 1.0 2.8 2.0 1.0 2.1 1.6 
Anxiety disorder 3.1 6.4 4.9 6.5 12.9 9.7 
     Generalised anxiety 
     disorder 
0.2 0.4 0.3 0.6 1.0 0.8 
     Panic disorder 0.1 0.5 0.3 0.8 2.2 1.5 
     Agoraphobia (without  
     panic disorder) 
0.0 0.4 0.2 0.6 1.4 1.0 
     Specific phobia  0.2 1.3 0.8 3.1 8.0 5.5 
     Social phobia 1.5 1.1 1.3 2.8 4.7 3.7 
     Obsessive-compulsive 
     disorder 
0.9 1.8 1.4 0.3 0.2 0.3 
Eating disorder 0.0 0.7 0.4 0.1 0.4 0.3 
     Anorexia Nervosa 0.0 0.1 0.1 0.0 0.0 0.0 
     Other eating disorders 0.0 0.6 0.3 0.1 0.4 0.3 
a after correction for gender, age, and urbanisation; due to comorbidity, cumulative 
percentages of diagnostic groups within a given category may exceed percentages 






6.4.1 Study limitations 
The fact that the respondents were recruited as a random sample from the 
patient registers of GPs had two consequences. The first consequence was an 
advantage: we were able to check for selectivity by means of the prescription 
rate for psychotropic medication. The second consequence was a 
disadvantage: the medical ethics committee deemed that the epidemiological 
part of the study was no longer a field survey in the general population, but a 
patient-oriented study. As a result, potential respondents seemed to be deterred 
by the exhaustive informed consent letter judged to be necessary by the 
medical ethical committee. Consequently, the response rate did not meet our 
expectations. Nevertheless, with respect to the survey, the sample turned out to 
be representative of the general population as far as psychiatric morbidity was 
concerned. That was shown by the fact that there were neither significant, nor 
relevant differences in the prescription rates for psychotropic drugs, which was 
adopted as an indication of mental illness. The non-response between phases 
T1 and T2 (19%) corresponded to that of other two-phase studies in the general 
population (McConnell et al. 2002; Roca et al. 1999). The choice of an 
expensive and demanding clinical interview instrument naturally imposed 
limitations on the number of interviewees in comparison with the number in the 
NEMESIS and the National Comorbidity Study (NCS) study (Bijl et al. 1998; 
Kessler et al. 1994; Narrow et al. 2002).  
 
6.4.2 Psychiatric prevalence 
In the NHA-2 study, we found the overall prevalence rate for psychiatric 
disorders in the general population to be 17.6%. Prevalence rates for 
psychiatric morbidity vary considerably (WHO 2000). In their overview of a 
number of larger studies in the general population, Goldberg and Huxley (1992) 
cite a mean 1-month prevalence rate of 16.4%, for which the range is large 
(7.3% (Hodiamont et al. 1987) to 26.2% (Cheng 1988)). Their data are based 
on the PSE and the Diagnostic Interview Schedule (the DIS, the precursor of 
the CIDI), which have a limited diagnostic range in comparison with later 
interviews. The prevalence rate in the NHA-2 for the incomplete range was 
11.9%, which was 5.8% lower than for the complete range. This implies that the 
estimated 1-month complete prevalence rate cited by Goldberg and Huxley 
would increase to 22.2% if the integral diagnostic range were adopted. 
The NHA-2 study is the first epidemiological survey in the general population in 
the Netherlands to have used a semi-structured, clinically oriented interview 
(SCAN-2.1) covering the complete range of DSM-IV disorders (with the 
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exception of disorders usually first diagnosed in infancy, childhood, or 
adolescence). From this perspective, the overall prevalence rate of 17.6%, 
although significantly higher than the rate determined from the 1983 NHA-1 
data (see chapter 5), can be considered as below average, given the 
contribution of sleep, somatoform, and dissociative disorders, which usually are 
not assessed. (Angst et al. 2005; Bijl et al. 1998; Kessler et al. 1994; Kessler et 
al. 2005b). One important reason for this finding is the clinical nature of the 
SCAN-2.1 (Brugha et al. 1999a; Brugha et al. 2001; Cooper & Singh 2000; 
Goldberg & Huxley 1992; Narrow et al. 2002). 
 
6.4.3 Distribution of psychiatric disorders 
The demographic distribution of the diagnoses in the NHA-2 study 
constitutes a recognisable picture (Dohrenwend & Dohrenwend 1974), with 
higher rates for females than for males for most disorders, with the exception of 
substance-related disorders. In agreement with other studies, higher rates were 
found in the city than in the surrounding communities (Glover et al. 1998; 
Hodiamont et al. 1992; Jenkins et al. 1997; Peen et al. 2002). On the other 
hand, there is no consensus in the literature on the relationship between age 
and psychiatric morbidity. Hodiamont et al. (1987) reported a general increase 
in prevalence rates with increasing age, whereas other investigators state that 
the rates tend to decrease with age. Goldberg and Huxley (Goldberg & Huxley 
1992) suggested that “generally speaking, rates for common mental disorders 
peak in the middle years”. In our study, we found a significant peak in the 
prevalence rates for persons aged 45 to 54 years (Table 6.3.4 and Table 6.3.6) 
and a lower rate for the highest age group, despite the fact that psycho-organic 
disorders were part of our diagnostic spectrum. With regard to educational level 
and marital status, our findings are consistent with those reported in the 
literature in that the prevalence rate for caseness for subjects with little 
education, and unemployed, chronically ill and divorced subjects was higher. 
 
6.4.4 Psychiatric comorbidity 
In the NHA-2 study, which was based on the SCAN-2.1, the comorbidity rate of 
the subjects with a diagnosis was substantial (26%), but lower than in most CIDI 
studies. The overall 1-month comorbidity rate for the NEMESIS was slightly 
higher, namely just over 30% (Bijl et al. 1998; Ravelli et al. 1998). Roca (1999) 
reports the 1-month comorbidity rate of the Formentera study to be 36.2%. One-
month comorbidity data from the NCS study are not available. With the 
prolongation of the period of reference, comorbidity rates in subjects with at 
least one diagnosis increase to 56% (NCS) and even 60% (ECA) when lifetime 
is used as a reference (Bijl et al. 1998; Kessler et al. 1994; Ravelli et al. 1998; 
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Robins et al. 1991). Kessler (2005b) reports the 12-month comorbidity rate of 
the NCS-Replication study to be 45%. 
 
6.4.5 Influence of the three newly determined categories 
The three psychiatric diagnostic categories newly determined in the general 
population contributed substantially to the psychiatric prevalence rate, which 
increased by almost 50% when they were included. Bebbington et al. (1997) 
reported a contribution of sleep disorders to the prevalence rate amounting to 
almost one third.  
The three categories had the same sociodemographic distribution as most other 
diagnostic categories, apart from the somatoform disorders, for which there was 
no difference in distribution between the sexes, and a higher prevalence rate for 
the elderly and the rural dwellers. One important explanation of the deviation 
from the regular pattern of the sociodemographic distribution of these disorders 
(no gender difference and a higher prevalence rate for rural dwellers) is that 
pain disorders (somatoform disorder) and dyssomnia (sleep disorder) in 
particular share key symptoms with major mood and anxiety disorders. Because 
mood and anxiety disorders prevail hierarchically over dyssomnia and pain 
disorders, the latter two disappear. As a consequence, higher prevalence rates 
for mood and anxiety disorders in females and city people have a reducing 
effect on the prevalence rates of these two newly determined categories. When 
the hierarchical rules of DSM-IV are omitted, these differences disappear and 
the expected pattern of higher rates for females and city dwellers is observed. 
The additional three newly determined categories also contributed to the 
comorbidity rate (36.7%) to a greater extent than the commonly determined part 
of the diagnostic range (22.3%). Furthermore, as these categories are partially 
hidden as a result of the DSM hierarchical rules, comorbidity would be much 
higher still if these rules were not taken into account. This illustrates their 
importance to this health issue, since, on the one hand, comorbidity points to 
the complexity of the underlying problems, and on the other, most interventions 
(medication, psychotherapy, etc.) are not comorbidity ‘proof’, in that they are 
focussed on the treatment of well-defined monomorbid disorders. 
 
6.4.6 The NEMESIS 
The NHA-2 study and the NEMESIS are two epidemiological studies on 
psychiatric morbidity in the general population, the two of them having been 
carried out in the Netherlands at about the same time. Because of the co-
occurrence of the two studies, it is meaningful to compare their results with one 
another. The comparability of the NEMESIS and the NHA-2 results is hindered 
by a number of differences between the two designs. In particular, the 
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NEMESIS data were collected from a nation-wide sample of the general 
population aged 18 through 64 years, in one phase, and throughout 1996, with 
the CIDI, a fully structured interview based on the DSM-III-R with a limited 
diagnostic range, which was administered by trained lay interviewers. In 
contrast, the NHA-2 addressed a regional sample of the general population 
aged 18 through 75 years, from September 1997 to February 1998, on the 
basis of a two-stage, two-phase design, with the aid of the SCAN-2.1, a semi-
structured, clinical interview based on the integral diagnostic range of DSM-IV 
and administered by trained clinicians. For two of the differences (age and 
diagnostic range), the NHA-2 data could be adjusted before comparison. All 
things considered, the differences could be attributed to differences in the 
diagnostic instrument (CIDI vs. SCAN) that was used, the classification 
system (DSM-III-R vs. DSM-IV) that was adopted, and the geographical area 
(national vs. regional) in which the sampling was done.  
The two studies generated markedly different results. The higher overall 
prevalence rate found in the NEMESIS (16.5% vs. 11.7% in the NHA-2) can to 
a great extent be accounted for by the anxiety (i.e., specific phobia) rates. 
Specific phobia is one of the diagnoses that are based on the subject’s account 
of his or her experiences in everyday life situations. 
Unlike the SCAN ratings, the CIDI ratings are based purely on the subjective 
respondent’s answers (‘yes’ or ‘no’), which tend to be influenced by subjective 
feelings of perceived morbidity (illness), no account being taken of a judgement 
about the clinical relevance of each experience, sign or symptom separately. 
Given the preceding, it is conceivable that comparable items are scored more 
readily in the CIDI than in the SCAN, resulting in a higher prevalence rate 
(Brugha et al. 1999a; Brugha et al. 2001; Cooper & Singh 2000).  
The fact that the rate of substance-related disorders was lower in the NHA-2 
than in the NEMESIS has more than one explanation. One of these is the 
difference in the criteria used in the DSM-III-R (NEMESIS) and the DSM-IV 
(NHA-2): the DSM-III-R requires at least three out of nine symptoms, whereas 
the DSM-IV requires three out of sevenvii, the latter being harder to satisfy 
statistically. Furthermore, there is a difference between the two manuals with 
regard to the period of reference: this is “a longer period than the person 
intended” in DSM-III-R, and a fixed 12-month period in the DSM-IV, the former 
literally introducing subjectivity as the point of reference. As a result of these 
differences, the higher dependence rate in the NEMESIS reduces the abuse 
rate because of the hierarchical relationship in the DSM between dependence 
and abuse (the existence of dependence is an exclusion criterion for abuse in 
both manuals). Another explanation of the lower dependence rate in the NHA-2 
might be that the NEMESIS, being a national study, included metropolitan 
areas, which possibly contributed to a higher rate of these disorders than in the 




All in all, we deem the SCAN-2.1 to be a clinical instrument feasible for use in 
general population surveys, its advantage being that clinical standards can be 
maintained. Comparison of the results of the NHA-2 with those of the NEMESIS 
supports our conclusion that clinical interviews are suitable for testing the 
psychiatric (clinical) relevance of common signs and symptoms, and 
consequently lead to lower and more plausible prevalence rates (Brugha et al. 
2001).  
The use of the SCAN-2.1 and the integral range of the DSM-IV resulted in a 
prevalence rate of 17.6%, to which the diagnostic categories newly determined 
in the general population, such as sleep, dissociative, and somatoform 
disorders, contributed a substantial part, namely 5.7%. The sociodemographic 
distribution of psychiatric disorders turned out to be as Dohrenwend and 
Dohrenwend described it years ago.  
Despite the use of the complete diagnostic range, comorbidity rates in the NHA-
2 can be classified as moderate, notwithstanding the boosting effect of the three 
newly determined diagnostic categories. 
Fully structured interviews like the ones used in the NEMESIS and the NCS 
yield higher caseness rates than clinical interviews like the SCAN-2.1. Although 
the literature on general population studies performed with the SCAN is still 
limited, it may be concluded that the NHA-2 has the most moderate levels of 
psychiatric caseness to date. 
With regard to costs, the CIDI makes general population studies more feasible 
than the SCAN, but currently gives rise to improbably high prevalence rates for 
specific diagnostic categories. Because of the large discrepancies in prevalence 
rates between the SCAN and the CIDI for diagnostic caseness and also 
diagnostic categories, the use of the former is preferable as far as 
methodological validity is concerned. But it has its price and the challenge 
before us is to improve the CIDI in this respect. More direct comparative studies 
between the SCAN and the CIDI (as presented in chapter 9) will be needed to 
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7.1 Introduction 
Before any survey is started, insight into the psychometric properties of the 
proposed instrument is necessary to estimate the quality of the data that will be 
collected. This is even more pressing when the instrument is new or has been 
fundamentally revised. 
The development of the Schedules for Clinical Assessment in Neuropsychiatry 
(SCAN-2.1), one of the latest instruments developed by the WHO for the 
assessment of psychiatric disorders, is part of a rich tradition (Janca et al. 
1994). The core part of the SCAN-2.1 is the tenth version of the Present State 
Examination (PSE-10), a semi-structured interview, and the successor to the 
PSE-9 (Wing et al. 1990; Wing 1996). Another instrument for the assessment of 
psychopathology is the Composite International Diagnostic Interview (CIDI), 
which is a highly structured interview, frequently used in epidemiological studies 
(Sartorius & Janca 1996). Interviewer-rated (semi-structured) interviews target 
the clinical situation better than highly structured interviews or self-rated 
questionnaires, probably at the cost of loss of reliability. Consequently it is 
essential to assess the psychometric properties of the SCAN-2.1. There is clear 
evidence of the reliability of the PSE-9 (Duine et al. 1985a; Wing et al. 1974) 
and also of the CIDI (Andrews & Peters 1998; Sartorius & Janca 1996; Wittchen 
et al. 1991; Wittchen 1994). Although some studies have been undertaken to 
obtain information on the reliability of specific sections of previous versions of 
the SCAN (Andrews et al. 1995; Easton et al. 1997; Tomov & Nikolov 1990; 
Wing et al. 1990), the psychometric properties of the entire interview SCAN-2.1 
have never been tested.  
 
In 1997 a general population survey was carried out in the Nijmegen Health 
Area (the Netherlands) with the Dutch version of the SCAN-2.1 (Giel & Nienhuis 
1996) for psychiatric assessment. Prior to the survey data collection, a study on 
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the psychometric properties of the SCAN-2.1 had been carried out with the use 
of two designs, each with its own approach to the design-specific causes of 
measurement errors (Shrout 1995). In one design, pairs of independent live 
interviews with the same subject were compared (test-retest procedure). In the 
other, ten videotaped interviews by experts were rated by each of the 
interviewers (standardised procedure) and the outcomes were compared with 
the scores of the interviews conducted by the other interviewers and also with a 
reference score (the consensus score of the experts). 
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7.2 Subjects and methods 
In addition to the PSE-10 semi-structured interview, the SCAN-2.1 includes two 
instruments recently developed by the WHO, the Clinical History Schedule and 
the Item Group Checklist, neither of which is an interview. They are used in 
clinical settings to obtain information from medical records or from significant 
others when the PSE-10 information from the subject is insufficient. These were 
not part of this study. 
The PSE-10 consists of two parts: the first deals with anxiety, mood, and other 
neurotic signs and symptoms and the second with psychotic and cognitive signs 
and symptoms and observation items that target speech, behaviour and affect. 
For all data, specific DSM-IV diagnoses are computed by means of the SCAN-
2.1 algorithm, which covers all the DSM-IV diagnoses except disorders usually 
first diagnosed in infancy, childhood or adolescence.  
 
For the purpose of this study, specific DSM-IV diagnoses were assigned to 
three aggregation levels: closely related specific diagnoses (e.g. single-episode 
and recurrent depressive disorder) were classified into one diagnostic group 
(e.g. depressive disorder); associated diagnostic groups (e.g. depressive, 
dysthymic, and bipolar disorders) were classified into one diagnostic category 
(e.g. mood disorder), in accordance with the structure of the DSM-IV; and 
finally, the criterion for caseness was the presence of at least one specific 
diagnosis. 
The same grouping procedure was used for syndromes, which were defined as 
complexes of psychopathologic symptoms, pursuant to the structure and 
description of the DSM-IV, no account having been taken of the criteria of 
organic attribution, duration, exclusion by other disorders or the explicit criteria 
of impaired functioning. 
In this study, the entire interview from the SCAN-2.1 version published in July 
1997 was tested, the final form of which contained no major changes.  
 
Consistent with the clinical, semi-structured nature of the SCAN, 30 
psychologists and psychiatric nurses were selected for their knowledge of 
psychopathology. Special sessions on psychiatric phenomenology were 
organised to optimize their actual clinical judgement. All interviewers 
participated in a 1-week training course given by the WHO-SCAN collaborating 
centre in Groningen so that they could learn how to work with the pencil-and-
paper version of the SCAN. A total of ten booster sessions were held to improve 
their knowledge of psychopathology and their interviewing skills. The training 
consisted of reviewing videotaped interviews and discussing problems 
encountered during the data checks by the investigators. The interviewers were 
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also introduced to the computerised version of the SCAN, which had been 
approved by the WHO advisory committee for this instrument.  
 
During the study, three interviewers dropped out. All the other interviewers (27) 
completed the study and subsequently took part in the survey data collection. 
 
7.2.1 Test-retest procedure 
Over a 3-month period in the spring of 1997, patients and non-patients were 
invited for an interview to be held twice in the same week. To guarantee a broad 
variety of disorders, the interviews were planned with three categories of 
subjects: 
 
1 non (mental health care-identified) patients; 
2 mental health care-identified out-patients; 
3 mental health care-identified in-patients. 
 
The non-patients were people with no known mental health care problem over 
the 3 months preceding the interview. They were invited to participate in the 
study in an announcement in a house-to-house circular or by their general 
practitioner during a visit. For the second and third categories (out-patients and 
in-patients), several mental health care institutions in the region were asked to 
invite their patients to participate in the study. For in-patients, this included 
Overwaal, a psychotherapy clinic, the Derde Orde Huis, an institute for 
psychosocial in-patient treatment, and the Psychiatric Centre Nijmegen, a 
psychiatric hospital. Out-patients were recruited from the RIAGG Nijmegen, an 
institute for ambulatory mental health care and the PCN out-patient department.  
 
Every subject was interviewed twice in the same week by different, randomly 
assigned interviewers. In all interviews, only one interviewer was present. To 
facilitate supervision all interviews were videotaped. After completion of the 
second interview, the interview data were paired. Given the equivalence of the 
paired data, Cohen's kappa (κ) was considered an adequate measure of 
reliability. Kappa was estimated with regard to the three aggregation levels of 
diagnoses and syndromes (Landis & Koch 1977a; Landis & Koch 1977b). For a 
reliable κ, it is important to have a sufficient number of cases. Consequently, 




7.2.2 Standardised procedure 
Experts (RG, FJN and CAThR) interviewed three subjects with psychotic 
disorders, three with neurotic disorders and four non (mental health care-
identified) patients. The video recordings of these SCAN interviews were rated 
by at least one other experienced psychiatrist (PPGH and CAThR). The data 
were combined and used as a reference score in the analysis of the results of 
the 27 interviewers, each of whom rated the ten videotapes. Because of the 
non-equivalence of the data of the interviewers and of the reference scores of 
the experts (gold standard), κ was not found to be the best parameter for 
agreement (Streiner & Geddis 1998). Consequently, sensitivity, specificity, and 
percentage of total agreement were assessed for the three aggregation levels 
of diagnoses and syndromes and also for the individual interviewers. 





7.3.1 Test-retest procedure 
During the study, 181 interviews were conducted with 92 subjects, three of 
whom were interviewed only once. This resulted in 89 paired interviews (Table 
7.3.1).  
 
Table 7.3.1  
Number of subjects, interviews, and pairs of SCAN data per patient 
category 
 Subjects Interviews Pairs of SCAN data 
Non-patients 30 60 30 
Out-patients 21 40 19 
In-patients 41 81 40 
Total  92 181 89 
 
 
For diagnostic caseness, the κ was 0.64 (Table 7.3.2), which indicated that the 
reliability was substantial (Landis & Koch 1977b). With reference to the 




Test-retest reliability for diagnostic category, group and caseness on the 
basis of 89 sets of paired SCAN data 
Category 




κ 95% CI 
Mood disorder 26 0.53 0.32 - 0.75 
 Depression 23 0.52 0.29 - 0.75 
Anxiety disorder 43 0.49 0.31 - 0.68 
 Phobic or panic disorder 16 0.48 0.21 - 0.76 
 Obsessive compulsive disorder 22 0.64 0.44 - 0.84 
 Anxiety disorder NOS b 12 0.24 0.00 - 0.55 
Sleep disorder 12 0.35 0.01 - 0.68 
 Dyssomnia 11 0.38 0.04 - 0.72 
Caseness 56 0.64 0.48 - 0.80 
a  If at least one of the interviewers scored a diagnosis, the subject was 
classified as a case; only groups and categories containing at least 10 cases 
were listed; 






Test-retest reliability for syndromes with reference to syndrome category, 






κ 95% CI 
Mood syndrome 33 0.59 0.40 - 0.77 
 Depressive syndrome 27 0.59 0.39 - 0.80 
 Dysthymic syndrome 14 0.06 0.00 - 0.30 
Anxiety syndrome 56 0.46 0.28 - 0.65 
 Phobic or panic syndrome 41 0.36 0.16 - 0.56 
 Obsessive compulsive syndrome 36 0.55 0.37 - 0.74 
Somatoform syndrome 54 0.46 0.28 - 0.64 
 Somatoform syndrome NOS 54 0.46 0.28 - 0.64 
Sleep syndrome 40 0.50 0.31 - 0.69 
 Parasomnia syndrome 35 0.54 0.35 - 0.73 
 Dyssomnia syndrome 26 0.49 0.27 - 0.71 
Caseness 62 0.47 0.25 - 0.69 
a  If at least one of the interviewers scored a syndrome, the subject was 




For syndrome caseness, κ was 0.47, which is slightly lower than for diagnosis. 
With reference to syndrome categories and groups, the κ-values were 
comparable to those found for diagnoses, except for the dysthymic syndrome 
(Table 7.3.3). 
 
7.3.2 Standardised procedure 
The reference scores from the ten videotaped interviews showed that three out 
of the four non-patients had been assessed as having had neither a psychiatric 
diagnosis nor a syndrome. The diagnosis of the fourth subject was a sexual 
disorder due to a general medical condition. Of the three subjects with psychotic 
disorders, two had a schizophrenic disorder (one of the two also had a 
diagnosis of a depressive disorder) and one had a delusional disorder 
combined with a bipolar disorder NOS. Of the three subjects with neurotic 
disorders, one had a depression combined with an obsessive compulsive 
disorder. The second subject was diagnosed as bipolar in the depressive 
phase, and the third had a diagnosis of cannabis dependence comorbid with a 
nightmare disorder. 
For diagnostic caseness, the average total agreement of the 27 interviewers 






Total agreement, sensitivity and specificity for diagnostic category, group 









Substance use-related disorder 97 67 100 
  Dependence 97 67 100 
Psychotic disorder 87 56 100 
  Schizophrenia 81 9 99 
   Delusional disorder, non-aff. psychosis 93 89 93 
Mood disorder 87 70 98 
  Depression 84 59 90 
  Bipolar disorder 90 50 100 
Anxiety disorder 96 80 100 
  Phobic or panic disorder 95 52 100 
  Obsessive-compulsive disorder 100 100 100 
Sleep disorder 97 93 97 
  Dyssomnia 98 93 98 
Other psychiatric disorder 98 85 99 
Caseness 94 86 99 
 
The great majority of the cases were recognised by the interviewers (sensitivity: 
86%) and almost no one assessed a case where the referents rated a non-case 
(specificity: 99%). 
 
The most remarkable finding, however, was a sensitivity of only 9% to 
schizophrenic disorders, while in other diagnostic groups the sensitivity was in 
the 50-100% range. Sensitivity for diagnostic categories varied from 56% to 
96%, whereas specificity ranged from 93% to 100% for both groups and 
categories.  
The sensitivity and specificity for syndromes were excellent for syndrome 
caseness and also for categories and groups, with the exception of bipolar 
syndrome, for which sensitivity was 57% (Table 7.3.5). For schizophrenic 








Total agreement, sensitivity and specificity for syndrome category, group 









Substance use-related syndrome  100 100 100 
   Dependence syndrome  100 100 100 
   Abuse syndrome 100 100 100 
Psychotic syndrome 99 98 100 
   Schizophrenic syndrome 94 79 100 
   Delusional or non-affective psychotic syndrome 99 96 100 
Mood syndrome 99 99 100 
   Depressive syndrome 98 96 100 
   Bipolar syndrome 91 57 100 
Anxiety syndrome 96 80 100 
   Phobic or panic syndrome 96 80 100 
   Obsessive-compulsive syndrome 100 100 100 
Somatoform syndrome 93 84 99 
   Pain syndrome 99 89 100 
   Other somatoform syndrome 93 84 99 
Dissociation syndrome 99 93 100 
Sleep syndrome 96 98 94 
   Parasomnia syndrome 96 98 94 
   Dyssomnia syndrome 97 96 97 
Other psychiatric syndromes 97 96 97 




The interviewers were also judged on their individual agreement with the 
reference scores for each of the 10 videotaped interviews (Table 7.3.6). With 
regard to caseness, there was one reference score (case or non-case) for each 
interview, while for diagnostic categories, the number per tape varied from 1 to 
3 (there were a total of 15 reference scores for the 10 tapes). For diagnostic 
groups, there were in total 14 reference scores. Since one interviewer scored 
substantially and consistently lower than all the others, Table 7.3.6 shows his 
scores separately.  
 
 
The total mean agreement was 94% for diagnostic caseness, 90% for 
categories and 87% for groups. If the three tapes with the psychotic subjects 
had been left out in assessing reliability for part one of the SCAN, the average 







Agreement per interviewer with regard to reference diagnoses per 
interview for the three diagnostic aggregation levels 
 % Agreement 
 Diagnostic group 
N = 14 
Diagnostic category 
N = 15 
Caseness 
N = 10  
Interviewer 1 - 26    
 Range 82 - 95 84 - 100 90 - 100 
 Mean 87 91 95 
Interviewer 27 70 73 74 





Globally, the reliability of the SCAN-2.1 can be described as moderate to 
substantial. For the test-retest procedure, reliability was fair to moderate. The 
standardised procedure showed substantial to almost perfect agreement.  
 
7.4.1 Study limitations 
The lack of interview experience of the interviewers and instructions from the 
experts on the videotapes may have impacted negatively on the findings. 
First, the most prominent exception in the standardised procedure, a low 
sensitivity for schizophrenia, can be explained as follows. To diagnose 
schizophrenia one has to record observations, the duration of the active 
symptoms and their interference with daily activities in four sections of the 
SCAN, in which there are no explicit questions. During the taped sessions, the 
interviewers were not reminded of the requirement to record these items, so the 
majority failed to rate them. This also explains the difference in sensitivity 
between the diagnosis of schizophrenia and its corresponding syndrome (9% 
and 79%), since, for the latter, duration and interference are not part of the 
definition of the pathology. Because the training was concentrated on the verbal 
part of the interview itself, we had to correct this imbalance during the booster 
sessions. 
Second, although the limited number of cases for the dysthymic syndrome in 
the test-retest procedure reduced the significance of κ, the low reliability was 
probably caused by the confusing structure of the section in the SCAN on the 
depressed mood and thoughts. The diagnosis of dysthymic disorder depends 
completely on items that have explicit questions on depression in the beginning 
of this section. The answers corresponding to these items must be re-evaluated 
later on for their dysthymic quality without the aid of explicit questions.  
Finally, a substantial number of the interviewers missed the bipolar diagnosis in 
one of the tapes even though they had correctly assessed a depressive 
episode. Although the interview data contained the necessary information, they 
failed to record two items (without explicit interview questions) that link the 
current depressive episode to the underlying bipolar disorder. This could be 
explained by the announcement by the expert on the tape that he would skip 
the rest of the section, whereas he actually recorded the two items himself.  
All factors considered, lack of interviewing experience at the beginning of the 






Although the literature contains no information on the psychometric properties 
of the SCAN-2.1, there is substantial evidence on the reliability of the SCAN-1, 
its predecessor the PSE-9, and the CIDI, a more structured interview for use in 
psychiatric epidemiological surveys. In the test-retest procedure adopted in this 
study, the entire SCAN-2.1 interview, with the full range of DSM-IV diagnoses, 
was used in a mixed population of subjects who reflected the psychiatric 
comprehensiveness of the general population. In contrast, the majority of the 
previous reliability studies referred to partial populations (clinical or outpatient) 
for which the diagnostic range was limited (e.g., substance-related or anxiety 
disorders) and to a restricted number of sections from a particular instrument 
(Andrews & Peters 1998; Duine et al. 1985a; Ustun et al. 1997; Wing et al. 
1990). 
 
In addition, it is noteworthy that the CIDI tends to produce more diagnoses than 
clinicians claim are clinically relevant (Andrews & Peters 1998); the SCAN-1 
proved to be as reliable as the CIDI (Ustun et al. 1997); and lay interviewers 
can administer the SCAN reliably (Brugha et al. 1999b). 
In view of all the preceding aspects, it can be concluded that the reliability of the 
SCAN-2.1 is satisfactory for the assessment of psychiatric disorders in general 
populations by non-clinical (but well-trained) interviewers. The findings from this 
study lead to the following recommendations: 
 
During the 1-week training course, special attention should be paid to the 
structure of the SCAN and its underlying sections. The use of a checklist of 
items, which should be checked for their completeness at the end of the 
interview, might be very beneficial. Finally, from the standpoint of cost-
effectiveness, it might be more efficient to train all interviewers intensively on 
part one of the SCAN, and to select a few of them for training on the entire 
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8 The relevance of clinical judgement in the 
SCAN-2.1 
8.1 Introduction 
The essential questions in (descriptive) epidemiology are: “What condition 
occurs in whom, where and when?” (see chapter 3). It is the psychiatric 
diagnostic process that makes or breaks the quality of the assessment of the 
condition. In the past half century, a lot of energy has been spent on improving 
the quality of the diagnostic process. In the mid-1950s, under the influence of 
developments in biological, pharmacological and epidemiological research, the 
focus of the diagnostic process shifted from an individualised or idiographic to a 
categorical or nomothetic approach. Evidence from a global perspective 
indicated that there was a lack of uniformity with regard to the psychiatric 
diagnostic process. The US-UK study and the International Pilot Study of 
Schizophrenia (IPSS) established that the diagnostic discrepancy did not reflect 
a true difference in psychiatric prevalence rates (Kendell et al. 1971; Kendell 
1975a; Sartorius et al. 1972), but rather a diagnostic inaccuracy, due to 
three methodological sources of variance:  
1. the information variance; 
2. the observation and interpretation variance; 
3. the criterion variance. 
The information variance concerns the process of gathering information, which 
relates to, for example, the kind and order of the questions and the context in 
which the interview is held. The observation and interpretation variance has to 
do with inconsistencies in interpreting the meaning of the explicit and 
circumstantial information. Finally, the criterion variance is about the variation in 
the reference criteria against which the information is interpreted. Ward et al. 
(1962b) elaborated on the three basic sources of variance and, at the time, 
regarded the criterion variance, which accounted for two-thirds of the total 
variance, as the most important of the three, while the former two, were 
estimated to make a joint contribution of only one third of the total variance.   
Because the US-UK study and the IPSS stressed the importance of the criterion 
variance, it is this source of variance that helped drive the development of the 
current criterion-based psychiatric classification systems. Nowadays, the 
criterion variance is significantly less important, because of the almost global 
use of standard classification systems.  
With a view to minimising the remainder of the variance, two lines of 
standardised diagnostic interviews were developed: the fully standardised 
interviews of which the DIS/CIDIviii tradition is the most well-known and the semi 
standardised interviews, including the PSE/SCANix. With respect to the 
 
146 
information variance, the two interview traditions differ in that the DIS/CIDI is 
fully structured (with the requirement to put the designated questions only) and 
the PSE/SCAN is semi-structured (with the recommendation to probe further 
until the interviewer is able to score the item). With respect to the observation 
and interpretation variance, the two traditions use divergent approaches. The 
DIS/CIDI has the response of the subject for each sign and symptom as the 
sole source of information, sometimes followed by a set of questions to check 
for clinical significance. This results in a measure of perceived morbidity or 
illness. The PSE/SCAN facilitates the interviewer’s clinical judgement, bringing 
about an opportunity for such judgement for each sign and symptom. This 
results in a measurement of disease, in the form of a characteristic constellation 
of signs and symptoms, as diagnosed on the basis of clinical (professional) 
judgement (see chapter 3).  
Throughout several decades, the respective interview traditions have yielded 
different prevalence rates (Brugha et al. 2001; Narrow et al. 2002; Surtees et al. 
1983). The impact of clinical judgement and of the clinical significance criterion 
on this variation is still unclear (Beals et al. 2004; Murphy 2002). 
 
To make clinical judgement operational, it is important to identify the aspects of 
signs and symptoms that should be clinically assessed. So that a sign or 
symptom can be evaluated as being clinically relevant, in version 2.1 of the 
SCAN the following questions have to be addressed qualitatively: 
• Does the symptom produce sufficient distress? 
• Does the symptom occupy a disproportional place the subject’s life? 
• Does the symptom escape the subject’s control? 
 
Having been made operational in this way, clinical judgement was taken into 
account in the rating scale of the SCAN-2.1. Not only can a symptom be rated 
as being clinically significant as indicated by score 2 (moderate) and 3 (severe); 
it can also be rated as present, but at a subclinical level (score 1). Hence, the 
symptom is recorded, but has no value in meeting the criteria for a disease.  
 
Both positive and negative answers by the subject can result in a (clinical or 
subclinical) positive or negative score by the observer (Table 8.1.1). In other 
words, perceived morbidity (illness, response “yes”) can indicate that a 
symptom is present, but without the formal value of a disease entity 
(subclinical). In contrast, in a fully structured interview, the subject’s answers 













No No No No Yes Yes Yes Yes 
No Yes Yes Yes No Yes Yes Yes 
 Sub 
clinical 
Moderate Severe  Sub 
clinical 
Moderate Severe 
Illness score 0 0 0 0 1 1 1 1 
Disease score 0 1 2 3 0 1 2 3 
Illness ‘result’ - - - - + + + + 
Disease ‘result’ - - + + - - + + 
 
The difference between the two interview traditions resulting from the clinical 
judgement of the symptoms is indicated in the pale-shaded area of Table 8.1.1. 
The difference in diagnostic status of the symptoms in the two interviews is 
shown in the grey- and black-shaded areas of Table 8.1.1.  
The SCAN-2.1 is a semi-structured, clinical diagnostic interview that creates the 
opportunity to elaborate on the effect of the clinical judgement on the diagnostic 
status, in particular with respect to the subclinical score (1-1), for which the 
result is represented by the black area of Table 8.1.1. The other subclinical 
score (0-1), which in itself is indistinguishable from the former score, is much 
less important for the following reason: 
Except in psychotic disorders, the likelihood that a subject’s negative answer 
will result in a positive (sub-)clinical score is very low. The same applies to the 
first two left-hand cells of the grey-shaded area, with a dissimilar result for the 
measurement of illness and disease, a difference (although the other way 
around) that also occurs when a persistent positive response is rated as totally 
absent (third left-hand cell). For this reason, we assume that the importance of 
the clinical judgement in the SCAN is best reflected by the use of the subclinical 
score.  
The following questions constitute a guideline on the importance of the clinical 
judgement with the SCAN. 
• Does the clinical judgement in the SCAN make a difference?  
o What is the number of positive cases and of diagnostic groups when the 
SCAN is used in accordance with the formal protocol and when clinical 
judgement is omitted? 
• Does the omission of the clinical judgement have consequences for the 
epidemiological results? 
o What is the prevalence rate of psychiatric disorders across caseness, 
categories and groups with and without clinical judgement? 
o Does clinical judgement influence the distribution of psychiatric disorders 
across gender, age, and urbanisation? 




8.2.1 Design of the basic study 
In 1997 the Nijmegen Health Area-2 project (NHA-2) was carried out in the 
general population of the city of Nijmegen and the surrounding communities 
(SC). In a sample of 1813 Dutch-speaking subjects aged from 18 to 75 years, 
psychiatric morbidity was assessed in a two-phase design. In phase one (T1) 
the General Health Questionnaire (GHQ-30) was used for screening, while in 
phase two (T2, see chapter 6) the psychiatric signs and symptoms were 
assessed with the Schedules for Clinical Assessment in Neuropsychiatry 
(SCAN-2.1). In this way, at T2, detailed information with reference to individual 
symptoms was obtained from 767 subjects, which created the opportunity to 
investigate the consequences of the application of clinical judgement in the 
SCAN. 
 
8.2.2 Operationalising clinical judgement in SCAN 
In T2, the subjects were interviewed with the SCAN-2.1, which includes the 
latest (tenth) version of the PSE (PSE-10), the successor to PSE-9 (Wing et al. 
1990; Wing 1996). The PSE-10 consists of two parts, the first dealing with 
anxiety, mood and other neurotic manifestations and the second with psychotic 
and cognitive phenomena, and observation items on speech, behaviour and 
affect. In this survey, the interview in the July 1997 version of SCAN-2.1 was 
used (Giel & Nienhuis 1997). As this was a preliminary version of the current 
SCAN-2.1, the software algorithm was written by our own staff (C.R.) in 
consultation with, and subject to the approval of, the WHO workgroup on the 
SCAN. This facilitated the realisation of the modifications of the algorithm 
necessary for this study. 
Consistent with the clinical, semi-structured nature of the SCAN, 30 
psychologists and psychiatric nurses were selected for their knowledge of 
psychopathology. Special sessions on psychiatric phenomenology were 
organised to optimise their clinical judgement. All interviewers participated in a 
1-week training course given by the WHO-SCAN collaborating centre in 
Groningen so that they could learn to work with the pencil-and-paper version of 
the SCAN. A total of ten booster sessions were held to improve their knowledge 
of psychopathology and their interviewing skills.  
The claim that clinical interviews are imperfect because of low interrater 
reliability and potential validity problems (Wittchen et al. 1999) has been 
rebutted for the Present State Examination-9 (PSE-9: (Duine et al. 1985b; 
Lesage et al. 1991; Wing et al. 1977)) and for the Schedules for Clinical 
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Assessment in Neuropsychiatry-2.1 (SCAN-2.1: (Andrews et al. 1995; Brugha 
et al. 1999b; Cheng et al. 2001; Rijnders et al. 2000; Tomov & Nikolov 1990)).  
Clinical judgement in the SCAN has been incorporated into pre-defined rating 
scales with the following basic format (Giel & Nienhuis 1997): 
0. A positive rating of absence. It does not mean ‘not known’ or ‘uncertain 
whether present or not’x. It can be used only if sufficient information is 
available to establish its accuracy. 
1. A positive rating of presence, but presence in such a slight degree that it is 
not appropriate for use in classification. Like 0, it does not mean ‘not known’ 
or ‘uncertain’.  
2. The item is present at a level sufficient to use in classification. For this 
purpose it is equivalent to 3. In general, it is used when symptoms are of 
moderate severity during most of the period being assessed.  
3. Similar to 2, except that the symptom is present in severe form for most of 
the period under review. 
The formally used algorithm of SCAN-2.1 uses level 2 and 3 symptoms to 
assess disorders in accordance with DSM-IV. In this chapter, we have treated 
the subclinical scores corresponding to a rating of 1 as being equal to the 
clinical scores 2 and 3, resulting in the inclusion of all perceived morbidity. 
 
8.2.3 Analyses 
For all analyses, the Statistical Analyses for Social Sciences software package 
(SAS v8.2) was used. 
In view of the evaluation of the clinical judgement in the SCAN, the NHA-2 data 
were re-analysed, essentially with the same algorithm as in chapter 6, but in this 
case, for each symptom for which it was necessary to assess whether specific 
DSM-criteria were fulfilled, the subclinical score (1) was assigned a weight 
equal to that of the clinical score (2). For the purpose of this survey, SCAN 
diagnoses were grouped on three levels: first, closely related diagnoses like 
single episode and recurrent depressive disorder were sorted into one 
diagnostic group (e.g., depressive disorder); then, associated diagnostic groups 
(e.g., depressive, dysthymic, and bipolar disorders) were classified into one 
diagnostic category (e.g., mood disorder), in accordance with the structure of 
DSM-IV; finally, the highest level of aggregation was represented by diagnostic 
caseness, defined as “the presence of at least one specific diagnosis”. 
The relation between the GHQ and SCAN “caseness” was expressed in a 
logistic regression model in which the probability of an individual’s qualifying for 
“caseness” was formulated as a linear function of the GHQ score: 
 
 p(caseness)   =    1    
1+e 
-( α + β * GHQ) 
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where p indicates the probability that a certain GHQ score corresponds to 
SCAN caseness on the basis of the assessed α and β,which reflect the 
relationship between the GHQ and the SCAN caseness as estimated from the 
outcome of all T2 interviews (Henderson et al. 1979; Hodiamont & Veling 1984). 
Because only 25% of the subjects with a GHQ score of less than 4 during their 
T1-interview were interviewed in T2, a weighting procedure was used for this 
group to restore the proportions initially present in the T1 group. Through 
substitution of the assessed probability for SCAN caseness for the GHQ score 
for all subjects in T1, the prevalence rate for the population was calculated. 
The prevalence rates for the diagnostic groups and categories were calculated 
through weighing the extent to which they occurred in the two GHQ classes with 
scores < 4 and ≥ 4 for T2 subjects. The weighting factors were determined by 
the ratio of the sizes of the two GHQ classes to one another in the first phase of 
the sample. The significance of the difference between results with and without 
clinical judgement was tested with the Wilcoxon (Mann-Whitney) procedure. 
So that the data for the general population could be interpreted, a post-
stratification weighting procedure was applied with the aid of 16 defined strata 
for gender, age (4), and urbanisation (2) on the basis of the 1997 census data 
(CBS 1997).  
To estimate the 95% two-sided confidence intervals for these weighted data, 
the logistic model was integrated into a bootstrap procedure, i.e. a re-sampling 
technique with duplication (Dunn et al. 1999; Efron & Tibshirani 1993).  
The significance of the difference in prevalence rates within sociodemographic 




8.3.1 The difference between results obtained with and without 
clinical judgement  
In the NHA-2 study, 767 subjects were interviewed with the SCAN-2.1, 197 of 
whom fulfilled the DSM-IV criteria of psychiatric caseness. When clinical 
judgement was omitted from the formal SCAN procedure, the number of 
positive cases increased by more than a fifth, to 245 subjects (Table 8.3.1).  
With reference to the diagnostic categories, the most substantial differences in 
numbers of positive cases between results obtained with and without clinical 
judgement were found in somatoform and psychotic disorders (almost a 100% 
increase) and mood disorders (nearly a 50% increase). When clinical 
judgement was omitted, anxiety disorders increased by around 20%. No change 
was found for substance-related, dissociation and eating disorders. An 
important similarity of the latter categories is that the majority of their diagnostic 
criteria refer to aspects of behaviour that leave (almost) no possibility for 
subclinical scores or for feelings and beliefs. 
For the somatoform category, all additional diagnoses concerned the diagnostic 
group of somatoform disorders not otherwise specified (NOS) – a catch basin of 
single, unexplained, physically perceived conditions. Most subjects in question 
had a subclinical score on the single item of perceived fatigability and 
exhaustion, which changed their status as a healthy subject into a case. Only 
four of the subjects also had two to four somatic symptoms. These could be 
attributed to somatisation, but were not sufficient to qualify as a somatisation 
disorder. 
Of the 25 additional cases in the category of mood disorders, 23 subjects were 
assessed as having a depressive episode, one subject a combined depressive 
and dysthymic disorder and one subject a bipolar disorder. Table 8.3.2 shows 
that the effect of clinical judgement on the number of DSM-IV criterion A 
symptoms for depression was substantial (a classical example of possible 
divergence between perceived morbidity and clinical relevance). For those 
subjects with an additional diagnosis of depression, the increase in the number 
of scored criterion A symptoms when clinical judgement was omitted ranged 
from 1 (for four subjects) to 4 or more (for seven subjects).  
The ten subjects with an additional anxiety disorder presented a more varied 
picture: four had a generalised anxiety disorder, four had a phobic disorder and 
two had an anxiety disorder NOS.  
As for sleep disorders, the eight additional subjects all had dyssomnia.  
Remarkably, in addition to the near doubling of subjects with a somatoform 





Comparison of number of positive cases and diagnostic categories with 
and without clinical judgement (N = 767) 
 With clinical 
judgement 
Without clinical judgement 
 Cases / 
      diagnoses 
Additional positive 
cases / diagnoses 
Lost positive 
cases / diagnoses 
Caseness  197    48    -- 
Psycho-organic disorder  2  --  -- 
Substance-related  41  --  -- 
Psychotic disorder  4  3  -- 
Mood disorder  54  25  -- 
Anxiety disorder  54  10  -- 
Eating disorder  5  --  -- 
Somatoform disorder  31  27  3 
Dissociation disorder  14  --  -- 
Sleep disorder  48  8  9 
Other psychiatric disorder  7  4  -- 
 
 
The addition of eight diagnoses with reference to sleep disorders was more 
than neutralised by the loss of subjects who had a formal sleep disorder, but 
who now lost their sleep disorder diagnosis due to the omission of clinical 
judgement. This did not mean that subjects who had ‘lost’ their specific sleep 
disorder diagnosis would no longer be a case; all of those subjects who had lost 
their sleep disorder diagnosis had dyssomnia, which turned into a part of a 
diagnosis of a higher hierarchy (for example depressive disorder) when clinical 
judgement was left out. Parasomnia was consequently not related to the 
variation in the category of sleep disorders. 
 
Table 8.3.2 
Number of criterion A symptoms for depressive episode in subjects with 
an additional diagnosis of depression when clinical judgement was left 
out 




0 1 2 3 4 
Without clinical 
judgement 
5 -- 1 2 2 4 
6 1 -- 2 3 5 
7 -- -- 1 1 1 
9 -- -- -- -- 1 
 
 
The contribution of the additional diagnoses listed in Table 8.3.1 to 
monomorbidity and to comorbidity is shown in Table 8.3.3. Psychotic and 
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anxiety disorders, unlike all other diagnoses, did not contribute more to 
monomorbidity than to comorbidity. Almost all additional diagnoses contributing 
to monomorbidity were ‘new’ cases, the vast majority having been (minor) 
somatoform and sleep disorders. Four subjects were already monomorbid and 
one subject was comorbid when the formal SCAN algorithm was used but 
became monomorbid when clinical judgement was omitted. The diagnoses for 
the latter five subjects were transposed into a depressive disorder, which, owing 
to the hierarchy, switched off the underlying formal diagnoses.  
Additional disorders contributing to comorbidity mainly had the effect of 
changing monomorbidity into comorbidity; to a lesser degree these disorders 
became part of an already existing comorbidity. Rarely did they result in the 
attribution of a comorbid state to healthy subjects. 
 Consequently, within the group of subjects who constituted a case originally, 
omitting clinical judgement also had a qualitative effect with respect to the shift 
of specific diagnosis. 
Although many diagnostic groups showed an increase when clinical judgement 
was omitted, there was a marked difference in this increase between groups. Of 
the 25 new mood disorders diagnosed when clinical judgement was omitted, 13 
were new cases, while 12 represented a qualitative shift of the specific 
diagnosis. Six out of 10 and 2 out of 3 new diagnoses for anxiety disorders and 
psychotic disorders respectively resulted from the qualitative shift. In contrast, 
22 of the 27 new somatoform disorders and 7 out of the 8 new sleep disorders 
were new cases. 
 
Table 8.3.3 
Contribution of the additional diagnoses to monomorbidity and 
comorbidity with respect to caseness and diagnostic categories 














Non → Mono* 46 1 12 3 21 7 2 
Mono → Mono -- -- 4 -- -- -- -- 
Como → Mono -- -- 1 -- -- -- -- 
Non → Como 2** -- 1 1 1 -- -- 
Mono → Como -- -- 5 3 5 1 2 
Como → Como -- 2 2 3 -- -- -- 
Total 48 3 25 10 27 8 4 
* Non  = Non-morbidity 
 Mono  = Monomorbidity 
 Como  = Comorbidity 
The first condition resulted from the formal SCAN and the second from the omission 
of clinical judgement. 




8.3.2 The consequences of the omission of clinical judgement 
on epidemiological data 
8.3.2.1 Clinical judgement and the prevalence rate of psychiatric 
disorders  
The effect of the omission of clinical judgement on the prevalence rates of 
caseness, diagnostic categories and diagnostic groups in the general 
population is presented in Table 8.3.4. 
The prevalence rate of caseness without clinical judgement was 21.4%, which 
is 3.8% higher than when the formal clinical SCAN-algorithm was used. In other 
words, caseness increased by one fifth when clinical judgement was not used.  
The prevalence rates of somatoform, mood and anxiety disorders were 
significantly higher when clinical judgement was not used. The prevalence rates 
of other psychiatric disorders, sleep disorders and psychotic disorders tended to 
increase and the prevalence rates of psycho-organic, substance-related, 
dissociation and eating disorders were stable and consequently seem to be 
independent of clinical judgement.  
With respect to the diagnostic groups, the prevalence rate of other somatoform 
disorders more than doubled, and for depression it nearly doubled. The 
prevalence rate of the category ‘other psychiatric disorders’ doubled, but owing 
to the smallness of the sample size in the category, it could not be established 





Prevalence ratesa of psychiatric disorders with and without clinical 
judgement with reference to caseness, diagnostic categories and groups 
 Prevalence (%) p 





Caseness 17.6 (± 2.6) 21.4 (± 3.0) *** 
Psycho-organic disorder 0.3 0.3  
 Dementia   0.3  0.3  
 Other organic brain disorder  0.0  0.0  
Substance-related disorder 4.0 4.0  
 Dependence  0.9  0.9  
 Abuse   3.2  3.2  
Psychotic disorder 0.5 0.7  
 Schizophrenia  0.4  0.5  
 Delusional disorder, non-aff. psychosis  0.1  0.2  
Mood disorder 3.8 5.6 *** 
 Depression  2.7  4.5 *** 
 Mania, hypomania, mixed disorder  0.3  0.4  
 Dysthymic disorder  1.9  2.0  
Anxiety disorder 4.6 5.5 ** 
 Generalised anxiety disorder  0.3  0.6  
 Phobic or panic disorder  2.6  3.0  
 Obsessive-compulsive disorder  1.3  1.3  
 Other anxiety disorders  0.6  0.7  
Eating disorder 0.4 0.4  
 Anorexia Nervosa  0.1  0.1  
 Other eating disorders  0.3  0.3  
Somatoform disorder 2.8 4.9 *** 
 Somatisation disorder  0.1  0.1  
 Pain disorder  1.2  1.0  
 Other somatoform disorder  1.5  3.7 *** 
Dissociation disorder 1.4 1.4  
Sleep disorder 4.8 5.1  
 Dyssomnia  2.2  2.2  
 Parasomnia  2.1  2.1  
Other sleep disorder 0.5 0.8  
Other psychiatric disorder 0.7 1.4  
a after correction for gender, age, and urbanisation 
p: Mann-Whitney: *:  .01 < p ≤ .05; **: .001 < p ≤ .01; ***: p ≤ .001 
The total increase in the diagnostic categories was 6.0%, which was strikingly 
higher than the 3.8% increase for caseness. This discrepancy was mainly a 
consequence of the increase in comorbidity, and consequently of the qualitative 




8.3.2.2 Clinical judgement and the distribution of psychiatric disorders 
When clinical judgement was omitted, the sociodemographic groups with the 
highest and those with the lowest prevalence rates all showed roughly the same 
proportional increase in caseness (Table 8.3.5). As a result, the 
sociodemographic groups with the highest prevalence rates increased the most 
numerically. Likewise, the lowest prevalence rates increased the least 
numerically. It can be concluded that generally, clinical judgement does not 
affect the distribution of psychiatric disorders in the general population.  
For those diagnostic categories and groups for which clinical judgement 
affected the prevalence rate (Table 6.3.3), the sociodemographic distribution 
across gender, age and urbanisation is presented with reference to clinical 
judgement in Table 8.3.5.  
Globally, clinical judgement for diagnostic categories brought about larger 
proportional changes for females than for males, in particular for somatoform 
(2.04 vs. 1.39), anxiety (1.25 vs. 1.03) and other psychiatric disorders (4.00 vs. 
1.00, but with low numbers), while for mood disorders, for instance, males were 
more affected (1.35 vs. 1.81). The underlying diagnostic groups showed the 
same trends.  
With respect to age, the effect of clinical judgement varied for most of the 
diagnostic categories. The largest proportional increase for somatoform 
disorders occurred in the younger age range (≤ 44 yrs, 2.22). As far as sleep 
disorders were concerned, the older subjects (≥60 yrs) were more affected 
(1.34), especially in the case of dyssomnia, while the youngest age group 
actually showed a decrease (0.78). For mood and anxiety disorders, the middle-
aged subjects (aged 45 - 59 yrs) were relatively more affected (1.58 and 1.38), 
but the highest proportional increase for mood disorders occurred in the 
youngest age group (1.78). 
City dwellers had a slightly larger proportional increase in anxiety disorders 
(1.32 vs. 1.16), while rural dwellers tended to present a larger effect on mood 




Sociodemographic distribution of psychiatric caseness with and without 
clinical judgement (Males) 
 Total Males 
 N = 1797 
Nijmegen 
N = 214 
SC 
N = 589 
Clinical judgement  Yes No  Yes No  Yes No 
 N % % N % % N % % 
Caseness 1799 17.6 21.4 214 18.8 22.6 589 14.8 18.1 
Age group (yrs)          
18-24 120 16.0 19.7 16 21.9 26.3 28 12.4 15.5 
25-34 359 18.4 22.4 44 18.5 22.8 93 13.2 16.2 
35-44 461 16.8 20.4 64 17.9 21.6 151 15.2 18.5 
45-54  a 391 20.1 25.2 41 20.7 24.8 144 18.1 21.8 
55-64 272 16.7 20.2 26 19.8 23.1 102 15.2 18.4 
≥ 65  b 194 14.7 17.8 23 14.9 17.9 70 12.7 15.3 
Marital status          
Single 141 19.8 24.4 41 22.2 27.2 33 20.8 25.4 
Living with parents 68 15.4 19.0 5 24.5 29.0 32 13.2 16.3 
Living with partner 214 18.2 22.1 35 17.9 21.8 39 17.0 20.5 
Married 1209 17.2 20.8 117 18.1 21.5 454 14.4 17.5 
Divorced 88 22.7 27.2 11 15.2 18.9 24 20.6 24.4 
Widowed 77 16.9 20.7 5 14.2 17.8 6 19.3 24.1 
Employment status  **          
Full-time  bd 706 15.6 19.1 130 16.2 19.9 384 14.4 17.5 
Part-time   bd 378 18.0 21.9 23 15.1 18.5 27 14.3 17.2 
Retired   bd 189 14.8 17.7 28 15.6 18.8 100 14.7 17.6 
Chronically ill/unable to work a 74 29.5 34.7 6 58.8 65.7 42 21.5 26.0 
Unemployed  c 40 29.5 34.6 10 35.0 39.8 12 20.3 24.5 
School or college student  b 60 17.8 21.8 12 24.6 29.3 14 15.4 19.3 
Householder  285 19.9 24.0 -- -- -- 1 7.5 8.7 
Others without an occupation  b 59 17.4 20.8 5 25.7 29.7 7 16.4 20.3 
Educational level          
University 151 17.4 21.3 46 18.7 22.6 35 16.0 19.5 
Higher vocational education 314 15.3 18.7 36 16.8 20.7 97 14.0 17.1 
Higher secondary education 162 17.9 21.7 36 19.5 23.5 40 10.9 13.3 
Lower-stream sec. & post-sec. 
lower vocational education 338 16.0 19.4 26 17.2 21.3 130 14.6 17.6 
Lower-stream sec. education 226 18.5 22.3 18 17.9 21.2 55 16.7 20.6 
Continued primary education 423 19.7 23.6 38 21.9 25.5 156 15.7 18.9 
No education or only primary 
education 183 20.0 24.2 14 17.9 21.0 75 17.5 21.2 
** N = 6: missing  
Age group: Kruskal-Wallis: .0001 < p < .001; Scheffé, p = .05 a – b 
Marital status: Kruskal-Wallis: .001 < p < .01; Scheffé, not significant 
Employment status: Kruskal-Wallis:  p < .0001; Scheffé, p = .05 a – b ,  c – d  
Educational level: Kruskal-Wallis:  .001 < p < .01; Scheffé, not significant 
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Table 8.3.6 (continued) 
Sociodemographic distribution of psychiatric caseness with and without 
clinical judgement (Females) 
 Total Females 
 N = 1797 
Nijmegen 
N = 311 
SC 
N = 685 
Clinical judgement  Yes No  Yes No  Yes No 
 N % % N % % N % % 
Caseness 1799 17.6 21.4 311 21.3 25.7 685 17.8 21.7 
Age group (yrs)          
18-24 120 16.0 19.7 29 19.6 24.0 47 13.9 17.3 
25-34 359 18.4 22.4 86 20.9 25.3 136 20.4 24.7 
35-44 461 16.8 20.4 80 19.8 23.8 166 16.5 20.1 
45-54  a 391 20.1 25.2 53 25.3 30.4 153 20.0 26.6 
55-64 272 16.7 20.2 28 26.9 31.8 116 14.9 18.3 
≥ 65  b 194 14.7 17.8 35 17.6 21.2 66 15.2 18.5 
Marital status          
Single 141 19.8 24.4 48 19.1 23.6 19 14.9 18.5 
Living with parents 68 15.4 19.0 3 25.0 30.1 28 15.4 19.0 
Living with partner 214 18.2 22.1 84 20.1 24.2 56 16.5 20.4 
Married 1209 17.2 20.8 124 22.6 27.0 514 18.2 22.1 
Divorced 88 22.7 27.2 31 27.3 32.7 22 22.2 26.7 
Widowed 77 16.9 20.7 21 16.3 19.5 45 17.2 21.2 
Employment status  **          
Full-time  bd 706 15.6 19.1 92 16.2 20.0 100 18.7 23.0 
Part-time   bd 378 18.0 21.9 90 21.6 26.2 238 17.4 21.2 
Retired   bd 189 14.8 17.7 20 20.8 24.7 41 11.3 13.8 
Chronically ill/unable to work  ae 74 29.5 34.7 9 36.3 40.3 17 35.4 42.6 
Unemployed  c 40 29.5 34.6 9 39.5 46.9 9 25.6 30.0 
School or college student  b 60 17.8 21.8 13 19.3 23.6 21 14.6 18.1 
Householder  f 285 19.9 24.0 57 26.9 31.9 227 18.2 22.1 
Others without an occupation  b 59 17.4 20.8 19 16.0 19.0 28 17.1 20.6 
Educational level          
University 151 17.4 21.3 62 17.1 21.0 8 18.4 23.1 
Higher vocational education 314 15.3 18.7 82 16.8 20.6 99 14.7 18.0 
Higher secondary education 162 17.9 21.7 35 21.7 26.6 51 19.7 23.9 
Lower-stream sec. & post-sec. 
lower vocational education 338 16.0 19.4 16 24.4 28.3 166 16.1 19.6 
Lower-stream sec. education 226 18.5 22.3 32 20.5 24.4 121 18.8 22.6 
Continued primary education 423 19.7 23.6 53 28.7 33.8 176 20.0 24.2 
No education or only primary 
education 183 20.0 24.2 31 28.9 34.3 63 18.9 23.5 
** N = 6: missing  
Age group: Kruskal-Wallis: .0001 < p < .001; Scheffé, p = .05 a – b 
Marital status: Kruskal-Wallis: .001 < p < .01; Scheffé, not significant 
Employment status: Kruskal-Wallis:  p < .0001; Scheffé, p = .05 a – b ,  c – d , and for 
females only e - f 
Educational level: Kruskal-Wallis:  .001 < p < .01; Scheffé, not significant 
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Table 8.3.7 
Distribution * of psychiatric caseness, diagnostic categories and groups 
across gender, age and urbanisation with reference to clinical judgement 
(with clinical judgement) 
 Gender Age (yrs) Urbanisation 






















Caseness 16.2 19.1 *** 17.1 17.2 20.1 a 15.5 b *** 20.1 16.3 *** 
Psychotic disorder 0.5 0.5  1.7 0.4 0.2 0.0  1.4 0.2  
  Schizophrenia 0.3 0.5  1.7 0.2 0.2 0.0  1.4 0.1  
  Delusional disorder 0.2 0.0  0.0 0.2 0.0 0.0  0.0 0.1  
Mood disorder 2.2 5.1 * 2.3 3.7 4.8 3.5  6.6 2.7 ** 
  Depression 1.3 3.9 ** 1.4 d 2.3 4.1 c 2.6 * 4.7 2.0 * 
  Mania, hypomania, 
  mixed disorder 
0.3 0.3  0.0 0.4 0.5 0.0  0.0 0.4  
  Dysthymic disorder 1.0 2.7 * 1.4 1.8 2.6 1.3  3.7 1.2 * 
Anxiety disorder 3.0 6.0  4.9 4.8 4.8 3.0  5.0 4.3  
  Generalised anxiety 
disorder 
0.2 0.4  0.5 0.2 0.2 0.4  0.5 0.2  
  Phobic or panic disorder 1.8 3.2  1.8 3.2 2.6 1.3  1.8 2.8  
  Obsessive-compulsive 
  disorder 
0.8 1.8  2.2 1.1 1.4 0.9  1.3 1.3  
  Other anxiety disorders 0.3 0.9  0.5 0.5 1.0 0.4  1.3 0.4  
Somatoform disorder 2.8 2.8  2.7 2.9 2.4 3.1  2.4 2.9  
  Somatisation disorder 0.2 0.1  0.5 0.0 0.2 0.0  0.5 0.0 * 
  Pain disorder 1.0 1.4  0.9 1.1 0.7 2.7  1.6 1.0  
  Other somatoform 
disorder 





1.8 d 4.3 d 6.7 c 5.3 ** 4.5 4.8  
  Dyssomnia 0.6 3.5 ** 0.0 2.5 2.6 2.7  1.6 2.4  
  Parasomnia 0.8 3.2 ** 0.5 d 1.8 3.3 c 2.2 * 2.6 1.9  
Other sleep disorder 0.6 0.4  1.4 0.0 0.7 0.4  0.3 0.6  
Other psychiatric disorder 1.0 0.4  0.5 0.2 1.4 0.9  1.9 0.3  
* after correction for gender, age, and urbanisation 
p: caseness: ANOVA: *: .01 < p ≤ .05; **: .001 < p ≤ .01; ***: p ≤ .001,  
Scheffé, p = .05) a – b   
categories and groups: χ2: *: .01 < p ≤ .05; **: .001 < p ≤ .01; ***: p ≤ .001;  





Table 8.3.8 (continued) 
Distribution * of psychiatric caseness, diagnostic categories and groups 
across gender, age and urbanisation with reference to clinical judgement 
(without clinical judgement) 
 Gender Age (yrs) Urbanisation 






















Caseness 19.6 23.1 *** 21.0 20.8 24.2 a 18.7 b *** 24.2 19.9 *** 
Psychotic disorder 0.6 0.8  2.2 0.5 0.2 0.4  1.9 0.3  
  Schizophrenia 0.5 0.6  2.2 0.4 0.2 0.0  1.6 0.2  
  Delusional disorder 0.3 0.1  0.0 0.2 0.2 0.4  0.3 0.2  
Mood disorder 4.0 6.9 * 4.1 4.9 7.6 4.3  8.6 4.3 ** 
  Depression 3.0 5.7 ** 3.2 d 3.3 d 6.9 c 3.9 * 6.6 3.7 * 
  Mania, hypomania, 
  mixed disorder 
0.3 0.4  0.0 0.5 0.5 0.0  0.3 0.4  
  Dysthymic disorder 1.1 2.7 * 1.4 1.8 2.9 1.3  3.7 1.3 * 
Anxiety disorder 3.1 7.5  4.9 5.5 6.6 3.5  6.6 5.0  
  Generalised anxiety 
disorder 
0.3 0.9  0.5 0.4 1.2 0.4  1.3 0.4  
  Phobic or panic disorder 1.8 4.0  1.8 3.5 3.5 1.7  2.9 3.0  
  Obsessive-compulsive 
  disorder 
0.8 1.8  2.2 1.1 1.4 0.9  1.3 1.3  
  Other anxiety disorders 0.3 1.0  0.5 0.7 1.0 0.4  1.0 0.6  
Somatoform disorder 3.9 5.7  6.0 6.0 3.1 3.9  4.0 5.1  
  Somatisation disorder 0.2 0.1  0.5 0.0 0.2 0.0  0.5 0.0 * 
  Pain disorder 0.8 1.3  0.5 0.9 0.7 2.7  1.0 1.0  
  Other somatoform 
disorder 
3.1 4.3  5.0 5.1 2.4 1.3  2.7 4.1 * 
Sleep disorder 2.2 7.6 **
* 
1.4 d 4.5 d 6.9 c 7.1 ** 4.7 5.1  
  Dyssomnia 0.9 3.3 ** 0.0 1.7 2.8 4.4  1.6 2.4  
  Parasomnia 0.8 3.2 ** 0.5 d 1.8 3.3 c 2.2 * 2.6 1.9  
Other sleep disorder 0.5 1.1  0.9 1.0 0.7 .04  0.5 0.9  
Other psychiatric disorder 1.0 1.6  0.9 1.0 2.3 0.9  2.4 1.0  
* after correction for gender, age, and urbanisation 
p: caseness: ANOVA: *: .01 < p ≤ .05; **: .001 < p ≤ .01; ***: p ≤ .001,  
Scheffé, p = .05) a – b   
categories and groups: χ2: *: .01 < p ≤ .05; **: .001 < p ≤ .01; ***: p ≤ .001;  
age: Scheffé, p = .05 c – d 
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8.3.2.3 Clinical judgement and the rate of comorbidity 
For the population as a whole, when clinical judgement was omitted, 
monomorbidity increased by 1.6%, while comorbidity increased by 2.2% (Table 
8.3.9). In other words, when clinical judgement was used, a quarter (26.1%) of 
all subjects diagnosed as a case were comorbid, whereas this was true for one 
third of all subjects (31.6%) when clinical judgement was not used. No 
significant differences were found for the influence of clinical judgement on the 




Distribution of diagnostic mono- and comorbidity across age, gender and 
urbanisation with reference to clinical judgement 
  Total Gender Age Urbanisation 


































Caseness 17.6 16.2 19.1 *** 17.1 17.2 20.1 a 15.5 b *** 20.1 16.3 *** 
             
1 diagnosis 13.0 12.3 13.8 ** 12.7 12.8 14.4 c 11.9 d *** 14.4 12.3 *** 
2 diagnoses 3.0 2.7 3.3 ** 2.7 2.9 3.6 c 2.7 d ** 3.6 2.7 *** 
3 diagnoses 0.7 0.6 0.8  0.5 0.7 1.0 0.6 * 1.1 0.5 *** 














Caseness 21.4 19.6 23.1 *** 21.0 20.8 24.2 a 18.7 b *** 24.2 19.9 *** 
             
1 diagnosis 14.6 13.6 15.6 ** 14.2 14.3 16.4 c 13.1 d *** 16.4 13.6 *** 
2 diagnoses 5.0 4.7 5.3 ** 4.9 4.9 5.6 c 4.6 d ** 5.6 4.7 *** 
3 diagnoses 0.9 0.7 1.0  0.6 0.8 1.3 0.7 * 1.3 0.7 *** 
4 diagnoses 0.9 0.7 1.0  0.6 0.8 1.3 0.8 * 1.3 0.6 *** 
Caseness: ANOVA: *: .01 < p ≤ .05; **: .001 < p ≤ .01; ***: p ≤ .001, Scheffé, p = .05 a - b 
Number of diagnoses per subject: χ2: *: .01 < p ≤ .05; **: .001 < p ≤ .01; ***: p ≤ .001; 






8.4.1 Study limitations 
Our findings on the effect of the clinical judgement in the SCAN are an 
underestimation for two reasons. First, because we were not able to 
operationalise all other forms of clinical judgement (as explained in the 
introductory part of this chapter), this contributed to the underestimation. 
Second, the SCAN is a comprehensive interview, composed of sections each of 
which covers a specific area of signs and symptoms. Each section starts with a 
brief set of core questions that screen for the probability of positive signs and 
symptoms in the second, extensive part of the section in question. As a 
consequence, when the interviewer is convinced that the remaining part of the 
section will not yield any major symptoms relevant to the assessment of a 
possible diagnosis, the rest of the section is omitted. As the primary goal of the 
NHA-2 project was to carry out an epidemiological study, this rule of thumb was 
formally followed, with the result that not every possible symptom was scored 
for every individual subject. Consequently, the differences between prevalence 
rates with and without clinical judgement probably are somewhat 
underestimated. 
 
8.4.2 The difference with and without clinical judgement  
Without clinical judgement, the number of psychiatric cases among the subjects 
we interviewed in T2 of the survey increased by 25%. The various diagnostic 
categories show a differentiated sensitivity to clinical judgement. In addition to 
an increased number of cases (pronounced for somatoform and sleep 
disorders), in some categories the additional diagnoses represented a 
qualitative shift of specific diagnoses, especially for mood and anxiety disorders. 
Three findings can be distinguished between the situations with and without 
clinical judgement: no difference; an increase in positive cases; and a change of 
positive cases of lower into major diagnostic categories, higher in hierarchy (see 
Table 8.3.1).  
An explanation for the first finding, as with substance-related, eating and 
dissociative disorders (no difference), is that in the DSM-IV and the SCAN, for 
these three categories, the important symptoms constituting the diagnostic 
criteria are based mainly on for the subject or for the interviewer quantifiable, 
observable, behavioural features and not on feelings and thoughts. Because a 
specific behaviour is either present or absent, there is hardly any room for 
clinical judgement.  
The second finding, as for example with mood and anxiety disorders (an 
increase in positive cases), is what would be expected when clinical judgement 
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is omitted. In these diagnostic categories, many of the diagnostic criteria are 
based on symptoms concerning feelings and thoughts, which make them 
sensitive to clinical judgementxi. Furthermore, these DSM criteria are often 
composed of a complex of possible symptoms, which also increases the 
influence of clinical judgement. 
Another large increase when clinical judgement is left out was found for 
somatoform disorder. Of all the subjects with an additional somatoform disorder, 
22 (81%) changed from non-morbidity to a case, whereas they only had a single 
common experience, now counted as a symptom. Clinical judgement clearly 
had a corrective effect on this perceived morbidity.  
The third finding, as with somatoform and sleep disorders (an increase in 
positive specific diagnoses combined with a loss of these diagnoses) reflects 
two different mechanisms. The fact that additional positive cases were found is 
part of the second finding. But, for example, at the same time, of the 48 positive 
subjects with a sleep disorder as assessed with the formal version of the SCAN, 
nine lost their sleep disorder when clinical judgement was omitted. This finding 
can be traced to the hierarchy in the DSM-IV (“is not better accounted for 
by…”), which tries to locate specific symptoms as part of one, and no more than 
one, diagnosis. For instance, symptoms can be either part of sleep or 
somatoform disorders or part of other, hierarchically ‘higher’ diagnoses, like 
depression (floating symptoms). For some subjects who had only just failed to 
reach the threshold for depression when clinical judgement was used, a floating 
symptom like insomnia can be attributed to a sleep disorder and pain to a 
somatoform disorder. With the omission of clinical judgement, one or more 
subclinical symptoms pushed depression over its threshold, resulting in 25 
subjects being diagnosed with a mood disorder, mainly depression, which was 
not assessed with the formal version of the SCAN. At the same time, this 
increase in depressive cases was at the expense of a loss of positive cases for 
the diagnostic category lower in the hierarchy. 
 
8.4.3 The consequences of omitting clinical judgement for 
epidemiological data  
When clinical judgement was omitted, the prevalence rate of psychiatric 
disorders increased significantly by 3.8% (p ≤ .001) in comparison with the rate 
when the formal version of the SCAN was used. With respect to diagnostic 
groups, the increase was mainly attributable to somatoform disorders NOS and 
depression. For the other diagnostic groups, the power was insufficient to 
establish a significance level for the increase (for example, for schizophrenia, 
delusional disorder and phobic and panic disorder) or there was no difference at 




It can be concluded from this study that clinical judgement does not affect the 
distribution of psychiatric disorders in the general population. Nearly all 
increases were proportional to the prevalence rate established with the formal 
version of the SCAN.  
With respect to comorbidity, without clinical judgement the absolute number and 
the percentage of the comorbid subjects increased by more than for the 
monomorbid subjects. In addition to the 25% increase in caseness, omitting 
clinical judgement had an even larger effect on the qualitative shift of an 
additional specific diagnosis for those subjects who were already a case. 
 
8.4.4 Conclusions 
All in all, clinical judgement interfered significantly with the prevalence rates 
found.  
First, the prevalence rate of caseness increased by one quarter when clinical 
judgement was omitted from the SCAN. Second, not all specific diagnoses are 
equally sensitive to clinical judgement as operationalised in the SCAN. 
Diagnoses based on subjective experiences are more sensitive than those 
based on behaviour. Third, when clinical judgement was left out, the specific 
diagnoses of lower hierarchical ranking of those subjects who were already a 
case, tended to shift towards the major diagnostic categories. Fourth, some 
specific diagnoses (like somatoform disorder NOS) are extremely sensitive to 
clinical judgement, because the presence or absence of one single sign or 
symptom (related to daily life troubles) is crucial. Consequently, it is imperative 
that more specific research should be done into the meaning and the 
significance of clinical judgement in the diagnostic process in psychiatry (Table 
8.1.1). Also, in any new research into clinical judgement in the SCAN, in order 
to avoid underestimation, the routine practice of omitting the second part of 
sections for which core questions do not yield positive symptoms should be 
abandoned. Finally, as clinical judgement is the gold standard to make a 
difference between illness and disease (see chapter 3), more research is 
needed to carefully unravel the way in which the answer of the subject turns into 
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Recent epidemiological investigations of psychiatric disorders have shown large 
discrepancies in prevalence rates (Andrews et al. 1995; Brugha et al. 2001; 
Narrow et al. 2002; Surtees et al. 1983) between studies that use the 
Composite International Diagnostic Interview [CIDI] as a diagnostic interview 
(Robins et al. 1988) and those that use the Schedules for Clinical Assessment 
in Neuropsychiatry [SCAN] (Wing et al. 1990).  
The CIDI is a comprehensive, fully-structured diagnostic interview without 
clinical judgment that maps psychiatric symptoms onto DSM-IV and ICD-10 
diagnostic criteria in a top-down approach (Üstün & Tien 1995). Because it is 
fully structured, the CIDI is suitable for application in large epidemiological 
studies in which well trained lay survey interviewers are used.  
The SCAN-2.1 is a semi-structured, bottom-up clinical diagnostic interview 
developed by the World Health Organization (WHO), which includes the latest 
(10th) version of the Present State Examination (PSE-10), the successor to the 
PSE-9 (Wing et al. 1990; Wing 1996). The SCAN explicitly provides scope for 
interviewer probes and interviewer judgement with reference to rating signs and 
symptoms as present or absent. The SCAN-2.1 requires clinically experienced 
trained interviewers and is primarily designed for use by psychiatrists and 
clinical psychologists. The interview is time-consuming and consequently less 
suitable for large-scale epidemiological surveys.  
An extensive literature on the CIDI (Sartorius & Janca 1996) has established 
that its inter-rater reliability is good to excellent (Cottler et al. 1991; Cottler et al. 
1997; Wittchen et al. 1991), its test-retest reliability good (Wittchen 1994) and 
its validity satisfactory to good (Peters et al. 1996).  
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Kurdyak and Gnam (2005), focussing on the depression module, pointed out 
that the CIDI has never been validated in a general population sample and 
interpret this fact as a major flaw in its development. Until now, validity studies 
have been done in clinical samples, in which the depression prevalence rate is 
substantially higher than the rate in community samples. Kurdyak and Gnam 
(2005) state that the lower prevalence of psychiatric disorders in a community-
based setting most likely results in a high rate of false positives and 
consequently in inflated prevalence rates when the CIDI is used.  
There is less literature on the SCAN than on the CIDI. Nevertheless, the claim 
that clinical interviews like the SCAN-2.1 are imperfect because of low inter-
rater reliability and potential validity problems (Wittchen et al. 1999) has been 
rebutted for the PSE-9 (Duine et al. 1985b; Lesage et al. 1991; Wing et al. 
1977) and the SCAN-2.1 (Andrews et al. 1995; Brugha et al. 1999b; Cheng et 
al. 2001; Rijnders et al. 2000; Tomov & Nikolov 1990). Globally, the reliability of 
the SCAN-2.1 can be described as moderate to substantial. For the test-retest 
procedure, reliability has been shown to be fair to moderate. In the standardised 
procedure agreement has been found to be substantial to almost perfect 
(Rijnders et al. 2000).  
There is a scarcity of studies analysing diagnostic agreement between the CIDI 
and the SCAN. Using confirmatory SCAN interviews and the CIDI as a 
screening method for identifying subjects with schizophrenia and affective 
disorders in a community survey, Shibre et al. (2002) found that the 
performance of the CIDI was modest; in particular, the CIDI identified only 55% 
of the subjects with schizophrenia and, slightly better, only 66% of the subjects 
diagnosed with an affective disorder. Compton et al. (1996) reported fair to 
good CIDI-SCAN agreement for alcohol and cocaine dependence, but only poor 
agreement for opiate and cannabis dependence. Pull et al. (1997) also 
observed fair to good agreement between the CIDI and the SCAN for ICD-10 
diagnoses of substance dependence, but extremely poor agreement for 
diagnoses of substance abuse. In an early study, Andrews et al. (1995; 
Andrews & Peters 1998) compared agreement for diagnoses of depression on 
the basis of independent CIDI and SCAN interviews. They found that this was 
moderate and that more diagnoses were attributed by the CIDI than by the 
SCAN. Andrews et al. (1995) expressed doubt about the appropriateness of 
Cohen’s kappa coefficient (κ). Consequently, they suggested the use of 
canonical correlation analyses. Following their own advice, they obtained for the 
1-month timeframe three significant, albeit rather moderate, canonical 
correlations – 0.69, 0.59, and 0.44, and for the lifetime timeframe also three 
significant canonical correlations – 0.66, 0.65, and 0.42. Basing themselves 
primarily on the latter findings, they concluded that the diagnostic distinctions 
made with the CIDI and the SCAN are highly similar. 
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More recently, in a sample of non-clinical young adults in Finland, Aalto-Setälä 
et al. (2002a) investigated diagnostic accuracy in the assessment of depression 
with the short form of the CIDI [CIDI-SF] (Kessler et al. 1998) and the SCAN 2.0 
(WHO 1994). They found a modest correspondence between the CIDI-SF major 
depression episode (MDE) and the SCAN-1 (consensus) MDE: nearly one-third 
(28%) of the participants diagnosed with the SCAN MDE were not identified 
with the CIDI-SF MDE, and more than half (55%) of the participants diagnosed 
with MDE with the CIDI-SF were not identified with the SCAN. The κ for the 
correspondence of the two instruments with reference to the MDE was 0.43. In 
the analyses of the correspondence of the CIDI-SF MDE to the SCAN 
consensus, the κ value was substantially higher (0.60) for any affective 
disorder. These outcomes suggest that the CIDI-SF identifies a broader kind of 
affective disorder. Consistent with these outcomes are the results of the CIDI-
SCAN comparisons reported by Brugha et al. (2001), who obtained a κ of 0.15 
for depressive episode and a κ of 0.39 for any mood disorder.  
In a recent study, Jordanova et al. (2004) compared the psychometric 
properties of the CIDI with those of the SCAN, conventionally considered the 
gold standard, in a sample of primary care recipients. The agreement for 
depressive episodes was moderate: κ = 0.54. In line with the results of the study 
by Andrews et al. (1995), the CIDI showed a marked tendency to over-
diagnose, resulting in a prevalence of 18.1%, whereas the corresponding figure 
with the SCAN was 7.6%. Agreement was excellent for any depression, as 
established by a κ value of 0.97. 
In conclusion, the available evidence is far from decisive. Consequently, we 
agree fully with Jordanova et al. (2004), who concluded that much more 
research is required to determine the extent and limits of the validity of the CIDI. 
We should add that the last word has not been said regarding the psychometric 
and clinimetric qualities of the SCAN and the CIDI-SCAN correspondences. 
This study was undertaken in order to improve our understanding of the 
common finding that lay and clinical psychiatric diagnostic interviews 
administered in the general population consistently furnish discrepant findings, 
which suggests that they yield different information. We focused our study on 
depressive disorders for two reasons: first, these disorders form one of the 
diagnostic groups that are very sensitive to clinical judgement, probably 
because diagnosis criteria are based on subjective experiences rather than on 
objective behaviour; and second, in the data that we gathered for this CIDI-
SCAN comparison, more depressive disorders were found than any other 






This study was conducted as part of the Nijmegen Health Area 2 (NHA-2) 
project, a general population survey that was carried out in this area (NHA, the 
Netherlands) with the Dutch version of the SCAN-2.1 in 1997.  
9.2.2 Instruments and design 
In this study, we used the CIDI-2.1 auto version of August 1997 and the 
preliminary computerised SCAN-2.1 interview version of July 1997. Consistent 
with the clinical, semi-structured character of the SCAN, 30 psychologists and 
psychiatric nurses were selected for their knowledge of psychopathology. 
Special sessions on psychiatric phenomenology were organised to optimise 
their clinical judgement. All interviewers participated in an intensive 1-week 
training course given by the WHO-SCAN collaborating centre in Groningen so 
that they could learn to work with the pencil-and-paper version of the SCAN. A 
total of 10 booster sessions were held to improve their interviewing skills. 
Furthermore, a WHO-approved computerised version of the SCAN-2.1 was 
introduced, inclusive of an algorithm for determining DSM-IV diagnoses. During 
the fieldwork, problems that arose while the data were being checked were 
discussed with a psychiatrist. The CIDI was administered by 13 lay interviewers 
who had also participated in the 1996 wave of the NEMESIS study and were 
trained by the WHO-CIDI centre in Amsterdam. To avoid any differences due to 
the sequence of the two interviews, the study was carried out in 
counterbalanced order. In a first wave in the NHA, a sample of 70 subjects 
stratified by age, gender, extent of urbanisation and GHQ-score who had been 
interviewed as part of the NHA-2 sample with the SCAN-2.1 were interviewed 
with the CIDI-2.1 within a week after the initial interview. In a second wave a 
sample of 69 subjects were selected in the Tilburg Health Area in accordance 
with the same stratification procedure as that used for the Nijmegen wave. 
These participants were interviewed in the reverse order (first the CIDI, then the 
SCAN, within a 1-week timeframe). The two health areas are comparable in that 
they both include one larger city with a large student population and a number 
of surrounding communities that are urbanised to varying degrees. None of the 
interviewers conducted both interviews with the same patient.  
9.2.3 Participants 
The subsample of 70 subjects who were evaluated first with the SCAN and then 
the CIDI contained 28 males and 42 females. The average age of the males 
was 50.4 years (range 26 - 75; SD = 13.0) and of the females 47.6 years (range 
21 - 73; SD = 15.0). The subsample of 69 participants who were evaluated first 
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with the CIDI and then with the SCAN contained 27 males and 42 females. The 
average age of the males was 48.4 years (range 20 - 75; SD = 16.4) and of the 
females 52.4 years (range 19 - 75; SD = 14.8). 
 
9.2.4 Statistics 
Extent of agreement and patterns of agreement were studied with kappa (κ) 
coefficients (Cohen 1968) and canonical correlation analysis, respectively. 
Following Andrews et al. (1995), we conducted our analyses of the degree of 
agreement between the CIDI and the SCAN mainly with κ coefficients. The 
reason for doing these analyses is that at this stage of development of the two 
diagnostic methods we are not yet in a position to conclude which of the two 
assessment instruments can be considered the standard against which the 
other should be evaluated. The relationship between the two sets of variables 
was further examined by means of canonical correlation analysis [see 
Tabachnik & Fidell (1996) for an overview]. Canonical correlations establish the 
degree of association between two latent variables (canonical variates). In this 
study, one variate represents a set of CIDI items and the other a set of SCAN 
items. There may be more than one significant canonical correlation and each 
canonical correlation is optimised so that the linear correlation between the two 
latent variables is maximised. The process is repeated until a successive linear 
combination is no longer significant.  
In the canonical correlation program of SPSS version 13.0 (CANCORR) that 
was used, the size of each set of items is restricted to a maximum of 25. As a 
consequence, we had to reduce the number of items by aggregating those that 
target loss of energy and sleep problems (SCAN), and thinking disturbances, 
suicidal ideation, self-confidence and appetite changes (CIDI); only the items of 
the basic diagnosis of the depressive episode according to the DSM-IV were 
used. The explicit observational items of the SCAN (n = 15) were excluded 





The CIDI identified 39 subjects with a psychiatric disorder (case), while the 
SCAN identified 34 such subjects. Of the 39 subjects with a CIDI diagnosis, the 
SCAN identified 22, leaving 17 subjects undiagnosed. Of the 100 subjects with 
no CIDI diagnosis, 12 were indicated by the SCAN as a case. It follows that 88 
subjects were not diagnosed by either method. At 0.46, the κ value was modest. 
Re-scoring of the SCAN by ignoring the clinical judgements raised the number 
of cases to 47. In that case, 29 subjects diagnosed with the CIDI were also 
diagnosed by the SCAN, so that 10 subjects were undiagnosed. Of the 100 
subjects without caseness according to the CIDI, the SCAN identified 22, i.e. 78 
subjects were not identified by either method. The percentage of SCAN cases 
that were picked up by the CIDI decreased from 64.7% to 61.7%, while the 
percentage of CIDI cases that were also diagnosed using the SCAN increased 
from 56.4% to 74.4%. In spite of this, at 0.53, the κ value was modest. 
With reference to the diagnostic categories, agreement of the CIDI with the 
original SCAN was in the range 0.09 – 0.51, the lowest κ having been found for 
somatisation disorders and the highest for mood disorders. κ coefficients for 
disorders related to substance use and anxiety disorder were 0.27 and 0.35, 
respectively. When the clinical judgement of the SCAN was omitted, there was 
only a modest increase in κ for mood disorders (κ = 0.54).  
Agreement analyses of the items involving comparisons of corresponding CIDI 
items and original SCAN items yielded κ values ranging from -0.03 to 0.53 (see 
Table 9.3.1). These coefficients were in the poor to fair range (Landis & Koch 
1977b)xii. When the clinical judgement of the SCAN was left out, the 
comparisons of corresponding CIDI and SCAN items yielded κ values ranging 
from 0.14 to 0.41 (see Table 9.3.2). Removing the clinical judgment somewhat 
raised the correlations; all κ coefficients reached significance, while the average 
κ value reached 0.28, in comparison with a mean κ of 0.27 for the original 




Agreement on the diagnosis of individual depression symptoms between 
the CIDI and the original SCAN 
CIDI symptoms SCAN symptoms Kappa 95%-CI p ≤ 
Moving all the time (E11) Subjective restlessness (3.006) 0.31 ± 0.24 0.001 
Lack of energy/feeling tired 
(E3) 
Fatigability and exhaustion; 
loss of energy; feelings of 
being overwhelmed by daily 
tasks (3.007, 7.006, 7.007) 
0.36 ± 0.18 0.001 
Periods of feeling sad, empty 
or depressed (E1) 
Depressive mood (6.001) 0.53 ± 0.18 0.001 
Loss of interest in most matters 
(E2) 
Anhedonia (6.004) 0.41 ± 0.20 0.001 




0.20 ± 0.27 0.005 
Frequent thoughts about 
committing suicide (E19) 
Suicide or self-inflicted damage 
(6.011) 
0.39 ± 0.55 0.001 
Guilt feelings (E12A) Pathological guilt (6.013) 0.27 ± 0.27 0.001 
Inferiority feelings, low self-
confidence (E13, E14) 
Loss of self-confidence (6.015) 0.19 ± 0.20 0.009 
Feelings of worthlessness 
(E12) 
Loss of self-respect (6.017) 0.24 ± 0.21 0.001 
Trouble concentrating (E15) Loss of concentration (7.002) 0.25 ± 0.21 0.003 
Trouble thinking: slow thinking, 
indecisiveness (E16,E17) 
Subjective, inefficient thinking 
(7.003) 
0.19 ± 0.19 0.006 
Inability to enjoy good fortune 
(E24) 
Loss of interests (7.004) 0.25 ± 0.22 0.002 




0.13 ± 0.23 0.002 
Appetite changes (E4,E6) Appetite changes (8.005) 0.22 ± 0.23 0.007 
Weight loss (E5) Body weight loss (8.006) -0.03 ± 0.02 ns 
Weight gain (E7) Body weight gain (8.007) 0.32 ± 0.49 0.001 
Trouble sleeping (E8) Difficulty getting to sleep, 
insomnia, early awakening 
(8.011, 8.013, 8.014) 
0.35 ± 0.19 0.001 





Agreement on the diagnosis of individual depression symptoms between 
the CIDI and the SCAN without clinical judgment 
CIDI symptoms SCAN symptoms Kappa 95%-CI p ≤ 
Moving all the time (E11) Subjective restlessness (3.006) 0.24 ± 0.16 0.001 
Lack of energy/ feeling tired 
(E3) 
Fatigability and exhaustion; 
Loss of energy; feelings of 
being overwhelmed by daily 
tasks (3.007, 7.006, 7.007) 
0.32 ± 0.15 0.001 
Periods of feeling sad, empty 
or depressed (E1) 
Depressive mood (6.001) 0.41 ± 0.13 0.001 
Loss of interest in most matters 
(E2) 
Anhedonia (6.004) 0.36 ± 0.18 0.001 




0.24 ± 0.24 0.005 
Frequent thoughts about 
committing suicide (E19) 
Suicide or self-inflicted damage 
(6.011) 
0.39 ± 0.55 0.001 
Guilt feelings (E12A) Pathological guilt (6.013) 0.30 ± 0.25 0.001 
Inferiority feelings, low self-
confidence (E13, E14) 
Loss of self-confidence (6.015) 0.19 ± 0.20 0.009 
Feelings of worthlessness 
(E12) 
Loss of self-respect (6.017) 0.17 ± 0.20 0.042 
Trouble concentrating (E15) Loss of concentration (7.002) 0.27 ± 0.16 0.001 
Trouble thinking: slow thinking, 
indecisiveness (E16,E17) 
Subjective, inefficient thinking 
(7.003) 
0.32 ± 0.20 0.001 
Inability to enjoy good fortune 
(E24) 
Loss of interests (7.004) 0.28 ± 0.19 0.001 




0.20 ± 0.25 0.020 
Appetite changes (E4,E6) Appetite changes (8.005) 0.22 ± 0.24 0.007 
Weight loss (E5) Body weight loss (8.006) 0.17 ± 0.22 0.004 
Weight gain (E7) Body weight gain (8.007) 0.14 ± 0.19 0.009 
Trouble sleeping (E8) Difficulty getting to sleep, 
insomnia, early awakening 
(8.011, 8.013, 8.014) 
0.29 ± 0.15 0.001 
Excessive sleeping (E9) Hypersomnia (8.016) 0.20 ± 0.25 0.016 
 
 
Canonical correlation analyses were performed between the set of depression-
related CIDI items and the set of depression-related SCAN items with the 
original scoring applying the SPSS CANCORR procedure. The CIDI set 
included 19 items reflecting general manifestations of depression; these 
targeted periods in which the subject felt sad or empty or depressed and had 
lost interest in most matters, and also specific markers of depression, in 
particular lack of energy, appetite change, loss of libido, sleep disturbances, 
slowness and restlessness, feelings of worthlessness, guilt feelings, lack of 
confidence, thinking disturbances and thoughts of death. The SCAN set (19 
items) targeted subjective restlessness, fatigue and exhaustion, depressive 
mood, anhedonia, preoccupation with death or disaster, suicide or self-inflicted 
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damage, pathological guilt, ideas of reference accompanied by guilt feelings, 
loss of self-respect and self-confidence, loss of concentration, subjective 
inefficient thinking, loss of interest, subjectively experienced slowness, loss of 
energy, feelings of being overwhelmed by daily tasks, appetite change, loss of 
libido, changes in body weight and sleep disturbances.  
Seven canonical correlations were found that reached statistical significance 
and were meaningful and interpretable (see Table 9.3.3). The first canonical 
correlation was 0.85. With reference to the CIDI, the first pair of canonical 
variates had significant loadings (> 0.30) on nearly two-thirds of all CIDI items, 
the highest loadings (> 0.60) having occurred for the items slowed talk or 
slowed movement. Hence the first canonical variate in the CIDI represented the 
core symptoms of depressive disorder, i.e. periods of feeling sad or empty or 
depressed, loss of interest in most matters, lack of energy, general slowing 
down and appetite change. As for the SCAN, the first canonical variate 
indicated a variety of manifestations of depression: one quarter of the SCAN 
items had high loadings, the highest loading having occurred for depressive 
mood. The second canonical correlation (r = 0.84) established that the items 
feelings of worthlessness, low self-confidence, preoccupation with death and 
loss of pleasure had substantial loadings (> 0.50) with reference to the CIDI. 
These findings corresponded to substantial loadings on the SCAN items 
preoccupation with death and disaster and loss of self-respect. The third 
canonical correlation was 0.81. This pair of canonical variates showed 
substantial loadings for the CIDI items restless movements and guilt feelings, 
with an equal loading for subjective experience of slowness for the SCAN. For 
the fourth canonical correlation for the CIDI, the only substantial marker was 
related to suicide, while for the SCAN, in addition to a high loading on the 
suicide item, ideas of reference, pathological guilt and hypersomnia had positive 
loadings, whereas the items low self-confidence, loss of self-respect and 
appetite changes had a negative loading. The fifth pair of canonical variates 
represented a broad pattern of depression indicators on the CIDI, and contained 
five items that also had high loadings on the first canonical variate, 
supplemented by almost all items that did not have sufficient loadings on the 
first variate. The major markers of the first variate, i.e. periods of feeling sad or 
empty, or depressed and preoccupation with death did not contribute in this 
respect. As for the SCAN, the canonical variate contained both major markers 
of the depressive disorder, depressed mood and anhedonia, and loss of interest 




Canonical variates, canonical loadings, canonical correlation, percentual 
variance, and redundancies between CIDI and SCAN variables and their 
corresponding canonical variates 
Item  
Number 
 Canonical variates and canonical loadings 
Item I II III IV V VI VII 
CIDI  
E1 Periods of feeling sad, empty or 
depressed 
0.43 0.41 0.32     
E2 Loss of interest in most matters 0.35  0.37  0.49   
E3 Lack of energy or feeling tired 0.35 0.40 0.36  0.36   
E4,E6 Appetite change 0.46 0.39      
E5 Weight loss     0.40   
E7 Weight gain 0.39   -0.32   0.43 
E8 Trouble sleeping  0.38 0.44  0.49   
E9 Excessive sleeping 0.39     0.56  
E10 Slowed talking or movements 0.62    0.40   
E11 Moving all the time   0.56   0.35  
E12 Feelings of worthlessness  0.59   0.41  0.30 
E12A Guilt feelings 0.37  0.51     
E13, E14 Inferiority feelings; loss of self-
confidence 
 0.51   0.31 0.30  
E15 Trouble concentrating  0.31 0.39  0.38 0.31  
E15A Inability to read, watch television 0.43 0.35   0.41  0.31 
E16,E17 Trouble thinking 0.33 0.36      
E18 Frequent thoughts about death 0.30 0.58      
E19; E20 Feeling low, frequent thoughts about 
committing suicide, suicide attempt 
0.36   0.53 0.38 
  
E24 Loss of pleasure  0.53 0.41  0.36   
Percentual variance 0.13 0.13 0.11 0.03 0.11 0.07 0.04 




With reference to the CIDI, the sixth canonical correlation had the highest 
loading for the item excessive sleeping, while regarding the SCAN, the item 
appetite changes had the highest loading. Both instruments contained the item 
related with problems with self-confidence. Finally, the seventh canonical 
correlation was still 0.62, with, for the CIDI, a sufficient loading for weight gain, 
feelings of worthlessness and inability to read. With reference to the SCAN, loss 
of energy and weight gain had the highest positive loadings and the suicide item 
a negative loading. 
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Table 9.3.3 (continued) 
Canonical variates, canonical loadings, canonical correlation, percentual 
variance, and redundancies between CIDI and SCAN variables and their 
corresponding canonical variates 
Item  
Number 
Canonical variates and canonical loadings
Item I II III IV V VI VII 
SCAN  
3.006 Subjective restlessness   0.46     
3.007/7.006/ 
7.007 
Fatigability, loss of energy, feelings 
of being overwhelmed by daily tasks 
0.36    0.41  0.36 
6.001 Depressive mood 0.51 0.31 0.45  0.41   
6.004 Anhedonia   0.45  0.54 0.43  
6.010 Preoccupation with death or disaster  0.55      
6.011 Suicide or self-inflicted damage    0.31   -0.36 
6.013 Pathological guilt 0.33 0.44  0.36    
6.014 Ideas of reference with guilt content    0.54    
6.015 Loss of self-confidence    -0.48  0.43  
6.017 Loss of self-respect  0.60  -0.57    
7.002 Loss of concentration   0.48     
7.003 Subjective, inefficient thinking     0.33   
7.004 Loss of interests  0.42   0.40   
7.005 Subjective experience of slowness 0.35 -0.37 0.53     
8.005 Appetite changes    -0.41  0.59  
8.006 Weight loss      0.31  
8.007 Weight gain       0.46 
08.011/13/14 Sleep problems   0.32     
08.016 Hypersomnia    0.30    
Percentual variance 0.05 0.09 0.07 0.08 0.07 0.06 0.04 
Redundancy 0.04 0.06 0.05 0.05 0.03 0.03 0.02 






The major objective of this study was to compare the CIDI with the SCAN in 
terms of case identification with respect to mental disorders in general and 
depressive disorders in particular. The present state of affairs reflects a 
remarkable heterogeneity of findings due to characteristics of the populations 
under study but also features of the assessment methods used (Fontenelle et 
al. 2006). Accordingly, we felt that the current CIDI-SCAN comparison could 
further epidemiological knowledge since this study was not limited to subjects in 
treatment, which, unfortunately, is often the case. Furthermore, this comparison 
enables a confrontation between two instruments that differ clearly with respect 
to the scope for clinical judgement, which is encouraged in the SCAN and kept 
to a minimum in the CIDI. 
The main findings can be summarized as follows. First, the data indicated that 
overall there was only moderate agreement on rates of diagnosis between the 
two methods. Agreement regarding caseness in terms of any disorder was 
somewhat higher after the two methods were brought closer together through 
eliminating the influence of clinical judgement in the SCAN. But even after this 
methodological intervention, agreement was only fair. Second, comparisons of 
the individual diagnostic criteria showed significantly lower agreement for some 
criteria. Notable is the fair but relatively low agreement for somatisation 
disorders and the substantially better agreement for mood disorders. However, 
even for the latter category, agreement was moderate. Third, the focus on 
depression did not change this picture. Generally, κ values for individual 
depression criteria were poor to fair. In spite of a certain degree of face validity 
(e.g., slowed talk or movement [CIDI] versus subjective experienced slowness 
[SCAN]), κ values indicated only low agreement. Actually, moderate agreement 
was obtained only for the comparisons between (1) the CIDI item periods of 
feeling sad or empty or depressed and the depressive mood item of the SCAN 
and (2) the CIDI item loss of interest in most matters and the SCAN item 
anhedonia. Filtering the influence of clinical judgement out of the SCAN 
diagnoses had no effect whatsoever.  
In contrast to this rather disappointing level of concordance, the CIDI/SCAN 
canonical correlation analysis, which was conducted to explain the relation 
between the two sets of latent variables, established convincingly that the CIDI 
and the SCAN agree substantially. 
Andrews et al. (1995) suggested that there are at least two possible reasons for 
a lack of agreement in the assignment of individuals to particular diagnoses with 
the two instruments: first, they point to the possible unreliability of one or both of 
them; and second, they suggest that the instruments may differ in the definition 
of the symptoms that contribute to diagnostic categories. They conducted a 
rather global canonical correlation analysis based on broad diagnoses (e.g., 
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agoraphobia/panic, social phobia, obsessive-compulsive disorder, depression) 
and concluded that the outcomes “strongly suggest that the less than perfect 
concordance between the CIDI and the SCAN is unlikely to be due to differing 
definitions of diagnoses” (p. 129). The present, much more fine-tuned canonical 
correlation analysis based on individual items for depression makes it possible 
to put their conclusion in perspective. Although we found high coefficients 
between latent variates for individual depression items, we were not able to 
confirm the strong agreement for items with the κ coefficient. It proved difficult to 
identify the corresponding items in the SCAN and the CIDI that represent the 
operationalisation of the DSM-IV diagnostic criteria for mood disorders. This 
divergence with reference to item operationalisation creates a fundamental 
mismatch between the two instruments, a mismatch that is amplified by the 
differences in the procedures for obtaining diagnoses. 
With reference to the preceding, we refer to Spitzer and Williams (1985), who 
distinguish three sources of data divergence: information variance, observation 
and interpretation variance, and criterion variance. The first source results from 
the fact that diagnoses can be based upon discrepancies in the information 
given by patients; the second arises from differences in the ways observers 
collect and interpret data; and the third reflects the employment of different 
criteria or differences with respect to conceptualisation and operationalisation. 
Because standard classification systems were used, Spitzer and Williams did 
not consider criterion variance to be a major source of variance in CIDI-SCAN 
comparisons. That might apply to theoretical diagnostic criteria, but the fact that 
the operationalisation of these criteria diverges between the two instruments 
introduces quite an important source of variance. A comparison of the CIDI and 
the SCAN with respect to items reveals that the questions do not have identical 
or even highly similar wordings. Although the two instruments are meant to tap 
the same phenomena, the phrasing is quite different. Presumably this difference 
reflects the fact that the fully-structured CIDI with its relatively simplified 
assessment task is suitable for use by lay survey interviewers, while the more 
sophisticated semi-structured SCAN requires clinically experienced trained 
interviewers. In sum, these different operationalisations imply a source of 
information variance. 
As for the observation and interpretation variance, unlike the CIDI, the SCAN 
explicitly uses clinical judgement as a criterion for the clinical relevance of the 
assessed phenomena, thereby knowingly introducing a considerable source of 
variance. 
Although all three sources of variance play a role in reducing the agreement in 
the assignment of individuals to particular diagnoses, when the CIDI and the 
SCAN are used, we firmly believe that the problem of criterion variance is not 
yet solved. The observation and interpretation variance and the information 
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variance from the SCAN represent the essence of the clinical approach and so 
cannot be easily dismissed. As far as the CIDI is concerned, observation and 
interpretation are abandoned in favour of face validation of the (illness) 
response of the subject, which introduces information variance from the act of 
recording a perceived morbidity. 
In conclusion, future research should be aimed at scrutinising the precise 
influence of those sources of variance that can be dealt with, especially the 
operationalisation of the theoretical diagnostic criteria of the current 
classification systems. Such research will pave the way for improvements in the 
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10 Research results and general discussion 
In this chapter the empirical data (parts II and III) will be viewed from the 
perspective of the theoretical principles of psychiatric epidemiology and 
diagnostics (part I). At the end of this chapter, recommendations are given on 




10.1 Case definition, case identification and case 
finding in psychiatric epidemiologyxiii 
Epidemiology emerged from the need to bring under control the large epidemics 
of the second half of the 19th century. This new discipline was very successful in 
that respect since identifying cases was relatively easy as far as infectious 
diseases were concerned. Matters got complicated, however, when 
epidemiological principles were applied to non-infectious and chronic diseases, 
particularly in psychiatry (Fleming & Hsieh 2002), because the definition of a 
case was not that clear.  
In psychiatric epidemiology, the solutions to the problems of defining and 
identifying cases came in three generations (Dohrenwend & Dohrenwend 
1982). The first generation of psychiatric epidemiological studies tried to avoid 
the complexity of the psychiatric case definition by identifying cases by means 
of data on hospitalised patients obtained from non-standardised, non-
structuredxiv, so-called free interviews. In the absence of a clear psychiatric 
classification system, the second generation used questionnaires to measure 
general distress as a synonym for psychiatric caseness in general population 
surveys. The third generation came in two waves: in a first group of studies, 
semi-structured, standardised diagnostic clinical interviews (like the Present 
State Examination, ninth version [PSE-9]) were conducted in the general 
population, but the data from these studies had to be classified in accordance 
with non-criterion-based definitions of the classification systems, such as the 
IDC-9xv and the DSM-IIxvi. The data generated by the second wave of the third 
generation of psychiatric epidemiological studies were classifiable on the basis 
of criterion-based definitions of the DSM-III/DSM-IV and the ICD-10 
classification systems. Besides improving the semi-structured interviews, these 
classification systems cleared the way for the development of fully structured, 
non-clinical, standardised diagnostic interviews, like the Diagnostic Interview 
Schedule (DIS).  
The oldest structured diagnostic interview tradition, which was in vogue in the 
first wave of the third generation of psychiatric epidemiological studies, was 
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represented by the Present State Examination/Schedules for Clinical 
Assessment in Neuropsychiatry (PSE/SCAN), which was first published in 1974 
for use in epidemiological surveys (Sartorius et al. 1972; Wing et al. 1967; Wing 
et al. 1974; Wing 1996). The main characteristic of this tradition is the clinical 
perspective of the case identification, which is in accordance with the 
requirement of Cooper (1979), who stated that it is the psychiatric 
epidemiologist who should choose (diagnostic) variables that are not only 
scientifically, but also clinically relevant, and that represent a need – as 
opposed to a demand – for care. The second interview tradition started in 
response to the limited usability (low cost effectiveness) of the clinical 
instruments in large-scale general population surveys. The development of the 
DIS began in 1978 at the request of the National Institute of Mental Health 
(NIMH). This body needed a low-cost, comprehensive diagnostic instrument for 
use by lay interviewers for its large-scale, multi-centre Epidemiological 
Catchment Area (ECA) study. Consequently, they required a fully structured 
and non-clinical instrument with comprehensive specifications of the 
classification criteria in the questions (Eaton et al. 1981). Even though the 
criterion-based classification systems used in the diagnostic interviews of the 
two traditions are the same, they differ considerably in the prevalence rates they 
yield. This fact raises questions about the quality of case finding and argues for 
greater interchangeability of the set of instruments used in psychiatric 
epidemiology. 
 
In order to get reliable and valid results, the ‘what’ in case identification (the 
diagnostic process) should be clear and unambiguously defined. Kendell (1993) 
recognised the importance of three methodological principles for improving the 
reliability of the diagnostic process:  
1. Structured and standardised instruments should be used; 
2. Any algorithms that are used should be transparent and unambiguous;  
3. All signs and symptoms that are determined should be defined in such a way 
that the rater understands the definitions.  
In the process of the development of the two diagnostic interview traditions 
(PSE/SCAN and DIS/CIDI), these three principles have been implemented in 
these traditions, but with a different timing and to a different extent. Both the 
DIS/CIDI and the PSE/SCAN tradition are characterised by structured and 
standardised instruments. With regard to the transparency and non-ambiguity of 
the algorithm used, the PSE/SCAN tradition has undergone appreciable 
improvement since the ‘black box’ of the PSE-9, whereas the transparency of 
the algorithm of the DIS/CIDI tradition is not yet up to scratch. With regard to the 
unambiguous definition of signs and symptoms, the PSE/SCAN, with the 
SCAN-2.1, clearly has an advantage over the DIS/CIDI tradition. The SCAN 
comes with an extensive and well defined glossary, while in the CIDI interview 
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the definition of the signs and symptoms depends on the respondent’s 
comprehension of the terms used in the formulation of the compulsory 
questions.  
 
The purpose of this study was to contribute to these areas of interest through 
presenting the epidemiological 1997 case-finding data of the Nijmegen Health 
Area project-2 (NHA-2) and comparing these data with the 1983 data of NHA-1. 
With respect to case identification, in this study we explored the effect of clinical 
judgement and compared data from the SCAN with data from the Composite 
International Diagnostic Interview (CIDI), the successor to the DISxvii. We also 
elaborated on the psychometric properties of the SCAN and the differences 
between the SCAN and the CIDI.  
The decision to use the SCAN-2.1 as the diagnostic instrument of choice in the 
NHA-2 made it possible to attain the following objectives: 
• compare the NHA-2 data with the data of the NHA-1 of 1983 by converting 
PSE-10 scores into PSE-9 scores (case finding [ICD-9], monitoring [1983-
1997], see 10.2.1); 
• study the consequences of the relative extension of the diagnostic range by 
determining diagnoses on the basis of the integral diagnostic axis 1 range of 
the DSM-IV (case finding [DSM-IV], mapping [1997], see 10.2.2); 
• study the reliability and the validity of the application of the semi-structured, 
clinically oriented SCAN-2.1 interview in open population surveys (case 
identification, see 10.3.1); 
• investigate the influence of clinical judgement in the diagnostic process by 
using the item scores along with their qualitative clinical perspective (case 
identification, see 10.3.2); 
• study the agreement and the differences between the results of the SCAN 
and the CIDI when these are obtained from the same survey sample of the 
open population (case identification, see 10.3.3).  
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10.2 Descriptive epidemiology, i.e. case finding: the 
prevalence and distribution of identified cases 
 
10.2.1 Monitoring 
The initial objective of the NHA-2 was to repeat the NHA-1 of 1983 (Hodiamont 
et al. 1987) in order to measure the psychiatric prevalence rate and its 
distribution in the general population in 1997 (descriptive epidemiology) and to 
compare these findings with those of the NHA-1. In the NHA-1 it was decided to 
assess psychiatric morbidity in the clinical tradition, i.e. at that time with the 
PSE-9 (Hodiamont 1986). In the NHA-2, we used the PSE-10, the principal part 
of the SCAN-2.1, which is the successor to the PSE-9, as the diagnostic 
instrument of choice in order to compare the results of the two surveys. 
Both clinical, semi-structured interviews, i.e. the PSE-9 and the SCAN-2.1, need 
to be administered by clinically experienced interviewers. Notwithstanding their 
common roots, there are noteworthy differences between the PSE-9 and the 
SCAN-2.1 (see Table 10.2.1).  
Because of the 23-year time gap between the introductions of the respective 
interviews, the then current classification system was used for each interview, 
with the possibility of an extended diagnostic range for the SCAN-2.1.  
The number of items increased from 140 in the PSE-9 to 1899 in the June 1997 
version of the SCAN-2.1. This substantial augmentation was a result of several 
developments. First, in order to fulfil the requirement of a separate examination 
of all possible signs and symptoms, many complex items of the PSE-9 had to 
be broken up. Second, two major classification systems are currently in use 
(DSM-IV and ICD-10). As there are some differences in the criteria used in the 
two systems, the number of items in the SCAN-2.1 was extended to cover all 
the data that have to be gathered so that these data can be classified in 
accordance with the two systems. Finally, as the number of diagnoses included 
in the classification systems has substantially increased, the number of items in 
the SCAN-2.1 had to be increased so that the diagnostic range would be 
covered.  
The difference in rating scales between the PSE-9 and the SCAN-2.1 mainly 
concerned the additional sub-clinical rating possibility (“1”) in SCAN-2.1, which 
enabled a more refined registration of all signs and symptoms, especially in 
general population surveys (Giel & Nienhuis 1996). Finally, the algorithm of the 
PSE-9 was not directly accessible and could be used to calculate a diagnosis 
only when the severity of the symptoms reached a threshold. In contrast with its 
predecessor, the algorithm of the SCAN-2.1 is transparent and diagnoses are 
directly calculated on the basis of the fulfilment of DSM-IV criteria. 
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With respect to this monitoring study, the differences between the two 
interviews listed in Table 10.2.1 were resolved by converting PSE-10/SCAN 
scores into PSE-9 scores. 
 
 
Table 10.2.1  
Differences between the PSE-9 and the PSE-10 (SCAN-2.1) interview 
              PSE-9 PSE-10/SCAN-2.1xviii 
Year of introduction 1974 1997 
Classification ICD-9 DSM-IV/ICD-10 
Diagnostic range schizophrenic psychoses psycho-organic disorders 
 paranoid states substance-related 
 manic and mixed affective psychotic disorders 
 depressive psychoses mood disorders 
 inhibited depressions anxiety disorders 
 neurotic depressions eating disorders 
 anxiety neuroses somatoform disorders 
  dissociation disorders 
  sleep disorders 
  other psychiatric disorders 
Number of items 140 1899 
Possible scores 0 symptom absent 0 symptom absent 
 1 symptom moderate 1 symptom sub-clinical 
 2 symptom severe 2 symptom moderate 
  3 symptom severe  
Algorithm black box, indirect open system, direct 
 
 
10.2.1.1 Monitoring outcomes 
10.2.1.1.1 Prevalence rates 
The most conspicuous finding is that the prevalence rate for caseness 
increased by as much as 50% in the 14-year interval (1983-1997) in the 
Nijmegen Health Area (7.8% in 1983 and 11.9% in 1997).  
The neurotic disorders (depression and anxiety disorders) contributed greatly to 
the prevalence rate for caseness (7.7% in 1983 and 9.7% in 1997). Although 
psychotic disorders accounted for a relatively small augmentation of the overall 
prevalence rate, they increased more than twofold over the 14-year period 
(0.8% in 1983 and 1.7% in 1997), which is substantially more than the almost 
one quarter increase for the neurotic disorders. 
 
10.2.1.1.2 Distribution 
We found no shift in the socio-demographic distribution of the disorders. The 
finding in the NHA-1 that females and males had equal prevalence rates was an 
exception to the usual pattern of distribution at that time, in particular a higher 
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prevalence rate for females than for males (Dohrenwend & Dohrenwend 1974; 
Surtees et al. 1983). This finding was not substantiated by the NHA-2 data, for, 
as expected, the prevalence rate was higher for females than for males. 
Consequently, the explanation that “role patterns in the Nijmegen Health Area 
may have changed in such a way that the inherent stress produced a similar 
amount of psychiatric disorder for the two sexes” (Hodiamont et al. 1987) can 
no longer be considered tenable. 
 
10.2.1.2 Discussion of monitoring outcomes  
When interpreting the monitoring outcomes in search of possible explanations 
of the shifts found, we have to take not only individual, but also societal and 
community factors into account, as the latter two determinants shape the 
experiences of persons living in these groupings. As for the societal and 
community levels, there were five notable observations. 
First, consistent with the large increase in the prevalence rate in our monitoring 
study, in a large-scale national Dutch replication study in GP practices, Verhaak 
et al. (2005) reported a substantial increase in neurotic problems over a 14-year 
interval (1987 - 2001). This study revealed that the prevalence rate of the GHQ-
12 scores ≥ 2 had risen from 16.8% in 1987 to 22.8% in 2001, which amounted 
to an increase of 36%. 
Second, the prevalence rate of psychotic disorders had doubled over the 14-
year interval. This increase can be explained by the planned de-
institutionalisation in the Netherlands in the late 1980s and early 1990s. For 
psychotic patients, the reorientation of inpatient care from long stay to acute or 
short stay care resulted in a revolving-door phenomenon, in which a minority of 
the former psychotic long-stay inpatients accounted for a high percentage of 
short-stay re-admissions (Ooms et al. 2002). Consequently, a larger number of 
psychotic patients lived in the open population and were potential subjects for 
the survey sample of 1997. 
A third circumstance was a complex of socio-demographic shifts: the increase 
in the mean highest (completed) level of education; the growing percentage of 
persons remunerated for their work; a decrease in the percentage of 
housewives; the substantial shift of persons moving to newly built areas in 
villages in the surrounding communities (SC). As an example of a societal 
factor, in this case the migrating city dwellers might have brought their neurotic 
burden with them, thereby contributing to a higher prevalence rate in the SC. In 
addition, after moving to the newly built areas, they might have lost their social 
support network and social cohesion, which had been beneficial to them before 
as a concomitant of city life. This unfortunate combination is in line with the 
thinking of Van Os (2000), who, in his article on the neighbourhood variation in 
the incidence of schizophrenia, concluded that the neighbourhood environment 
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modifies the individual risk for the disease and that premorbid vulnerability may 
be more likely to progress to overt disease in an environment with a higher 
perceived level of social isolation. 
Fourth, there is a paradox between the growth in prosperity of the population as 
a whole and the significant increase in psychiatric prevalence rates. Hodiamont 
et al. (2005) reported an overall increase in GHQ scores over the 14-year 
interval and, in particular, a deterioration of the scores for the GHQ items 
relating to social interaction, while the scores for the GHQ items on socio-
economic prospects were unchanged or even better. Verhaak et al. (2005) 
reported the same findings in their national Dutch replication study on GP 
practices (1987 - 2001). They found an increase in family and relational 
problems, while material problems were less often reported. As an illustration, in 
our study we found that in 1997 both students and housewives participated 
more in the workforce than they did in 1983, which brought about socio-
economic prosperity, but also led to two or more (sometimes confusing or 
conflicting) simultaneous social roles and consequently to greater stress. 
Concomitant with this work role, the time for supportive informal social 
interaction diminished. Despite the socio-economic prosperity, this social 
isolation might be regarded as a major environmental consequence, associated 
with higher stress levels and a lesser feeling of well-being.  
Finally, the fifth circumstance concerns the impending inundation of some of the 
villages of the SC. Part of the increase, especially in the neurotic (anxiety) 
states, can be explained by the fact that 1½ and 3½ years before the 1997 
survey, the part of the NHA near the large rivers was evacuated because of the 
threat of a major inundation. As a possible result, the prevalence rate of 
neurotic disorders (mainly mood and anxiety disorders) in these threatened 
areas was about 25% higher than in the other villages of the SC. 
This repeated cross-sectional survey provided us with a unique opportunity to 
explore time trends. We found neither age nor cohort effects. All five above-
mentioned circumstances or factors reflected period effects, which together 
impacted heavily on the psychiatric prevalence rates. 
 
 
10.2.2 Mapping  
In the NHA-2 mapping study, the complete diagnostic range of the DSM-IV was 
used for the first time. This innovation made it possible to investigate the impact 
of the extension of the diagnostic range.  
The following are major sources of variance that underlie the differences in 
prevalence rates found between studies – sources that are not based on real 
variations in the population: the sampling strategy, the age range, the 
classification systems, the diagnostic range, the time reference frame, the 
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interviewer’s technical skills, the setting of the interview, the interview strategies 
and the use of technological aids (Fontenelle et al. 2006). In the comparison of 
the mapping results with those of other surveys, these sources of variance were 
taken into consideration. 
 
 
10.2.2.1 Mapping outcomes  
10.2.2.1.1 Prevalence 
In the NHA-2, we found an overall prevalence rate of the integral range of 
psychiatric disorders in the general population of 17.6%. With respect to 
diagnostic categories, the highest prevalence rates were found for sleep, 
anxiety, substance use-related and mood disorders (4.8%, 4.6%, 4.0% and 
3.8%). The three psychiatric diagnostic categories newly determined in the 
general population contributed substantially to the prevalence rate, which 
increased by almost fifty percent when they were included (11.9% - 17.6%). The 
cumulative prevalence rate of the three categories (9%) contributed (+5.7%) not 
only to the overall prevalence rate, but also, and importantly, to the comorbidity 
rate. 
The comparison of the NHA-1 with the NHA-2 study also made explicit the 
influence of the diagnostic range. The prevalence rate when the PSE-9 design 
was used was 11.9% (monitoring [ICD-9], see chapter 5), while the rate was 
17.6% (mapping [DSM-IV], see chapter 6) when the SCAN (PSE-10) design 
was used.  
 
10.2.2.1.2 Distribution  
In the NHA-2, the highest prevalence rates were found amongst females, city 
dwellers, the unmarried, and the underprivileged groups (the unemployed, 
chronically ill and the lowest educated). 
With respect to the three newly determined categories, the prevalence rates for 
somatoform disorders and sleep disorders were higher in the SC than in 
Nijmegen, which contrasts with the distribution of higher prevalence rates that is 
usually found in the more urbanised regions. This deviation disappeared when 
the hierarchical rules were omitted (see Table 10.2.2) since these categories 








Distribution of somatoform disorders and sleep disorders across 
urbanisation, with and without hierarchy 
 With hierarchy Without hierarchy 
 Nijmegen SC Nijmegen SC 
Somatoform disorders 2.4 2.9 3.9 3.4 




Psychiatric comorbidity is a major health issue, given that it is associated with 
an extensive use of the health services and a substantial economic cost to 
society. Furthermore, most interventions (medication, psychotherapy, etc.) are 
not ‘comorbidity proven’, in that their effectiveness has been shown only for the 
treatment of well-defined monomorbid disorders. 
In the NHA-2 study, the comorbidity rate was substantial, with 26% of the 
subjects identified as a case.  
The additional three newly determined categories (dissociative disorders, 
somatoform disorders and sleep disorders) contributed to the comorbidity rate 
(36.7%) to a greater extent than the commonly determined part of the 
diagnostic range (22.3%). As these categories are partially hidden as a result of 
the DSM hierarchical rules, comorbidity would be much higher still if these rules 
were not taken into account. 
 
 
10.2.2.2 Discussion of mapping outcomes  
10.2.2.2.1 Prevalence rate 
To our knowledge, the NHA-2 was the first psychiatric survey worldwide in 
which the prevalence rate for the full diagnostic range was estimated with a 
clinical, semi-structured, diagnostic instrument. Although the full range of 
diagnostic categories was used, the 1-month prevalence rate was moderate. 
The number of studies that are in some respect methodologically comparable 
with the NHA-2 are limited. All comparisons fall short in one way or another with 
reference to either the use of a different diagnostic interview, a different (version 
of the) classification system, a different age range or a different range of the 
diagnoses that were assessed.  
Nevertheless, some recent surveys are worthy of mention since they create a 




Prevalence rate: SCAN studies 
A comparison of studies conducted with the SCAN is hindered by the fact that 
the SCAN is rarely used in open population studies, and when it is, an earlier 
version of the SCAN is used, in which classification is done with the ICD-10. 
Furthermore, limitations exist with respect to the generalisability of the 
populations of these studies, the diagnostic range used and the variability of 
age ranges.  
In the Formentera study, which was performed on a small Balearic Island on 
which educational standards were low (Roca et al. 1999), the SCAN-1 and the 
ICD-10 classification were used with a smaller diagnostic range than in the 
NHA-2. A 1-month prevalence rate of psychiatric disorders of 21.4% was found. 
In the Derry County study (McConnell et al. 2002) the SCAN-1 and the ICD-10 
were used in a rural area of Northern Ireland with a high unemployment rate. 
The diagnostic range and the age range were limited, resulting in a 1-month 
prevalence rate of mood disorders, anxiety disorders and substance-related 
disorders of 7.5%. In the Camberwell Needs for Care Survey in an inner city 
area characterised by substantial social deprivation and a high proportion of 
ethnic minorities (Bebbington et al. 1997), the SCAN-1 and the ICD-10 
classification were used with a smaller diagnostic range than in the NHA-2. The 
1-month prevalence rate of psychiatric disorders was 9.8%. 
 
When the diagnostic range of the NHA-2 was decreased to the size of the range 
used in the Formentera study (21.4%), the NHA-2 prevalence rate dropped from 
17.6% to 11.7%. However, when, in addition, the generally low educational level 
of the subjects in the Formentera study was used as criterion for selecting a 
sub-sample of the NHA-2, the difference between the two studies was 
substantially smaller (NHA-2 16.8%). With reference to the Derry County study 
(7.5%), when the results of the NHA-2 mapping study were recalculated on the 
basis of the same limited diagnostic range for the rural area only, the 
prevalence rate was 10.9%. If the diagnostic range had been limited to the 
diagnostic categories adopted in the Camberwell study (9.8%) and the smaller 
age range and the inner city area were taken into account, the NHA-2 
prevalence would have been 10.2%.  
The difference in 1997 between the results of the monitoring (see chapter 5, 
PSE-9 prevalence rate 11.9%) and the mapping study (see chapter 6, 
SCAN/PSE-10 prevalence rate 17.6%) can be accounted for by the difference 
in age range and diagnostic range between the two studies. When we corrected 
the SCAN data of 1997 for the smaller age-rangexix and limited the diagnostic 
range to the major diagnostic categoriesxx, the prevalence rate for SCAN/PSE-
10 was 11.9%, which was the same as the PSE-9 prevalence rate. 
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With respect to psychotic disorders, the ICD-9 classification system used in 
1983, and consequently in the monitoring study, resulted in a substantial 
difference with reference to the DSM-IV system that was used for mapping in 
1997. When the 1997 data were classified with the ICD-9 (as was done in the 
monitoring study), the prevalence rate of psychotic disorders (including affective 
psychoses) was 1.7%. When the 1997 data were classified with the DSM-IV, 
the prevalence rate of psychotic disorders was 0.5%, mainly because the 
affective psychoses were classified as mood disorders. This illustrates the 
importance of the use of a single well-accepted classification system for the 
interpretation of epidemiological data. 
It can be concluded that under similar conditions, the prevalence rates of NHA-2 
are quite similar to those of other SCAN-based studies, even though at first 
glance the results show major dissimilarities. 
 
 
Prevalence: CIDI studies 
In general, fully structured, non-clinical interviews yield higher diagnostic 
prevalence rates than clinical, semi-structured interviews (Alonso & Lepine 
2007; Brugha et al. 1999a; Brugha et al. 2001; Cooper & Singh 2000; Goldberg 
& Huxley 1992; Kessler et al. 2005b). This disparity is possibly due to the 
measurement of the morbidity perceived by the subject, instead of the signs and 
symptoms validated by the clinician. The prevalence figures from Dutch CIDI 
studies range from 16.5% in the NEMESIS study (first wave) (Bijl et al. 1998) to 
23.2% as determined with the CIDI in the Dutch capital Amsterdam shortly after 
the crash of an El-Al Boeing plane in the south-east part of the city (van 
Limbeek et al. 1994). The comparison of the NHA-2 with the NEMESIS first 
wave, described in chapter 6, was hampered by the use of the CIDI-2.1 and the 
DSM-III-R, the limited age range and the limited diagnostic range (Bijl et al. 
1997b; Bijl et al. 1997a). When the diagnostic and the age range of the NHA-2 
were reduced to the size of the ranges in the NEMESIS, the NHA-2 prevalence 
rate was 11.7%. 
Narrow et al. (2002) introduced the clinical significance criterionxxi into the 
interpretation of the results of the NCS study (originally the CIDI-1.1 and the 
DSM-III-R were used with a limited diagnostic and age range (Kessler et al. 
1994)) and as a result, the original 1-year prevalence rate decreased from 
30.2% to 20.6%. In the replication study of the NCS (NCS-R), the CIDI-3.0 was 
used to assess 1-year prevalence rates (26.2%, see Table 10.2.3) on the basis 
of a limited diagnostic range (Kessler et al. 2005b).  
In the European Study of the Epidemiology of Mental disorders (ESEMeD), the 
CIDI-3.0 and the DSM-IV were used in a large-scale general population survey 
in six European countries. For a limited diagnostic range in subjects aged 18 
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years or older, the researchers established the 1-year prevalence rate at 11.5% 
(Alonso et al. 2004; Alonso & Lepine 2007). 
The general conclusion is that the only comparison under similar conditions that 
can be made between the NHA-2 and the CIDI studies is with the NEMESIS 
since a 1-month reference period was used for it, as it was for the NHA-2. 
Nevertheless, the prevalence rates reported from that study, in which a fully 
structured, non-clinical interview was used, were substantially higher than those 
of the NHA-2 with its semi-structured, clinically oriented interview. The 
comparison of the NHA-2 results with those of all other CIDI studies mostly 
shows even larger differences, probably due to a combination of the use of a 
fully structured, non-clinical interview with the 1-year assessment instead of the 











































































































































































































































































































































































































































































Reference period  
Age range (yrs) 
Caseness 
Psycho-organic disorder 
  Dementia 
  Other organic brain disorder 
Substance-related disorder 
  Dependence  
  Abuse 
Psychotic disorder 
  Schizophrenia  
  Delusionaldisorder,non-aff. psychosis 
Mood disorder 
  Depression  
Mania, hypomania, mixed disorder 
  Dysthymic disorder 
Anxiety disorder 
  Generalised anxiety disorder 
  Panic disorder 
  Agoraphobia (without panic disorder) 
  Specific phobia  
  Social phobia 
  Obsessive-compulsive disorder 
Eating disorder 
  Anorexia Nervosa 
  Other eating disorder 
Somatoform disorder 
  Somatisation disorder 
  Pain disorder 
  Other somatoform disorder 
Dissociation disorder 
Sleep disorder 
  Dyssomnia 
  Parasomnia 
  Other sleep disorder 
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Legend to table 10.2.3 
a (Bebbington et al. 1997);  b (Roca et al. 1999);  c (McConnell et al. 2002);  
d (Bijl et al. 1997a); e (Kessler et al. 1994) and (Narrow et al. 2002); 
f(Kessler et al. 2005b); g (Alonso et al. 2004; Alonso & Lepine 2007) 




10.2.2.2.2 Distribution  
The socio-demographic distribution of the prevalence rates found in the NHA-2 
agrees with those found in most other large-scale surveys (Alonso & Lepine 
2007; Bijl & Ravelli 2000; Brugha et al. 2004; Dohrenwend & Dohrenwend 
1974; Kessler et al. 2005b). Fryers et al. (2005) concluded that “people of lower 
socio-economic status, however measured, are disadvantaged, and this 
includes higher frequencies of the conditions now called the 'common mental 
disorders'xxii.” All in all, the interview tradition does not affect the distribution of 
psychiatric disorders in the general population, which is consistent with the 
findings of Surtees et al. (1983). 
 
10.2.2.2.3 Comorbidity 
In the NHA-2 study, the comorbidity rate was 26% of all subjects identified as a 
case. A comparison of the comorbidity rates found in the NHA with those found 
in other studies comes up against the same difficulties as those mentioned 
above with respect to the prevalence rates. The only comparable general 
population study in which the SCAN was used as the diagnostic interview was 
the Formentera study by Roca et al. (1999), who reported a comorbidity rate of 
less than 27% for those subjects identified as cases. This rate is almost the 
same as that found in the NHA-2. As far as we know, no comorbidity rates were 
reported in the Derry County study. 
The majority of the general population studies in which comorbidity rates were 
reported used a fully structured, non-clinical diagnostic interview and adopted 
different reference periods from those used in the NHA-2, in addition to 
differences in the diagnostic and the age range.  
Only the NEMESIS studyxxiii reported an overall 1-month comorbidity rate that 
was slightly higher (30%) than that found in the NHA-2 (Bijl et al. 1998; Ravelli 
et al. 1998). Other studies reported only 1-year and lifetime measures, with 
higher comorbidity rates. There are several possible reasons for these artificially 
higher comorbidity rates: the use of various definitions of comorbidityxxiv, the 
variability of the classification systemsxxv and the consequences of fully versus 
semi-structured interviewsxxvi. 
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Although we found a comorbidity rate that was more moderate than the rates 
determined in other studies, comorbidity is widespread in the general 
population. Comorbidity has serious consequences for the individual and is 
responsible for a heavy burden on society (Bijl et al. 1998; Kessler et al. 1997). 
Comorbidity also poses problems for therapists as most therapeutic 
interventions are based on so-called monomorbid evidence. 
 
10.2.2.2.4 Three newly determined diagnostic categories 
The three psychiatric diagnostic categories (dissociative disorders, somatoform 
disorders and sleep disorders) newly determined in the general population 
contributed substantially to the psychiatric prevalence rate, which increased by 
almost fifty percent (from 11.9% to 17.6%) when they were included. 
Bebbington et al. (1997) reported that the inclusion of sleep disorders resulted 
in a prevalence-rate increase of almost one third. The importance of these 
categories is illustrated by Janca et al., who stated that much research has 
recently been conducted on somatoform disorders and that these investigations 
have established that they are clinically important, being associated with a 
serious burden on health services and the economy (Janca et al. 2006). 
Relative to the diagnostic categories on which measurements are usually 
carried out, these three additional categories turned out to occupy uncommon 
positions in the diagnostic system. 
First, diagnoses of at least two categories (sleep and somatoform disorders) 
share several symptoms with other (major) diagnoses in the DSM-IV. 
Consequently, they are especially sensitive to the hierarchy rules of the DSM 
system.  
Second, the application of the hierarchy rules might also explain the spurious 
lower prevalence rates for somatoform disorders and sleep disorders in 
Nijmegen with respect to the SC. The signs and symptoms of the two disorders 
are integrated into disorders like depression, which are higher in hierarchy and 
have a significantly higher prevalence rate in the city than in the SC.  
Third, the prevalence rates of somatoform and sleep disorders were 
significantly affected by the way in which they were assessed; in particular, 
when clinical judgement was omitted, these prevalence rates increased 
substantially (see chapter 8). This finding is supported by those of other studies 
(Jacobi et al. 2004; Quintana et al. 2007).  
Fourth, the three categories contributed to comorbidity to an even greater extent 
than the normally assessed diagnostic categories. Given their high prevalence 





Currently, in the light of the development of the DSM-V, the position of 
somatoform disorders is being called into question (de Waal et al. 2006; 
Henningsen & Lowe 2006; Mayou et al. 2005; Rief et al. 2006; Starcevic 2006; 
Stein 2006; Waller & Scheidt 2006). These authors differ in the solutions they 
propose for the problem of an overly inclusive conception of the category of 
somatisation disorders. Stein suggests limiting this category to only the few 
severely dysfunctional patients for whom it is so painful to acknowledge feelings 
that affects are expressed through physical symptoms. Mayou et al. take an 
extreme standpoint and transfer most of the somatoform disorders to the 
(physical) axis III of the classification system, as a useful step toward the 
elimination of unhelpful dualist thinking. On the other hand, Rief and Starcevic 
argue that since somatisation is clinically important and associated with a 
burden on the health services and the economy, the political pressure to 
change the category should be resisted, and it should be better defined rather 
than abolished. 
 
10.2.3 Conclusions regarding descriptive epidemiology 
Many of the sources of variance mentioned by Fontenelle et al. (2006) still play 
an important role in descriptive epidemiology. All these sources complicate 
simple comparisons of gross prevalence rates. In particular, classification 
systems and interview strategies are important as they tend to disappear into 
the background and become implicit as soon as prevalence rates are calculated 
and reported. 
With respect to the first objective of this thesis (comparison of the NHA-1 with 
the NHA-2 data), the monitoring of case finding revealed important shifts in the 
overall prevalence rates over the 14-year interval from 1983 to 1997 and a 
number of explanations have been advanced for these shifts. The semi-
structured, clinically oriented interview SCAN-2.1 (DSM-IV) has shown 
consistency with the prevalence rates as calculated with the PSE-9 (ICD-9). 
Furthermore, it has been established that the SCAN-2.1 is suitable for general 
population surveys. 
With respect to the second objective (to determine the consequences of the 
relative extension of the diagnostic range), the mapping, or case finding, 
revealed that the addition of the three newly determined categories resulted in a 
substantial contribution to the overall prevalence rate. 
The various prevalence rates obtained in surveys in which the SCAN interview 
was conducted were fairly similar when the study conditions were made 
comparable. Prevalence rates obtained in surveys in which the CIDI was used 
were all higher than the aforementioned SCAN prevalence rates. 
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When the prevalence rates of diagnoses of a lower hierarchical ranking are 
discussed, they should be presented with and without the application of 
hierarchy rules so that the impact of these diagnoses on the total psychiatric 
burden can be understood.  
Concerning the disorders of the three newly determined categories, a question 
that needs to be answered is whether they should be regarded as separate 
entities in the classification system. When a disease entity is not sequentially 
related to a disorder of a higher hierarchical ranking and when it is 
accompanied by a sufficient burden related to the overall health status, in our 
opinion, it deserves a separate place in the diagnostic range. When a disease 
entity is clearly sequentially related to a disorder of a higher hierarchical 
ranking, it should be included in the classification spectrum of that disorder, but, 
when a disease entity is not sequentially related to a disorder of a higher 
hierarchical ranking and is not accompanied by a sufficient burden to the overall 
health status, it deserves no place in the classification system at all. 
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10.3 Diagnostics: case identification 
10.3.1 Psychometric properties 
10.3.1.1 Psychometric outcomes  
The psychometric properties of the SCAN-2.1 were tested in a stratified sample 
of the general populationxxvii with two designs: a test-retest procedure and a 
standardised procedure. The test-retest procedure (two SCAN interviews 
administered to one subject by different interviewers within 1 week of each 
other) showed fair to moderate reliability. The standardised procedure 
(rescoring videotaped SCAN interviews, administered and scored for reference 
diagnoses by highly experienced clinicians) showed substantial to almost 
perfect agreement.  
 
10.3.1.2 Discussion of psychometric outcomes 
Our study differs from other psychometric studies in two ways: to begin with, it 
is the first study to explore the reliability and validity of the SCAN-2.1 with 
respect to the integral diagnostic range; second, for the purposes of this 
exploration, a stratified sample was used that reflected the general population. 
All former investigations into the psychometric properties of previous versions of 
the SCAN concerned specific sections tested in more or less clinically identified 
samples (Andrews et al. 1995; Easton et al. 1997; Tomov & Nikolov 1990; Wing 
et al. 1990). 
 
A number of studies produced evidence of a lower reliability for the clinically 
oriented interviews than for the fully structured, non-clinical interviews (Andrews 
et al. 1995; Compton et al. 1996; Regier 2000; Wittchen 1994; Wittchen et al. 
1999). On the other hand, there is also evidence that the SCAN-1, at least for 
certain diagnostic categories, is as reliable as the CIDI (Üstün et al. 1997) and 
that the CIDI-auto has poor validity with respect to clinical diagnoses 
(Rosenman et al. 1997).  
There is abundant evidence in the literature that lay interviewers perform 
differently from clinicians when administering a diagnostic interview (Andrews et 
al. 1995; Anthony et al. 1985; Haro et al. 2006; Helzer et al. 1985; McLeod et al. 
1990; Slade & Andrews 2002)xxviii. The most important difference seems to arise 
from the use of clinical judgement (see sections 10.3.2 and 10.3.3). Clinical 
judgement as used in the SCAN-2.1 results in an assessment of disease rates, 
whereas lay interviews generate rates on the basis of perceived illness.  
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In view of the preceding results and reflections, it can be concluded that the 
reliability and validity of the SCAN-2.1 is satisfactory for the assessment of 
psychiatric disorders in the general population.  
 
Notwithstanding this general conclusion, some recommendations can be made 
on improving the use of the SCAN-2.1. First, some diagnoses depend 
completely on items for which there are explicit questions at the beginning of 
the section concerned. The answers corresponding to these items have to be 
re-evaluated later on in the interview without the aid of explicit questions. This 
routing of these questions is confusing and can lead to a loss of information. 
Consequently, during the 1-week training course, special attention should be 
given to intensively teaching the structure of the SCAN and its underlying 
sections. It might be beneficial if a checklist of items to be reviewed for 
completeness at the end of the interview were used or if the information were 
reappraised at the time at which it was obtained.  
Second, from the standpoint of cost-effectiveness in general population studies, 
it might be more efficient to train all interviewers intensively on part one of the 
SCAN, and to select a few of them for training on the entire SCAN interview. If 
the screening section of psychotic and cognitive pathology (section 14) turns 
out to be positive, the clinically more experienced interviewer can conduct the 
second part of the SCAN interview. 
Finally, thanks to the comprehensive SCAN training undergone by the 
interviewers, the instrument has proved its reliability and validity for use in 
research. Ahead of the next topics in sections 10.3.2 and 10.3.3, we are 
convinced that this conclusion applies to clinical practice too. In future research, 
exploration of the effects of clinical judgement with the full version of the SCAN-
2.1 should be one of the principle objectivesxxix.  
 
10.3.2 Clinical judgement 
10.3.2.1 Clinical judgement outcomes 
The results presented in chapter 8 show that clinical judgement plays a crucial 
role in the assessment of multiple diagnoses and consequently, in general, has 
an important influence on prevalence rates. The following results are 
noteworthy since they reflected major shifts with regard to clinical judgement. 
First, not all diagnoses were equally affected by clinical judgement as 
operationalised in the SCAN. Diagnoses based on subjective experiences were 
more impacted than those based on behaviour. Second, some diagnoses (like 
somatoform disorder NOS) are extremely sensitive to clinical judgement since 
the presence or absence of a single sign or symptom (related to daily life 
problems) is crucial. Third, when clinical judgement was omitted, the diagnoses 
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of some of the subjects already identified as a case tended to shift towards the 
major diagnostic categories. Fourth, the prevalence rate of caseness increased 
by 25% when clinical judgement in the SCAN was omitted.  
 
10.3.2.2 Discussion of clinical judgement outcomes 
For the first time, thanks to its transparency we were able to explore the 
algorithm black box of a standardised interview (Kendell 1993). Clinical 
interviews, like the SCAN-2.1, combine the structure of the interview with the 
clinical judgement of the interviewer for the assessment of the clinical 
significance of the perceived signs and symptoms.  
Our results show that clinical judgement gives rise to outcomes that are 
crucially different from the outcomes of interviews in which this method of 
decision-making is not used.  
Why is clinical judgement important? Because clinicians start from the 
assumption that psychiatric morbidity more or less affects the patient’s 
evaluation of his or her underlying signs and symptoms. Clinical judgement 
expresses a considered clinical opinion about which signs and symptoms, and 
thoughts and experiences can be regarded as part of normal life (sometimes in 
difficult circumstances) and which should be declared pathological. With respect 
to epidemiological studies, this statement is summarised by Cooper (1979), who 
argued that researchers should choose their (diagnostic) variables on the basis 
not only of scientific, but also of clinical relevance. 
Clinical judgement is not merely a matter of adjusting the algorithm of fully 
structured, non-clinical interviews, but, as with the SCAN-2.1, it implies an 
explicit consideration preceding the acknowledgement of each sign and 
symptom. However, even when a clinical relevance criterion was introduced 
afterwards, as was done with the NCS revision, the prevalence rates were 
decreased by almost one third (Narrow et al. 2002). This finding stresses the 
importance of a differentiation between disease and illness measures and of the 
clarification of an adequate clinical judgement in diagnostic decision-making. 
The SCAN-2.1 has the properties needed to explore both these qualities. Even 
when no illness is manifest, a positive score for a sign or symptom can be 
obtained by the interviewer thanks to the opportunity that clinical judgement 
provides. 
Consequently, it is imperative that more specific research work should be done 
on the process, the meaning and the impact of clinical judgement in the 
diagnostic process in psychiatry. Furthermore, we plead for the abolition of the 
formal routine of omitting the second part of sections in which core questions do 
not yield positive scores. Such action would contribute to a closer-to-complete 
picture of all signs and symptoms present in the general population and hence 
to a better understanding of the process of clinical judgement. 
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10.3.3 Comparison of the CIDI and the SCAN 
10.3.3.1 CIDI-SCAN comparison outcomes 
In the comparison of the CIDI with the SCAN, both interviews were 
administered to the same subjects of a stratified sample of the open population. 
Consequently, the focus was not on the actual prevalence rates but on the 
comparison of the results generated by the two instruments. And striking 
differences between the two sets of results were indeed found. First, there were 
seven strong canonical correlations (0.85 - 0.62) between the set of depression-
related CIDI items and the set of depression-related SCAN items. The 
explained percentual variance of four of the CIDI correlates was substantial 
(0.11 - 0.13) and this was also the case for the SCAN (0.07- 0.09). Second, and 
paradoxically, the kappa (κ) values with respect to the agreement between the 
individual criteria of the depressive episode yielded by the CIDI and the SCAN 
were modest (0.03 - 0.53). Third, the overall κ values with respect to the mutual 
recognition of caseness (0.46) and diagnostic categories (0.09 - 0.51) were 
modest as well. 
 
10.3.3.2 Discussion of CIDI-SCAN comparison outcomes  
There are a limited number of direct comparative studies on the assessment of 
the CIDI and the SCAN. Most of these concentrate on a single diagnostic DSM-
IV category and all report disappointing agreement values, with the odd 
encouraging exception (Andrews et al. 1995; Andrews & Peters 1998; Compton 
et al. 1996; Pull et al. 1997; Shibre et al. 2002).  
At first glance, the CIDI and the SCAN results of the NHA-2 disagree 
substantially. But an in-depth analysis (canonical correlation) of the latent 
structure of the signs and symptoms of the depressive episode (DSM-IV) 
discloses an appreciable concordance between the two instruments. The 
canonical correlations are high and the underlying symptomatology (with 
reference to the SCAN and the CIDI items) shows high loadings on the 
contributing latent variables, although the latter are composed of a mix of single 
items. The explained variance of the first seven correlates with respect to both 
the CIDI and the SCAN is considerable (62% and 46%). Both interviews appear 
to measure the same burden, but each in its own way, with divergent 
operationalisations, which are reflected by appreciable differences in the 
prevalence rates found in studies in which one or other of these interviews is 
used.  
Most prevalence studies yield a lower rate for clinical, semi-structured as 
opposed to fully structured, non-clinical interviews (Alonso & Lepine 2007; 
Brugha et al. 1999a; Brugha et al. 2001; Cooper & Singh 2000; Goldberg & 
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Huxley 1992; Kessler et al. 2005b). The CIDI tends to generate more diagnoses 
than clinicians claim are clinically relevant (Andrews & Peters 1998; Rodgers & 
Mann 1986).  
Andrews et al. (1995) emphasised that “the less than perfect concordance 
between the CIDI and the SCAN is unlikely to be due to differing definitions of 
diagnoses”. Although we found high correlations between clusters of depression 
items on the SCAN and the CIDI, agreement between the individual depression 
items was poor. This was due to the fact that it proved difficult to match the 
corresponding items of the SCAN and the CIDI that represent the 
operationalisation of the DSM-IV diagnostic criteria for mood disorders. This 
divergence with reference to item operationalisation causes a fundamental 
mismatch between the two instruments, a mismatch that is amplified by the 
differences in the procedures for obtaining diagnoses. Consequently, we can 
not agree with the standpoint of Andrews et al. that “the similarity in the weights 
within the canonical variates suggests that the instruments produce similar 
diagnostic discriminations”. 
 
10.3.4 Conclusions regarding diagnostics 
The semi-structured SCAN-2.1 interview, with its clinical judgement, is suitable 
for case identification in the general population. The use of clinical judgement 
has important effects on case identification. These effects manifest themselves 
in a lower overall prevalence rate and a category-dependent lower prevalence 
rate for specific diagnoses. The CIDI and the SCAN (the major representatives 
of the two psychiatric diagnostic interview traditions) concord strongly with 
respect to a general level of depressive burden, but the agreement is poor to 
moderate for individual depression items, diagnostic criteria and psychiatric 
categories. 
Psychiatric epidemiological population studies should be based on clinically 
relevant variables, so that clinical judgement is an indispensable instrument for 
harvesting valid information on diseases. The availability of semi-structured, 
clinically oriented instruments like the SCAN-2.1 ensures that such data can be 
captured. The SCAN-2.1 yields disease rates as opposed to the illness rates 
found with fully structured, non-clinical instruments like the CIDI. Most evidence 
indicates that the CIDI is somewhat more reliable than the SCAN, but in our 
view, a maximal reliability rate should not be achieved at the expense of clinical 
validity. We are therefore convinced that clinically oriented instruments should 
be used, even though to some extent, this practice may incur a slight loss of 
reliability. 
Many of the sources of variance mentioned by Fontenelle et al. (2006) still play 
a role in the diagnostic process, but it is difficult to quantify their impact on case 
identification.  
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Notwithstanding, classification systems and interview strategies are important, 
as they tend to recede to the background and become implicit as soon as 




10.4 General conclusions and recommendations 
In retrospect, several topics stand out in this thesis that we will proceed to 
review briefly under the headings general conclusions, study limitations, 
recommendations and final remark. 
 
10.4.1 General conclusions 
As mentioned in the research questions (see chapter 4.4), this thesis uses 
descriptive epidemiological data generated by the SCAN-2.1 with the objective 
of focusing on the relevance of clinical judgement in psychiatric diagnostics. 
With respect to the descriptive epidemiological data, we found that the 
prevalence rate of psychiatric morbidity in the open population increased by 
almost fifty percent over the 14-year interval from 1983 to 1997. In the NHA-2, 
the distribution of psychiatric morbidity reflected a well-known pattern and the 
expansion of the diagnostic range brought about a significant increase in the 
overall prevalence rate and the comorbidity rate. 
The SCAN-2.1 proved to be a reliable and valid instrument and one that is 
sensitive to changes over time. 
We used descriptive epidemiological data to explore the sub-clinical rating “1” 
and found that the operationalisation of clinical judgement in the SCAN-2.1 
differentiates many of the presented signs and symptoms as sub-clinical, 
thereby decreasing the potential prevalence rates. To compare the SCAN-2.1 
with the CIDI we used a stratified sample of the general population and found 
that although a similar burden was assessed with the two instruments, they 
diverged substantially in their operationalisations, these divergences having 
manifested themselves in different prevalence rates. 
 
10.4.2 Study limitations  
The first point to note is that the cross-sectional design of the NHA studies 
contained potential limitations with regard to the comparability of the study 
populations and the compatibility of the measuring instruments and the 
diagnostic systems used. We controlled for these disadvantages and feel 
confident that we minimised the potential effects of this limitation. On the other 
hand, a cross-sectional design has the advantage that it makes possible an 
examination of secular population changes. 
Second, the non-response in 1997 appears to call into question the 
representativeness of the survey sample. Potential subjects seemed to be 
deterred by the exhaustive information campaign deemed necessary for 
informed consent by the medical ethics committee. The sampling design, in 
213 
which GP practices were used, however, enabled us to check for selectivity by 
means of the prescription data on psychotropic medication. There was no 
evidence of a selection bias in the sense of patients with (medicated) 
psychiatric morbidity being overrepresented in the sample. Furthermore, we 
corrected statistically for over- and under-response with respect to socio-
demographic variables.  
Third, the choice of an expensive and demanding clinical interview imposed 
limitations on the number of interviewees and thus on the power of the study. 
Nevertheless, our findings show significance and clinical relevancy.  
Finally, the data gathered for this study were restricted to those necessary to 
attain the primary objective of the NHA-2 project, which was to carry out an 
epidemiological survey. Consequently, we were not able to operationalise all 
forms of clinical judgement. Consequently, the differences between prevalence 




On the basis of the reflections and conclusions set out in the previous 
paragraphs, we shall now formulate some recommendations, which we will 
group under five themes: 
 
Clinical judgement  
In this study, in which it was possible to register the sub-clinical status of 
assessed signs and symptoms (illness, but not disease), we established that 
clinical judgement is of major importance and has vital consequences for the 
process of case identification.  
a. Replication studies with respect to the preceding finding are advisable. For 
these studies, it is recommended to omit the cut-off points in the routing of 
the SCAN-2.1 interview in order to assess all signs and symptoms, including 
those enquired about in the second part of sections in which core questions 
do not yield positive scores. 
b. In addition, the situation in which the subject does not present illness but the 
interviewer decides to classify a sign or symptom as present (disease or 
sub-clinical presence) needs to be investigated more explicitly. Such studies 
must provide for the registration of the subject’s verbatim answers. 
c. Similarly, it should be determined which signs and symptoms can be 
impacted by one or more types of clinical judgement and which can not be. 
On the one hand, this information can facilitate the search for less sensitive 
equivalents of those signs and symptoms that are (too) sensitive to clinical 
judgement, and on the other hand, the information can be used to identify 
sensitive signs and symptoms that should not be assessed with a non-
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clinical interview. Such studies would facilitate the comprehension of the 
underlying mechanisms of clinical judgement, thereby helping us to specify, 
standardise, develop and simplify clinical judgement. 
d. The reliability and validity of all modalities of clinical judgement should be 
established explicitly. 
 
The three additional categories 
The right to exist of the three newly determined additional categories 
(dissociative disorders, somatoform disorders and sleep disorders) is supported 
by their relatively high prevalence rate (9%) in the open population.  
a. The burden of subjects with a monomorbid manifestation of a disorder that is 
included in one of the three additional categories should be established and 
compared in a cross-sectional design with the burden of those subjects 
diagnosed with a monomorbid disorder that falls within the major diagnostic 
categories. These results would constitute evidence as to whether the 
additional categories were sufficiently important to occupy a position in the 
classification system in their own right. As some of the disorders have been 
found to be very sensitive to clinical judgement, a semi-structured, clinical 
approach would be needed. 
b. Comorbidity data should be gathered to clarify the hierarchical position of 
the three additional categories in the classification system. 
c. Likewise, the relation of the disorders included in the three additional 
categories to other correlates (for example coping styles, life events and 
social support) could provide information on the causes and effects of these 
disorders and such information would benefit curative and preventive 
interventions. 
d. Longitudinal studies are needed to clarify the relations of the disorders 
included in the three additional categories to the other diagnoses: These 
disorders may be precursors of other, major disorders, separate disease 
entities or initial manifestations of complex syndromes which could persist 
for the rest of the subject’s life.  
 
Comorbidity 
Whatever diagnostic interview is used, comorbidity is always of major 
importance since curative and preventive interventions typically are based on 
monomorbid disease entities. 
a. To avoid the confusion brought about by the ambiguous use of the term 
comorbidity, whereby it refers not only to concurrent but also to consecutive 
pathologies, this term should be reserved for the situation in which disease 
entities occur at the same time, i.e. in which they are concurrent. The term 
consecutive morbidity should be used when two or more disease entities 
exist in a subject, but with a time gap between them.  
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b. Longitudinal research will show a picture not only of comorbidity (concurrent 
morbidity) but also of separate, consecutive morbidity. Such a view could 
teach us to differentiate between real and artificial comorbidity, provide 
information on possible precursor syndromes and provide clues on the 
prevention of a deterioration into a major psychiatric disorder.  
c. Further study of the occurrence and composition of comorbidity as assessed 
with the SCAN-2.1 is needed since the SCAN will generate a mix of 
comorbid disease entities different from the mix that other instruments would 
disclose, among other reasons because clinical judgement is incorporated 
into the SCAN. Such data would enable us to investigate true comorbidity, 
its prevalence rate and distribution, and its importance for daily psychiatric 
practice. 
 
The CIDI-SCAN comparison 
It is unacceptable that the two major standardised interview traditions in 
psychiatry create divergent bodies of evidence with respect to caseness and 
diagnoses.  
a. Detailed studies on the differences between the CIDI and the SCAN should 
be carried out in order to obtain data on the information variance, the 
observation and interpretation variance, and the criterion variance. Such 
investigations could be carried out through a comparison of video-registered 
double interviews with respect to the answers to the questions and the 
additional information obtained, and also of the ways in which the items 
registered are processed by the algorithms. 
b. Such a study could contribute to the identification of those items for which 
clinical judgement is imperative, those for which it is advisable and those on 
which it would have no impact. 
  
The SCAN 
In the course of the NHA-2 project, a total of 983 subjects from the general 
population were interviewed with the SCAN-2.1, a semi-structured, clinically 
oriented instrument. To our knowledge, this was the first time that the SCAN-2.1 
had been used for the assessment of psychiatric morbidity in the general 
population. We consequently consider it appropriate to make some 
observations on the use of the instrument itself. 
a. The rating scales of the SCAN do not enable the registration of all forms of 
clinical judgement. Consequently, we propose that research should be done 
in which, in addition to the information gleaned with the formal SCAN, the 
verbatim answers of the subjects are registered.  
b. For a real bottom-up procedure, the cut-off points after the core questionsxxx 
in each section should be omitted so that a complete dataset can be 
obtained on subjects in the open population for all available items. Future 
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classification systems could be tested against these datasets for their 
innovative value. 
c. Items without questions that are reviewed later on in the interview so that 
information for additional diagnosesxxxi can be registered should either be 
prompted for and accompanied by the information that was procured earlier 
in the interview, or else these items should be scored at the time the 
information is gathered. 
 
10.4.4 Final remark 
Despite the fact that the development of classification systems and the 
standardisation of diagnostic procedures have improved understanding in the 
psychiatric community, the results of epidemiologic research are still 
characterised by an abundance of data that admit of several interpretations. 
Although these developments are necessary, we conclude that they are not 
sufficient for a satisfactory contribution to epistemological unity. With reference 
to the interpretation and valuation of the captured data, currently the 
classification system and the interview strategy are kept hidden in the 
background. We strongly recommend that both the classification system and 
the interview strategy should be used as an explicit frame of reference when it 
comes to the valuation of the research results and that the conclusions from 
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ABSTRACT 
Background. Decades of psychiatric epidemiological research have shown a 
wide variation in prevalence rates, but a consistent relationship between 
psychiatric disorder and sociodemographic variables. In this repeated cross-
sectional survey, the prevalence rate of psychiatric disorders and their 
distribution in the general population of the same area were determined in 1983 
and 1997. 
Methods. At an interval of 14 years, two two-phase studies of psychiatric 
prevalence were carried out among the inhabitants of a Dutch Health Area 
(Nijmegen). In phase 1, the GHQ-30 was administered to a random sample of 
persons, and in phase 2, the respondents were interviewed by means of a 
clinical semi-structured interview. Only the phase-1 data will be reported here. 
Results. The mean overall GHQ score changed significantly, from 3.1 (± 1.0) in 
1983 to 4.6 (± 1.8) in 1997.  
With respect to bivariate analyses, higher score rates were found consistently in 
the age category ≥ 50 years among divorced persons, poorly educated persons, 
the unemployed or chronically ill and urban residents. With regard to 
multivariate analyses (second-order effect), however, the variance explained by 
these socio-demographic variables doubled, revealing the importance of 
complex interactions.  
Limitations. Our objective of ensuring identical designs in 1983 and 1997 could 
not be completely achieved.  
Conclusions. Over the interval in question, psychiatric prevalence had 
increased in all sociodemographic categories, despite the improved socio-
economic conditions in the survey population as a whole. The increasing 
complexity of life is apparently taking its toll, even among the socially best 
equipped.  
Key words:  




Time and again it has been suggested that the prevalence rate of psychiatric 
disorders is rising owing to noxious factors that characterise the way of life in 
modern society. In spite of numerous social changes on a global scale, 
however, various studies have found psychiatric prevalence rates to be stable 
(Murphy et al. 1984; Nandi et al. 2000) or even declining (Bebbington et al. 
1981; Bebbington et al. 1997). Studies on the question of whether psychiatric 
prevalence rates are changing (Regier et al. 1998) are fraught with 
methodological difficulties. While a prospective cohort study has the advantage 
of consistency as far as the population is concerned, secular population 
changes cannot be examined adequately in this way since the cohort ages over 
time. A repeated cross-sectional survey, on the other hand, does offer that 
opportunity, but with the disadvantage of a relative incomparability of the study 
populations. Because of these difficulties, studies comparing community 
psychiatric surveys carried out in the same area at different points in time are 
few. 
To determine any change in psychiatric prevalence rates and to test the 
hypothesis of a consistent association between demographic characteristics 
and psychopathology (Dohrenwend & Dohrenwend 1974; Surtees et al. 1983), 
a repeated cross-sectional survey was carried out in the population of the 
Nijmegen Health Area (NHA) in 1983 (Hodiamont et al. 1987) and 1997. The 
General Health Questionnaire (GHQ-30) (Goldberg 1972; Goldberg 1978) and 
the Present State Examination (PSE) (Wing 1974; Wing 1996), combined in a 
two-phase design, were used to compare case rates and their distribution 
between 1983 and 1997. We shall restrict this paper to the results from the first 




The sample  
Random samples of 4,500 and 4,517 persons from the non-institutionalised 
Dutch-speaking population of the NHA aged 18-64 years were enrolled in 1983 
and 1997. For the 1983 sample (Hodiamont et al. 1987), the distribution of the 
3,245 respondents by gender, age, and marital status corresponded to the 
population distribution according to the 1982 census data of the Central Bureau 
of Statistics (CBS). A total of 3,232 persons completed the phase-1 interview.   
In order to have access to medical data, we recruited the 1997 sample through 
general practitioners (GPs). Since virtually every inhabitant of the Netherlands 
is registered in a general practice, the degree of this registration is equivalent to 
that of the registry offices (Boerma et al. 1993). The gross sample of 4,517 
persons, which corresponded closely to the population distribution by age and 
gender according to the 1997 census data and was distributed equally over the 
participating general practices, were sent a letter by their GP in which they were 
asked whether they would consent to take part in the survey on an informed 
basis. A phase-1 interview was conducted on 1,617 persons. To establish 
whether the response showed a selection bias and consequently whether the 
survey sample was an adequate representation of the general population, data 
on gender, age, degree of urbanisation and the prescription of psychotropic 
medication (as a parameter of mental illness) were collected (Table 11.1.1). 
Since no significant difference in prescription by the GP of psychotropic 
medication was found between the survey sample and the general population, it 
was concluded that a selection bias with respect to psychiatric disorders was 
unlikely.  
 
Females and rural dwellers were overrepresented in both survey samples and 
the elderly in 1997 only. Adjustments for these differences were made in the 
statistical analyses. Like the 1983 results, the 1997 results may consequently 
be considered representative of the general population. 
 
The general interview 
The phase-1 interview with the subjects in the survey sample covered, among 
other things, sociodemographic variables and the GHQ-30 items, which 
constitute a self-administered test that is well established as a detector of 






Comparison of the 1983 and 1997 survey samples (NHA-1 and NHA-2) with 
CBS data with respect to degree of urbanisation, gender and age; and 
representativeness of the 1997 survey sample for psychotropic 
medication prescription in comparison with GP practices.  
  1983 1997 
  Survey 
sample 
N = 3,245 
 
Population 





N = 1,617 
 
Population 
N = 294,782 
 
χ² 
  % %  % %  
Urbanisation Nijmegen 33.6 39.1 
p < .001 
29.2 34.3 p < .001 
 SC * 66.4 60.9 70.8 65.7 
Gender Males 48.7 50.5 
p = .037 
44.3 50.4 
p < .001 
 Females 51.3 49.5 55.7 49.6 
Age (years) 18-19 5.2 5.9 
p < .001 
1.5 3.6 
p < .001 
 20-24 14.7 15.3 5.9 11.1 
 25-29 15.5 14.7 9.2 13.2 
 30-34 14.9 14.0 13.2 13.3 
 35-39 12.7 11.5 15.9 12.5 
 40-44 10.3 9.3 13.0 11.8 
 45-49 6.9 8.5 12.7 11.7 
 50-54 7.6 7.8 11.6 8.7 
 55-59 7.4 7.1 9.2 7.5 
 60-64 4.9 5.9 7.7 6.7 
Prescriptions 
    Survey 
sample  
N = 1,617 
 
All patients 
N = 80,315 
 
 Antidepressants   3.4 3.4 .98 (NS) 
 Benzodiazepines   10.3 9.5 .21 (NS) 
 Antipsychotics   0.4 0.8 .07 (NS) 
 Analgesics   10.3 9.6 .33 (NS) 
 Other psychotropic drugs  2.7 2.7 .88 (NS) 




Version 8 of the SAS package was used for all statistical analyses. 
Gender, age, marital status, education, employment status and degree of 
urbanisation were tested to determine whether they had a significant impact on 
the mean GHQ scores. For the differences between the survey sample and the 
general population with respect to gender, degree of urbanisation and age, 
adjustments were made in the statistical analyses. A MANOVA was performed 
to identify both main and interaction effects. 
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11.1.3 Results  
Sociodemographic shifts  
From the CBS data (Table 11.1.1), it is obvious that the NHA population had 
increased by almost 20% in the 14-year interval in question, mainly (91% of the 
growth) on account of the newly built areas in the small towns and villages 
around the city of Nijmegen, i.e. the surrounding communities (SC). The 
population also showed marked aging. 
Our data (e.g., Table 11.1.2) show that the sociodemographic profile of the 
population changed markedly after 1983. With reference to marital status, there 
was an overall increase in the number of divorced persons and a decrease in 
the number of singles, while, in the rural areas only, there was an increase in 
the number of persons living with a partner. The mean highest completed level 
of education increased, which resulted in a smaller contribution by persons who 
had only a primary school education. 
The number of persons in remunerated employment grew substantially and the 
percentage of housewives in full-time employment was halved. The percentage 
of chronically ill or unemployed persons decreased for males, but was broadly 




Sociodemographic distribution in 1983 and 1997 (Males) 
    Males 
    Nijmegen SC 
  1983 1997 1983 1997 
512 191 1060 519 
  N % N % N % N % 
Marital status Single 123 24.0 47 24.6 227 21.4 60 11.6 
 Living with partner 369 72.1 131 68.6 814 76.8 436 84.0 
  Divorced or  Widowed  20 3.9 13 6.8 19 1.8 23 4.4 
Education Primary or none  200 39.1 43 22.5 537 50.7 177 34.1 
 Intermediate 147 28.7 72 37.7 265 25.0 211 40.7 
 Post-second. 165 32.2 76 39.8 258 24.3 131 25.2 
Employment status Employed or Retired 310 60.6 158 82.7 799 75.4 458 88.3 
 Chron. ill or Unemployed 110 21.5 16 8.5 189 17.8 45 8.7 
  Householder  or student 92 18.0 17 8.9 72 6.8 15 2.9 
In some subgroups, due to missing data, the cumulative N is lower than the N of the 




Table 11.1.2 (continued) 
Sociodemographic distribution in 1983 and 1997 (Females) 
    Females 
    Nijmegen SC 
  1983 1997 1983 1997 
571 276 1089 619 
  N % N % N % N % 
Marital status Single 114 20.0 52 18.9 149 13.7 40 6.5 
 Living with partner 408 71.5 199 72.4 880 80.8 544 87.9 
  Divorced or  Widowed  49 8.6 24 8.7 60 5.5 35 5.7 
Education Primary or none  241 42.2 56 20.3 580 53.3 176 28.5 
 Intermediate 196 34.3 70 25.4 346 31.8 337 54.5 
 Post-second. 134 23.5 150 54.4 163 15.0 105 17.0 
Employment status Employed or Retired 207 36.3 197 71.6 399 36.6 366 59.1 
 Chron. ill or Unemployed 32 5.6 17 6.2 42 3.9 21 3.4 
  Householder  or student 332 58.1 61 22.2 648 59.5 233 37.6 
In some subgroups, due to missing data, the cumulative N is lower than the N of the 




Table 11.1.3 presents the distributions of the GHQ-30 scores by gender, degree 
of urbanisation (Nijmegen and SC), and year of survey (NHA-1 - 1983 and 
NHA-2 - 1997). In both surveys, females scored higher than males and 
Nijmegen respondents scored higher than those of the SC. The mean scores 
increased significantly over time (.01 < p < .001), most markedly for females in 
the city of Nijmegen (+2.7). While the differences between Nijmegen and the SC 
were minimal in 1983, in 1997 the mean score for Nijmegen was clearly and 
significantly higher than that for the SC (p = .0017).  
The increase concerned the items on social dysfunction in particular, the scores 
for items on social interaction having deteriorated markedly. On the other hand, 
the scores for items on socio-economic prospects were unchanged or even 
better.  
In short, although the aforementioned shift from 1983 to 1997 indicated that the 
socio-economic status of the population had improved, its health status in terms 





Frequency distribution of GHQ-30 scores by gender, degree of 
urbanisation and year of survey*  
 Males Females 
 Nijmegen SC Nijmegen SC 
 1983 
N = 512 
1997 
N = 191 
1983 
N = 1060 
1997 
N = 519 
1983 
N = 571 
1997 
N = 276 
1983 
N = 1089 
1997 
N = 619 
GHQ score % % % % % % % % 
0 – 2 62.6 54.2 64.7 63.2 59.9 45.2 63.3 55.8 
3 – 5 18.4 18.1 17.5 14.8 18.5 18.8 18.1 14.9 
6 – 7 5.7 5.0 5.9 6.1 7.0 6.1 6.1 5.0 
8 – 9 2.5 3.8 4.4 4.1 4.9 6.1 4.1 6.3 
≥ 10 10.8 18.9 7.4 11.8 9.8 23.9 8.4 18.1 
Mean score 3.2 5.2 2.9 3.6 3.4 6.1 3.0 4.7 
S.D. 2.1 3.8 1.9 2.9 2.1 4.0 2.0 3.5 
* Adjusted for age  
 
 
The relation between GHQ data and sociodemographic variables  
(see Table 11.1.4) 
Gender 
Whereas the mean GHQ score did not differ for gender in 1983, the increase in 
mean score in 1997 was twice as high for females as for males, resulting in a 
significant difference.  
Age  
Our conclusion in 1983 that ‘the case prevalence more or less increases with 
age’ should be readjusted. In 1997 the mean GHQ scores were more or less 
the same in all age categories.  
 
Marital status  
The finding in 1983 of a higher mean GHQ score for divorced persons than for 
those living with a spouse or partner was confirmed in 1997. The difference in 
the mean GHQ scores between the two years was significantly higher for those 
living alone or with a spouse or partner than for divorced subjects.  
 
Education 
There was a strong inverse relationship between disorder and education. For 
the higher educated however, not only was there an increase in mean GHQ 





 Table 11.1.4 
Sociodemographic distribution of GHQ scores  
a Employment status * Gender .0055; Employment status * Age .0156; Employment 
status * Education .0008 
b Gender * Education .0029; Employment status * Marital status .0393; Employment 
status * Gender .0071; Employment status * Education .0086; Education * Marital 
status .0387; Gender * Education *Marital status .0016; Employment status * Age * 
Degree of urbanisation .0150; Age * degree of urbanisation * Education .0388 
c Gender * Education .0232; Employment status * Degree of 
urbanisation .0018; Employment status * Marital status .0219 
d Employment status * Degree of urbanisation .0001; Employment status * Marital 
status .0389; Gender * Education * Employment status .0043; Education * Marital 
status* Degree of urbanisation .0496. 


































Gender         
Male 3.0    4.0    
Female 3.1 -- -- -- 5.1 .0017 -- -- 
Age         
18-34 2.8    4.7    
35-49 3.1    4.5    
50-64 3.9 .0853 -- -- 4.8 -- .0456 .0258 
Marital status         
Single 2.8    5.0    
Living with a 
spouse/partner 
3.0    4.5    
Divorced or  
Widowed  
5.5 <.0001 <.0001 <.0001 5.9 -- .0142 .0313 
Education         
Primary or none 3.7    5.5    
Intermediate 2.9    4.4    
Post-second. 2.1 <.0001 .0068 .0038 4.1 .0045 .0017 .0066 
Employment 
status 
        
Employed or 
Retired 
2.4    4.1    
Chron. ill or 
Unemployed 
5.4    8.7    
Householder  or 
student 
3.3 <.0001 <.0001 <.0001 5.3 <.0001 <.0001 <.0001 
Degree of 
urbanisation 
        
Nijmegen 3.4    5.7    
SC 3.0 .0334 -- -- 4.2 <.0001 <.0001 .0002 
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Employment status 
A significant difference in rates of disorder was found in the comparison of the 
unemployed or chronically ill with the other categories, irrespective of gender, 
degree of urbanisation and year of inquiry (p < .05). 
 
Degree of urbanisation 
The difference in the mean GHQ scores between the city of Nijmegen and the 
SC almost quadrupled from 1983 to 1997. With respect to the distribution of 






11.1.4 Discussion  
The objectives of this paper were to compare the prevalence rate of the GHQ 
scores and their distributions between 1983 and 1997. At first sight, the notable 
non-response in 1997 appears to contradict the assumption of a representative 
survey sample and limit the comparability of the samples between 1983 and 
1997. Potential respondents seemed deterred by the exhaustive information 
campaign deemed necessary for informed consent by the medical ethics 
committee. On the other hand, our sampling design, in which GP practices were 
used, enabled us to check for selectivity by means of study-relevant variables, 
and there was no evidence of a selection bias. Consequently, we assume that 
in 1997 too, the sample was a fair representation of the general population.  
Using a cut–off point of 5/6, we estimated the prevalence rate of the GHQ 
caseness at 19.0% in 1983 and 28.9% in 1997 in representative samples of a 
Dutch general population, aged 18-64 years. Thus, we found the prevalence 
rate to have risen by about 50% for the health area as a whole. With respect to 
bivariate analyses, higher score rates were consistently found in the age 
category ≥ 50 years among divorced persons, the poorly educated, the 
unemployed or chronically ill, and urban residents. In the multivariate analysis 
on a second level, however, the variance explained by these sociodemographic 
variables doubled, revealing the importance of complex interactions. The mean 
GHQ score for females in Nijmegen, for instance, almost doubled from 1983 to 
1997.  
All factors considered, we may conclude that while the distribution of psychiatric 
disorder did not change, its prevalence rate grew substantially in the NHA from 
1983 to 1997. This increase in prevalence rate can be explained in terms of 
social change - which was definitely substantial in the Nijmegen Health Area, 
and especially in the city. Indeed, Murphy et al. (1984) hypothesised that such 
change is potentially noxious for mental health. Over time, the rates increased 
in all sociodemographic categories. Despite the improved socio-economic 
conditions in the survey population as a whole, the increasing complexity of 
modern life is apparently taking its toll, even among those best equipped to deal 
with it, in particular the highest educated and married persons. 
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11.2 Conversion table SCAN/PSE-10 to PSE-9 
PSE-9 SCAN (PSE-10) 










2 Physical illness or disabilities (obj.) 
 0 
 1 



































































10-a Sensitivity to noise 
 0 
 1 
























13 Delusional anxiety 
 0,1,2 
Not convertible 














- Highest score counts 
1,2 






- Highest score counts 
1,2 














2 Highest score counts 
3 

































PSE-9 SCAN (PSE-10) 


















































































33 Pathological guilt 











8.005    8.006 
0    0 
1,2,3  AND  1 
1,2,3    2,3,4 
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PSE-9 SCAN (PSE-10) 








36 Subjective feeling of retardation /  







2 Highest score counts 
3 


















































10.010  10.012 
0,1  0,1,2 
2  - Highest score counts 
3  3 





0 (score 1 not in use) 
2 
3 





0 (score 1 not in use) 
2 
3 





0 (score 1 not in use) 
2   
3 
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16.006/007    3.012xxxiii 
0    0 
1 Highest score counts  1  





16.008/009/010  3.012xxxiv 
0    0 
1 Highest score counts 1 
2,3    2,3 




























































18.004  18.007 
0  0 
1,2,3  - Highest score counts 
-  1,2,3 




18.005  18.008 
0  0 
1,2,3  - Highest score counts 
-  1,2,3 




18.009  18.010 
0  0 
1,2,3  - Highest score counts 
-  1,2,3 
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PSE-9 SCAN (PSE-10) 






















17.011  17.010 
 
0,2  0,2,3  
-  1 
1  - Highest score counts 
3  - 
62 Auditory hallucinations, 3rd person 
 0 
 1 
 2 xxxv  
17.008  17.009 
0,1  0,1,2,3 
-  - 
2,3   AND 4,5 
63 Auditory hallucinations, 2rd person 
 0 
 1 
 2 xxxvi 
17.009    17.010 
0,3,4,5    0,1,2,3 
-  - 
1,2  AND 4,5,9 




17.020  20.084 
0  - 
1,2,3  2,3  Highest score counts 
1,2,3  0,1 














17.015 17.016 17.017 
0 0 0 Highest  
1,2,3 - -  score  
- 1,2,3 1,2,3   counts  




ALS 66 21.119/121/123 xxxvii 
0  0,1 
1 AND 2 
2  2 
68 Olfactory hallucinations, delusions 




17.022  17.023 
 
0  0 
1,2,3  - Highest score counts 
-  1,2,3 




17.024  17.025 
0  0 
1,2,3  - Highest score counts 
-  1,2,3 
247 
PSE-9 SCAN (PSE-10) 




17.026/028/030   17.027/029 
0 0 
1,2,3 - Highest score counts 
- 1,2,3   
































75 Delusions concerning special help 
 0, 1, 2 
 
Not convertible 




10.016  19.029 
0  0 
-  - Highest score counts 
1,2,3  1,2,3 




10.017  19.030 
0  0 
-  - Highest score counts 
1,2,3  1,2,3 




























18.012  19.019 
0  0 
-  - Highest score counts 
1,2,3  1,2,3 
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PSE-9 SCAN (PSE-10) 






































17.027  19.017/018 
0  0 
-  - Highest score counts 
1,2,3  1,2,3 












19.025  6.018 
0  0 
-  - Highest score counts 
1,2,3  1,2,3 




19.031  16.012 
0  0 
-  - Highest score counts 
1,2,3  1,2,3 





16.013  19.032 
 
0  0 
-  - Highest score counts 
1,2,3  1,2,3 






-   Highest score counts 
1,2,3 









PSE-9 SCAN (PSE-10) 










94 Denying and hiding delusions 
 0, 1, 2,  3 
 
Not convertible 








19.036  17.001/19.001  19.020  17.014/21 
 
0   0  -  - 
-   8  -  - 
-   -     1,2,3  - 
1   - Highest -  1 
-   - score  -  2 
2   - counts -  3 














 3 →  Not convertible 
2.104  21.076 
0  0 
-  1 
1  2 
-  - 
98 Drug abuse 
 0 
 1 
 2  Highest score counts 
 3 
 4 
12.001  12.007  12.008  12.010/011  12.006/009 
1,2   -   -     -   - 
-   1-7   -     -    - 
-   -   1-7     -   - 
-   -   -     1-7   - 
-   -   -     -   1-7 




11.007  11.010/013/025/031/ 
0  - 
1,2  - Highest score counts 
-  1,2,3(,4) 




2.102/104/105/106/107 22.006    15.006 
0 - - 
1    Highest score counts - - 
- 1,2 1,2 




2.105/109/111/113  22.006 
0    - 
1    Highest score counts  - 
-    1,2 





15.006  22.006 
 
0  0 
1,2  - Highest score counts 
-  1,2 
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PSE-9 SCAN (PSE-10) 







≥ 21 EN ≤ 22 
≥ 18 EN ≤ 20 
≤ 17 












105 Insight into neurotic symptoms 












2.123  3.015  4.048/051/054/060  5.015 
6.027/062/072   7.009  8.021/028  9.005/026 




2                              Highest score counts 
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22.017  22.018 
0  0 
1  - Highest score counts 
2  1,2 
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PSE-9 SCAN (PSE-10) 






















































1 Highest score counts 1 
2 2 












































































































































PSE-9 SCAN (PSE-10) 





























13.125  20.114 
0  0 
1  1 Highest score counts 
2  2 
3  3 
 









The diagnosis of psychiatric disorders rests on the clinical assessment or 
professional objectification mainly of subjective experiences of the patient. This 
clinical judgement implies a professional answer to the question whether the 
presenting signs and symptoms (still) can be regarded as part of normal life or 
should be assessed as pathological. Clinical judgement is all the more 
important since psychiatric disorders themselves interfere with the patient’s 
ability to estimate this difference correctly. 
Psychiatric epidemiology turns around the question of what condition occurs in 
whom, where and when. If it is to be established properly whether a patient has 
a particular condition, the whole complex of case definition, case identification 
and case finding has to be taken into account, in which event case definition 
has to be valid and unambiguous, case identification based on clinical relevancy 
and the process of case finding reliable and valid. Prevalence rates are often 
not as important or clinically relevant as they seem to be at first glance. 
Although questionnaires and fully structured interview instruments are 
frequently used for case detection in general population surveys, questions can 
be raised about their clinical validity. 
The chapters of this thesis are grouped into four parts. Part I consists of four 
chapters of a theoretical nature and culminates in a description of the research 
objectives, Part II of two empirical chapters on psychiatric epidemiology and 
Part III of three chapters on the psychometric properties and aspects of the 
clinical judgement of the Schedules for Clinical Assessment in Neuropsychiatry 
(SCAN). Finally, in Part IV the results are discussed, the research questions 




In chapter 1, the history of the Nijmegen Health Area Project (NHA) is 
described, followed by a brief outline of the thesis. 
In chapter 2, on psychiatric epidemiology, first the definition and history of this 
discipline are given, and then the importance is explored of causality and the 
operational aspects of case identification with reference to the differences 
between the clinical/objective SCAN/PSE1 tradition and the respondent-
based/subjective CIDI-DIS2 tradition. 
In chapter 3, which addresses diagnostics in psychiatry, the three concepts of 
disease, illness and sickness are introduced and brought into relation with 
clinical judgement and classification. The latter converge in the diagnostic 
process, which in psychiatry is hindered for most disorders by a lack of infallible 
                                               
1
 Present State Examination 
2
 Composite International Diagnostic Interview-Diagnostic Interview Schedule 
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criteria. This fact underlines the importance of the psychometric quality of the 
diagnostic instruments used: these should assess accurately the clinically 
relevant signs and symptoms. The psychometric evaluation of the diagnostic 
process is explained and an account is given of the choice of the SCAN, a 
clinically oriented semi-structured diagnostic interview that yields DSM-IV 
diagnoses. 
In chapter 4, the research objectives are set out in terms of research questions. 
The thesis uses descriptive epidemiological data generated by the SCAN-2.1 
through focusing on the relevance of clinical judgement in psychiatric 
diagnoses, the objective being to improve the quality of the diagnostic process 




In chapter 5 the monitoring study of the NHA project (a repeated cross-sectional 
study) is described. The objectives were to compare the case rates and their 
distribution in 1983 and 1997, to explore the impact of urbanisation on these 
findings, and to investigate possible time trends in terms of cohort, period, and 
age effects on psychiatric prevalence. Through logistic regression, the one-
month prevalence rate of neurotic and functional psychotic caseness was 
estimated at 7.8 ± 2.3% (after reanalysis) in 1983 and at 11.9 ± 2.7% in 1997 in 
representative samples of the Dutch general population aged 18-64 years. It is 
thus seen that the prevalence rate of psychiatric disorders had risen by about 
50% for the NHA as a whole. For both years, a  more or less consistent 
relationship was found between psychiatric disorders and sociodemographic 
variables, with a higher prevalence rate for underprivileged groups (the 
unemployed, chronically ill and poorly educated). The apparent difference in the 
influence of degree of urbanisation on the rate of psychiatric disorders over the 
14-year interval (from 1983 to 1997) tended to decline. No age nor cohort 
effects were found, but the increase in prevalence rate from 1983 to 1997 may 
have been caused by several period effects. These concerned both the 
population as a whole, because of overall changes in social roles and a 
modified health policy, and in addition the rural communities, owing to the one-
way migration from the city and possibly also the imminent inundation of the 
homes and property of the rural dwellers.  
In chapter 6 the mapping study of the NHA-2 is presented. The objectives of 
this study were: to assess, by means of the SCAN, the 1997 prevalence rates of 
psychiatric disorders, their sociodemographic distribution and the comorbidity 
rate in the general population; to study the influence of three newly determined 
diagnostic categories (sleep, dissociative and somatoform disorders) on 
prevalence, distribution and comorbidity; and to compare the NHA-2 data with 
data from the NEMESIS study. The 1-month overall prevalence rate of 
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psychiatric morbidity in the NHA was 17.6% (± 2.6%). When the three newly 
determined diagnostic categories were left out, the prevalence rate decreased 
by one third to 11.9% (±2.5%). With respect to the sociodemographic 
distribution of psychiatric caseness, the prevalence rate of caseness was 
significantly higher for females, for subjects living in the city of Nijmegen, the 
age group 45-54 years, divorced, unemployed and chronically ill subjects and 
those in the lower education bracket as compared with the subjects in other 
sociodemographic subgroups. When the three newly determined categories 
were omitted, the sociodemographic distribution of caseness was characterised 
by about the same pattern. With respect to comorbidity, 26.1% of the total 
number of cases had more than one diagnosis. The comorbidity rate for the 
three newly determined categories themselves was 36.7%. When the survey 
sample (with respect to age) and diagnostic range in the NHA-2 were reduced 
to the extent adopted in the NEMESIS study, the prevalence rate for the NHA-2 
was 11.7% (±2.2%), which was substantially lower than the 16.5% (±0.4%) 
prevalence rate found in the NEMESIS study.  
The use of the SCAN-2.1 and the integral range of the DSM-IV resulted in a 
prevalence rate to which the diagnostic categories newly determined in the 
general population contributed substantially. The sociodemographic distribution 
of psychiatric disorders turned out to be as Dohrenwend and Dohrenwend had 
described it years ago. Despite the use of the complete diagnostic range, 
comorbidity rates in the NHA-2 can be characterised as moderate, 
notwithstanding the boosting effect of the three newly determined diagnostic 
categories. Fully structured interviews like the ones used in the NEMESIS study 




In chapter 7 the psychometric properties of the SCAN are described. This study 
is the first to test the psychometric properties of the SCAN-2.1 for most of the 
disorders covered and was carried out prior to the NHA-2 study. Two designs 
were used. In one of these, pairs of independent live interviews with the same 
respondent were compared (test-retest situation). In the other, ten videotaped 
interviews conducted by experts were rated by each of the 27 trained 
interviewers (standardised situation) and the outcomes were compared with 
those for the other interviewers and also with a reference score. In the test-
retest situation the kappa coefficient for diagnostic caseness was substantial 
(0.62) and for diagnostic categories and diagnostic groups it was moderate to 
good (0.24 to 0.64). In the standardised situation, in which videotaped 
interviews by experts were used, both sensitivity and specificity were substantial 
to almost perfect. The agreement per interviewer with regard to the reference 
diagnoses ranged from 87% (diagnostic group) to 94% (diagnostic caseness). 
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Agreement on the syndrome level (without the duration and interference criteria 
from the DSM-IV) was excellent. Although the instrument is traditionally used by 
experienced clinicians, this study showed that less experienced (but well 
trained) interviewers can administer the SCAN reliably.  
In chapter 8, the effect of the operationalisation of clinical judgement in the 
SCAN is elaborated on. As clinical judgement in the SCAN is incorporated into 
pre-defined rating scales, we were able to process the subclinical scores as if 
they were equal to the clinical scores, which resulted in the inclusion of all 
perceived morbidity. When clinical judgement was omitted, the number of 
positive cases increased by more than one fifth, from 197 to 245 subjects, the 
most pronounced differences having emerged for somatoform, psychotic and 
mood disorders. The prevalence rate of caseness without clinical judgement 
was 21.4%, which is 3.8% higher than when the formal clinical SCAN algorithm 
was used. The same proportional increase was found for all sociodemographic 
groups. When clinical judgement was used, one quarter of all subjects 
diagnosed as a case were comorbid, whereas this was true for one third of all 
subjects when clinical judgement was left out. In short, clinical judgement 
interfered significantly with the prevalence rates found, a more pronounced 
effect having been observed on diagnoses based on subjective experiences 
than on those rooted in behaviour. When clinical judgement was omitted, the 
specific diagnoses of lower hierarchical ranking of those subjects who were 
already a case tended to shift towards the major diagnostic categories. Some 
specific diagnoses (like somatoform disorder NOS) were extremely sensitive to 
clinical judgement. 
In chapter 9, given that the two instruments probably yield different information, 
the CIDI is compared with the SCAN in the general population with a view to 
achieving a better understanding of how each of them works. A total of 139 
subjects from the general population were interviewed with the CIDI and the 
SCAN (in a counterbalanced design). The fully structured CIDI was 
administered by well-trained lay interviewers and the semi-structured SCAN by 
well-trained clinically experienced interviewers. Agreement between the CIDI 
and the SCAN in DSM-IV caseness and diagnosis identification was only 
moderate. For major affective disorders, agreement with respect to individual 
signs and symptoms was only poor to fair, whereas canonical correlation 
analysis disclosed substantial to almost perfect concordance. 
Although latent variables identified in the two instruments were closely related, 
the instruments differed markedly with respect to the identification of cases, 
diagnoses and signs and symptoms. The goal of making the same DSM-IV 
diagnoses with the two instruments is compromised by divergent 






In chapter 10 the empirical findings reported in Part II (descriptive epidemiology) 
and Part III (diagnostics: case identification) are viewed from the perspective of 
the theoretical principles of psychiatric epidemiology and diagnostics (Part I). 
This discussion culminates in recommendations on how to improve the 
diagnostic process in psychiatric epidemiology. With respect to descriptive 
epidemiology, many of the sources of variance mentioned in the literature still 
play an important role and complicate simple comparisons of gross prevalence 
rates. In particular, classification systems and interview strategies are important 
as they tend to recede to the background and become implicit as soon as 
prevalence rates are calculated and reported. With respect to diagnostics, we 
conclude that the semi-structured SCAN-2.1 interview, with its clinical 
judgement, is suitable for case identification in the general population and that 
the use of clinical judgement has important effects on case identification. 
Therefore, psychiatric epidemiological population studies should be based on 
clinically relevant variables, so that clinical judgement is an indispensable 
instrument for harvesting valid information on diseases. 
To conclude, we strongly recommend that both the classification system and 
the interview strategy be used as an explicit frame of reference when it comes 
to the valuation of research results and that the conclusions from these results 




The appendix is comprised of two parts. The first consists of the published 
repeated cross-sectional NHA study, based on the General Health 
Questionnaire (GHQ) data, which was part of the NHA project and used as an 
important reference in chapter 5. The second presents the conversion table of 





De diagnostiek van psychiatrische stoornissen stoelt op de klinische inschatting 
of professionele objectivering van met name subjectieve belevingen bij de 
patiënt. Dit klinische oordeel impliceert een professioneel antwoord op de vraag 
of de klachten en verschijnselen als (nog) normaal dan wel als pathologisch 
moeten worden beschouwd c.q. om welk soort pathologie het dan wel gaat. 
Omdat psychiatrische stoornissen interfereren met het onderscheidings-
vermogen  van de patiënt, is dit klinische oordeel des te meer van belang.  
De psychiatrische epidemiologie, die berust op de vaststelling wat (welke 
stoornis) voorkomt bij wie, waar en wanneer, staat of valt met de correcte, dat 
wil zeggen betrouwbare en valide, bepaling van psychiatrische gevallen. Daarbij 
speelt het hele diagnostische complex van gevalsdefinitie, gevalsidentificatie en 
gevalsopsporing een rol: de definitie moet valide en eenduidig zijn, de 
identificatie gebaseerd op klinische relevantie en het opsporingsproces van 
gevallen volgens een erkende opzet verlopen. Bij de klinische validiteit van de 
voor diagnostiek in de open populatie gangbare vragenlijsten en volledig 
gestructureerde interviews kunnen vraagtekens worden gesteld. De zo gemeten 
prevalentie is dan ook niet zo eenduidig en klinisch relevant als wel wordt 
gesuggereerd.  
De hoofdstukken van dit proefschrift zijn gegroepeerd in vier delen. Deel I 
omvat vier hoofdstukken van theoretische aard en culmineert in een 
beschrijving van de onderzoeksdoelen, deel II twee empirische hoofdstukken 
over psychiatrische epidemiologie en deel III drie hoofdstukken over de 
psychometrische en klinische  eigenschappen van de Schedules for Clinical 
Assessment in Neuropsychiatry (SCAN). In deel IV worden tenslotte de 





In hoofdstuk 1 wordt de geschiedenis van het Regioproject Nijmegen (RN) 
geschetst en een kort overzicht gegeven van de inhoud van dit proefschrift. 
Hoofdstuk 2 gaat over de psychiatrische epidemiologie. Aan de orde komen 
haar definitie en historie, causaliteits- en operationele aspecten, c.q. het 
verschil  tussen  de klinisch/objectieve SCAN/PSE traditie en de respondent-
georiënteerde/subjectieve CIDI/DIS traditie. 
In hoofdstuk 3, diagnostiek in de psychiatrie, worden de concepten “disease”, 
“illness” en “sickness” geïntroduceerd en in verband gebracht met klinisch 
oordelen en classificeren. De kwaliteit van het diagnostische proces in de 
psychiatrie is afhankelijk van de deugdelijkheid waarmee klinisch relevante 
symptomen bepaald kunnen worden, met andere woorden van de 
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psychometrische kwaliteit van de gebruikte diagnostische instrumenten. In dat 
kader wordt de keuze verantwoord voor de SCAN, een klinisch georiënteerd, 
semi-gestructureerd diagnostisch interview dat DSM-IV diagnoses genereert. 
In hoofdstuk 4 staan de onderzoeksdoelen beschreven in termen van 
onderzoeksvragen. Epidemiologische data verzameld met de SCAN-2.1 worden 
gebruikt om de relevantie van het klinisch oordeel in de psychiatrische 
diagnostiek te onderzoeken, met als uiteindelijk doel verbetering van de 





In hoofdstuk 5 over de ‘monitoring’ studie worden de resultaten van de twee 
fasen van het RN-project (een herhaald cross-sectioneel onderzoek: RN1 en 
RN2) beschreven. Dit onderzoek richtte zich op de vergelijking van de 
prevalentie en de spreiding van psychiatrische stoornissen in 1983 en 1997, op 
het effect van de urbanisatie op deze bevindingen en op eventuele 
veranderingen van deze gegevens in termen van cohort-, periode- en 
leeftijdseffecten. Met behulp van logistische regressie kon de 1-maands 
prevalentie van neurotische en functionele psychotische stoornissen in een 
goede afspiegeling van de regionale Nijmeegse open populatie  tussen de 18 
en 64 jaar (na her-analyse) worden geschat op 7.8 ± 2.3%  in 1983 en op 11.9 
± 2.7% in 1997. De prevalentie van psychiatrische stoornissen bleek met 
ongeveer 50% gestegen voor de Nijmeegse gezondheidsregio als geheel. De 
relatie tussen de psychiatrische stoornissen en sociodemografische variabelen 
bleef in grote trekken gelijk, i.c. een hogere prevalentie voor de kansarmere 
groepen (de werkelozen, chronisch zieken en de laagst opgeleiden). De 
duidelijke  invloed van de urbanisatiegraad op de prevalentie van psychiatrische 
stoornissen nam  over de periode van 14 jaar (1983-1997) echter af. Leeftijds- 
of cohort effecten werden niet gevonden, maar een aantal periode effecten zou 
de stijging in de prevalentie tussen 1983 en 1997 kunnen verklaren. Deze 
betroffen zowel de populatie in het algemeen (veranderingen in de sociale 
rolpatronen en in de gezondheidszorgpolitiek) als die van de rurale gebieden in 
het bijzonder (selectieve migratie vanuit de stad en mogelijk de dreigende 
overstroming van de huizen en landerijen). 
In hoofdstuk 6 (de ‘mapping’ studie) komt het epidemiologische onderzoek in 
het kader van het RN-2 project aan de orde. Doel van dit onderzoek was 1) 
beschrijving van de prevalentie, de socio-demografische spreiding en de 
comorbiditeit van psychiatrische stoornissen in 1997, gemeten met behulp van 
de SCAN-2.1 in de open populatie, 2) bepaling van de invloed op de 
prevalentie, sociodemografische spreiding en comorbiditeit van drie nog niet 
eerder in de open populatie gemeten diagnostische categorieën (slaap-, 
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dissociatieve en somatoforme stoornissen) en 3) vergelijking van RN-2 
gegevens met de NEMESIS gegevens. De 1-maands prevalentie van 
psychiatrische stoornissen in de Nijmeegse gezondheidsregio was 17.6% (± 
2.6%). Als de drie niet eerder gemeten diagnostische categorieën buiten 
beschouwing werden gelaten, bleek de prevalentie een derde lager (11.9% 
±2.5%). De sociodemografische spreiding liet een significant hogere prevalentie 
van de psychiatrische stoornissen zien ten opzichte van andere subgroepen 
voor vrouwen, stedelingen, de leeftijdsgroep 45-54 jaar oud, de lager opgeleide 
en gescheiden, werkeloze en chronisch zieke personen. De drie niet eerder 
gemeten diagnostische categorieën hadden geen invloed op deze spreiding. 
Van alle personen met een psychiatrische stoornis vertoonde 26.1% 
comorbiditeit. De comorbiditeit van de drie niet eerder gemeten diagnostische 
categorieën zelf was 36.7%. Als de leeftijdscategorieën van de steekproef en 
de diagnostische categorieën werden terug gebracht tot de omvang gebruikt in 
NEMESIS, kwam de prevalentie voor psychiatrische stoornissen in RN-2 met 
11.7% (±2.2%) aanzienlijk lager uit dan die  gemeten in de NEMESIS studie 
(16.5%, ±0.4%). 
Het gebruik van de SCAN-2.1 met alle beschikbare categorieën van de DSM-IV 
resulteerde in een prevalentie waaraan de drie niet eerder gemeten 
diagnostische categorieën een aanzienlijke bijdrage leverden. Het patroon van 
de sociodemografische spreiding van de psychiatrische stoornissen kwam 
overeen met de bekende beschrijving van Dohrenwend & Dohrenwend. 
Ondanks het gebruik van alle beschikbare categorieën uit de DSM-IV en het 
versterkende effect van de drie niet eerder gemeten diagnostische categorieën, 
blijkt de gevonden comorbiditeit in RN-2 relatief beperkt. Volledig 
gestructureerde interviews zoals gebruikt in NEMESIS leveren hogere 
prevalenties en een hogere comorbiditeit op dan semigestructureerde, 




In hoofdstuk 7 staat het onderzoek beschreven naar de psychometrische 
eigenschappen van de SCAN-2.1 (voor het eerst in volle omvang), dat werd 
uitgevoerd voorafgaande aan het RN-2 onderzoek. In één onderzoeksopzet 
werden gegevens vergeleken van gepaarde, onafhankelijke live interviews met 
dezelfde respondent (test-hertest opzet). In een andere opzet werden tien op 
video geregistreerde interviews van experts opnieuw gescoord door alle 27 
getrainde interviewers (gestandaardiseerde opzet) en de uitkomsten vergeleken 
met die van de andere interviewers als ook met een referentie score. Voor de 
test-hertest opzet bleek de kappa coëfficiënt voor de aanwezigheid van ten 
minste één diagnose aanzienlijk (0.62), voor de te onderscheiden diagnostische 
categorieën en diagnostische groepen goed tot matig (0.64 tot 0.24). In de 
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gestandaardiseerde opzet, waarbij tien op video geregistreerde interviews van 
experts werden beoordeeld, bleken de sensitiviteit en specificiteit aanzienlijk tot 
bijna perfect. De overeenkomst per interviewer met de referentie diagnoses 
varieerde van 87% (op niveau van diagnostische groepen) tot 94% (op niveau 
van het hebben van ten minste één diagnose). Overeenkomst op het niveau 
van syndromen (zonder duur en hiërarchische criteria van de DSM-IV) was 
uitmuntend. Hoewel de SCAN meestal wordt gebruikt door clinici, laat dit 
onderzoek zien dat ook minder ervaren (maar goed getrainde) interviewers het 
instrument betrouwbaar kunnen hanteren. 
Hoofdstuk 8 gaat over de operationalisatie van de SCAN en de effecten van het 
klinisch oordeel. Omdat het klinisch oordeel is ingebouwd in de scoringsschalen 
van de SCAN, konden wij de subklinische scores behandelen alsof het klinisch 
relevante scores betrof. Per saldo telde de subjectief beleefde morbiditeit dan 
mee in de diagnostische resultaten. Wanneer het klinisch oordeel buiten 
beschouwing werd gelaten, steeg het aantal positieve gevallen met meer dan 
één vijfde, van 197 tot 245 personen. De grootste verschillen betroffen 
somatoforme, psychotische en stemmingsstoornissen. De prevalentie zonder 
klinisch oordeel kwam uit op 21.4%, 3.8% hoger dan bij gebruik van het formele 
SCAN-algoritme. Een verhoudingsgewijs gelijke stijging van de prevalentie 
werd gevonden voor alle sociodemografische groepen. Met klinisch oordeel 
was een kwart van alle positieve gevallen comorbide, zonder klinisch oordeel 
steeg dit tot één derde. Het klinisch oordeel had, kortom, op de gevonden 
prevalentie een aanzienlijk effect, dat groter was bij diagnoses gebaseerd op 
subjectieve belevingen dan bij diagnoses, waarbij waarneembaar gedrag een 
overwegende rol speelde. Personen met een diagnose van een lagere orde in 
de hiërarchie kregen een “belangrijkere” diagnose toegewezen wanneer het 
klinisch oordeel werd weggelaten. Sommige specifieke diagnoses (zoals 
somatoforme stoornis niet anderszins omschreven)  bleken buitengewoon 
gevoelig voor het klinisch oordeel. 
In hoofdstuk 9 wordt een vergelijking gemaakt tussen het Composite 
International Diagnostic Interview (CIDI) en de SCAN in de algemene populatie, 
teneinde beter inzicht te krijgen in de werkwijze van beide instrumenten, die 
kennelijk uiteenlopende informatie genereren. 139 Personen uit de algemene 
populatie werden geïnterviewd met zowel de CIDI als de SCAN (in een 
volgorde compenserende opzet). De volledig gestructureerde CIDI werd 
afgenomen door goed getrainde leken interviewers, de semi-gestructureerde 
SCAN door goed getrainde klinisch ervaren interviewers. De overeenkomst 
tussen de CIDI en de SCAN wat betreft het herkennen van DSM-IV gevallen en 
specifieke diagnoses was slechts matig. Waar op het niveau van individuele 
klachten en verschijnselen bij de grote stemmingsstoornissen een slechte tot 
redelijke overeenkomst werd gevonden, liet een canonische correlatie analyse 
echter een aanzienlijke tot vrijwel perfecte concordantie zien. 
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Hoewel de geïdentificeerde latente variabelen van de twee instrumenten een 
grote samenhang vertoonden, bleken de instrumenten op zich sterk te 
verschillen wat betreft herkenning van gevallen in het algemeen, specifieke 
diagnoses en klachten en verschijnselen. Het doel van beide instrumenten om 
tot dezelfde diagnoses te komen, wordt belemmerd door uiteenlopende 





In hoofdstuk 10 worden de empirische bevindingen uit deel II en III beschouwd 
vanuit het theoretisch perspectief van de psychiatrische epidemiologie en het 
diagnostische proces (deel I). Een en ander resulteert in aanbevelingen gericht 
op de verbetering van  het diagnostische proces in de psychiatrische 
epidemiologie. Allerlei bronnen van diagnostische variantie blijken de 
vergelijking van ruwe prevalentie maten binnen de descriptieve epidemiologie te 
compliceren. Van belang zijn met name de classificatie systemen en interview 
strategieën, omdat deze naar de achtergrond verdwijnen c.q.   impliciet worden 
in de fase dat prevalenties worden berekend en gerapporteerd. Met betrekking 
tot de diagnostiek kunnen we concluderen dat het semigestructureerde, op 
klinisch oordeel gebaseerde SCAN-2.1 interview bruikbaar is voor 
gevalsidentificatie in de open populatie en dat de toepassing van dat klinische 
oordeel belangrijke effecten heeft op die gevalsidentificatie. Het klinisch oordeel 
lijkt dan ook een onmisbaar instrument om valide informatie te verzamelen 
omtrent de stoornissen in psychiatrisch epidemiologisch bevolkingsonderzoek.   
Tot slot bevelen wij aan het classificatie systeem en de interview strategie als 
expliciet referentiekader te betrekken bij de waardering van psychiatrisch 
epidemiologische onderzoeksresultaten en daaraan conclusies te verbinden 
vanuit klinisch perspectief. 
 
Bijlage 
De bijlage bevat twee delen.  
Het eerste deel betreft het gepubliceerde cross-sectionele RN-onderzoek 
gebaseerd op de GHQ gegevens, een onderdeel van het RN-project dat als 
referentie is gebruikt in hoofdstuk 5.  
Het tweede deel bestaat uit de conversietabel van de SCAN/PSE-10 scores en 









Het behoeft geen betoog dat het schrijven van een proefschrift slechts met 
goed gevolg kan worden afgerond als er vele sterke schouders zijn die dat 
proces ondersteunen. In de ruim 11 jaren die zijn verstreken sinds de 
allereerste overwegingen om in het Nijmeegse Regioproject te stappen, zijn dit 
er zoveel dat ik me moet beperken tot die personen, die mij veelvuldig en 
nadrukkelijk in deze lange periode hebben bijgestaan. 
Ernst Roscam Abbing, Bert Tax en Christiane König (zij mag deze dag helaas 
niet meer meemaken) wil ik als medewerkers van het eerste uur hartelijk 
danken. Ook hartelijk dank aan de andere medewerkers van Sociale 
Geneeskunde, maar speciaal aan mijn maatjes van ‘de zaal’: Josien van den 
Berg, de eerste jaren altijd aanwezig als ik er maar twee dagen in de week kon 
zijn; Saskia Zandstra, met een niet aflatende ijver om de gegevens van 
huisartsen te verzamelen en later Eric van Rijswijk en Nathalie Donders. Jan 
Mulder wil ik danken voor zijn altijd weer indrukwekkende ‘simpele’ kijk op wat 
er statistisch moest en kon gebeuren. Fokko Nienhuis en Rob Giel wil ik 
hartelijk danken voor de introductie in de SCAN die ze hebben verzorgd Alle 
SCAN-interviewers zonder wie het betrouwbaarheidsonderzoek nooit tot een 
goed einde was gekomen en die daarnaast samen goed zijn geweest voor 983 
veldwerk interviews: hartelijk dank. 
De GGz Midden Brabant (en speciaal Willem van Hezewijk en Gerard Coonen) 
wil ik hartelijk danken voor de mogelijkheid die zij mij hebben geboden om het 
werk in Nijmegen nog een tijd door te zetten, nadat de initiële subsidie was 
opgesoupeerd. Ook Marlies Geurts wil ik hartelijk danken voor haar steun en 
ordening op de achtergrond, waardoor de andere werkzaamheden gewoon 
konden doorgaan en mijn aandacht bij het afronden van het proefschrift kon 
blijven. 
Paul Hodiamont, mijn promotor, en de aanstoker van dit alles. In Utrecht op een 
terras aan de Gracht bij een Cola kwam het eerste idee, in Atlanta met uitkijk op 
de Coca Cola toren ontstonden de eerste teksten. Maar zeker ook tijdens het 
verder volgen van het schrijfproces heb  ik (naast dat ik het er wel eens moeilijk 
mee had) zijn steun en kennis enorm gewaardeerd.   
Joop Furer was altijd een grote steun in moeilijke momenten (waren het maar 
momenten?) en van onschatbare waarde bij de kritische analyse van mijn 
teksten. Zijn overtuiging dat het allemaal nog goed zou komen heeft mede 
gemaakt dat dit proefschrift tot een goed einde is gekomen. 
De overige leden van de promotiecommissie, Aartjan Beekman, Harm Gijsman, 
Guus van Heck, Koos van der Velden, Jolanda de Vries en Frans Zitman, dank 
ik voor de tijd en de aandacht die zij hebben besteed aan dit proefschrift. 
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Dank aan Renier van Dinter van Janssen-Cilag en een speciaal woord van 
dank aan Jeff Lubin, voor zijn vele uren en de prettige samenwerking waarin hij 
mijn Engels aan Britse maatstaven onderwierp. 
Ik dank AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Janssen-Cilag, 
Lilly, Lundbeck en Wyeth voor hun bijdrage in de kosten van de uitgave van 
mijn proefschrift. 
 
Ik ben ook veel dank verschuldigd aan mijn meest dierbaren. Mijn vader en 
Marijke dank ik hartelijk voor de vele jaren waarin zij hun belangstelling hebben 
getoond. Mijn vader maakt dit niet meer bewust mee, maar in gedachten zie ik 
hem zitten, en glunderen. 
Ralph en Karen, het is nu eindelijk gedaan. Papa komt weer eens achter zijn 
laptop vandaan. 
Tot slot wil ik Claire heel hartelijk danken voor die vele jaren van ondersteuning, 
waarin zij van ons huis een thuis bleef maken en voor alle kritische noten, al 
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i The disease, the illness and the sickness model are explained in chapter 
3. 
 
ii  When reanalysed in accordance with the 1997 procedure, the 1983 
psychiatric prevalence rate turned out to be 7.8% (±2.3%). 
 
iii Psychosomatic problems (item 3), delusional anxiety (item 13), pre-
menstrual increase of symptoms (item 39), delusions concerning special 
guidance (item 75), denial or concealment of delusions and hallucinations 
(item 94), and insight into neurotic disorders (item 105) 
 
iv  (±95% confidence interval) 
 
v the Short Form Health Survey (SF-36), 4-neurotic symptoms (4-NS) 
(Henderson et al. 1981; Vermeulen & Bosma 1992), Social Support List 
12-item version (SSL 12-I), the short version of the Groningen 
Questionnaire about Social Behavior (GQSB), Loneliness Scale (de Jong-
Gierveld & van Tilburg 1993), Brugha Life Events Questionnaire (Brugha et 
al. 1985), short version of the Coping Inventory for Stressful Situations 
(CISS-21) and Self-Reported Chronic Diseases (Mootz & van den Berg 
1989; van den Berg & van den Bos 1989), psychiatric history, modified 
from the Longitudinal Aging Study Amsterdam (LASA), and some 
questions on political and religious convictions. 
 
vi This exception will be specified in 7.3.3.2 
 
vii DSM-III-R criterion A4 (frequent intoxications or withdrawal symptoms 
when the individual is expected to fulfil major role obligations at work 
school or home) has been removed and the withdrawal criteria A8 and A9 
of the DSM-III-R have been combined into a single criterion in the DSM-IV.  
 
viii DIS: Diagnostic Interview Schedule; CIDI: Composite International 
Diagnostic Interview 
 
ix PSE: Present State Examination; SCAN: Schedules for Clinical Assessment 
in Neuropsychiatry 
 




                                                                                                                                          
xi  For example, a subject is very concerned about something that the 
interviewer assesses as subclinical or irrelevant, or the subject presents 
real symptoms, but they are assessed as situationally adequate for the 
particular subject. 
 
xii  Landis and Koch (1977) proposed describing the degree of concordance 
as follows: < 0.21, “poor”; 0.21-0.40, “fair”; 0.41-0.60, “moderate”; 0.61-
0.80, “substantial”; and 0.81-1.00, “almost perfect”. 
 
xiii For practical purposes, we formulated the following definitions:  
• case definition: the theoretical concept underlying ‘what is a case’, 
based on the presence of a specified set of signs and symptoms. Case 
definitions are ordered in a classification system, on the one hand by 
describing the boundaries of each case and thus the distinctness of 
each case with reference to all others, and on the other hand by sorting 
cases into categories through matching characteristics; 
• case identification: the operationalisation of the theoretical diagnostic 
concept or classification system on the basis of a detailed description; 
• case finding: the application of case identification in a population 
study. 
 
xiv Standardised interview: the interview is conducted on the basis of a fixed 
question schedule which is determined in advance; 
 Semi-structured: the standardised question schedule is composed of 
compulsory questions, followed by optional questions allowing the 
interviewer to probe for additional information until satisfied. A bottom-up 
approach is used in the interview in a trawl-like search for positive signs 
and symptoms. As a consequence, when the classification system 
changes, the interview itself can be retained; only the algorithm for 
establishing the diagnoses has to be rewritten. 
 Fully structured: the standardised question-schedule is rigid and 
compulsory, without the opportunity for individual probing. The interview is 
based on a clear psychiatric classification system and is consequently 
restricted to questions that give a direct answer as to the question of 
whether certain diagnosis-related criteria are fulfilled (top-down 
procedure). As a result, when the classification system changes, both the 
interview itself and the algorithm for establishing the diagnoses have to be 
rewritten. 
 
xv ICD: International Classification of Diseases 
 
273 
                                                                                                                                          
xvi DSM: Diagnostic and statistical manual of mental disorders 
 
xvii The Composite International Diagnostic Interview (CIDI), written at the 
request of the World Health Organization/US Alcohol, Drug Abuse, and 
Mental Health Administration Task Force on Psychiatric Assessment 
Instruments, combines questions from the Diagnostic Interview Schedule 
with questions designed to elicit Present State Examination items (Robins 
et al. 1988). 
 
xviii Version of July 1997 
 
xix 18 to 64 years of age, as used in the NHA-1 study and in the NEMESIS 
 
xx As used in the NEMESIS study (and highly similar to the NHA-1 study, but 
with DSM-IV instead of ICD-9 for classification) 
 
xxi Indicative clinical severity was based on the lifetime history of suicidal 
ideation and suicide attempts and on whether in the past month the 
respondent had been unable to work or had to cut back on work or usual 
activities for two or more days. 
 
xxii Mostly anxiety and depression (Fryers et al. 2005) 
 
xxiii 1-month comorbidity data from the NCS and the NCS-R study are not 
available (Kessler et al. 1994; Kessler et al. 2005a; Kessler et al. 2005b). 
 
xxiv There is a broad variety of definitions for comorbidity, which results in an 
array of operational applications and an extended range of comorbidity 
rates (van den Akker et al. 1996). When the issue is restricted to 
psychiatric comorbidity, a major question is the reference period during 
which the disorders should co-occur. Feinstein (1970) defines comorbidity 
as “a distinct additional entity that has existed or may occur during the 
clinical course of a patient who has the index disease under study”. By 
definition, comorbidity in studies with point (or 1-month) prevalence rates is 
operationalised as two or more distinct entities existing at the same time 
(concurrent comorbidity). In studies aiming at longer reference periods, like 
a 1-year or a lifetime prevalence rate, there may be two or more disorders 
during the period of reference, not only at the same time (concurrent 
comorbidity) but also successively (consecutive morbidity). Because 
comorbidity in studies aiming at a prolonged reference period is used in 
both senses, the comorbidity rate tends to be higher. The effect of mixing 
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concurrent and consecutive comorbidity is illustrated by the results of the 
NCS and the German National Health Interview and Examination Survey 
(and with respect to the 1-year and lifetime reference periods, also the 
NEMESIS). With the prolongation of the reference period, comorbidity 
rates in subjects with at least one diagnosis increased from around 30% 
for the 1-month period to over 50% when lifetime was used as a reference 
period (Bijl et al. 1998; Jacobi et al. 2004; Kessler et al. 1994; Ravelli et al. 
1998). 
 
xxv The transition from DSM-II to DSM-III and its successors led to a growing 
number of specified diagnoses, accompanied by a recession of the 
hierarchical approach and has inevitably brought about an increase in the 
prevalence rate of comorbid psychiatric disorders (Kessler et al. 1997; 
Pincus et al. 2004). For example, the number of DSM-categories increased 
from 127 in DSM-I (1952) through 226 in DSM-III (1980) to 326 in DSM-IV 
(1994). 
 From this perspective, an important possible explanation of the 
considerable comorbidity rates was advanced by Maj (2005), who stated 
that to his knowledge the rule according to which the same symptom can 
not appear in more than one disorder has never been made explicit in 
DSM-based publications, and this rule creates an artificial delineation of 
syndromes. Pincus (2004) argues that the next evolution of the DSM 
needs to balance the current ‘rule-based system with diagnostic strategies 
that depend on clinical judgement’. 
 Another artefact has arisen through the use of the term comorbidity to 
indicate subjects presenting complex clinical presentations that do not 
meet the typological classification criteria of a single diagnosis, resulting in 
a comorbid classification (Alonso & Lepine 2007; Pincus et al. 2004). This 
artificial splitting up is one of the reasons for the morbid growth of the 
number of diagnoses in the DSM-IV, which has led to the resurrection of 
the hierarchy rules. Although the influence on the comorbidity rate of 
switching off the hierarchical rules in DSM-IV was only minimal in 
NEMESIS (Ravelli et al. 1998), the comorbidity rate for subjects with at 
least one diagnosis in the NHA-2 increased from 26% to almost 43% 
(Rijnders & Furer 2003). The explanation for this finding is the fact that in 
the NHA-2 study, three diagnostic categories were measured with an 
increased contribution to comorbidity that were not part of the diagnostic 
range in the NEMESIS. In our study, the hierarchy rules were used 
explicitly and studied for their effect (see sections 6.3.3.2 and 6.4.5). This 
procedure resulted in more moderate comorbidity rates. The highest 
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comorbidity rate was found when the hierarchical rules were omitted 
(Table 1).  
 
 
Table 1 Prevalence rates and associated comorbidity rates with 
respect to diagnostic range, hierarchy and clinical judgement 
 Prevalence rate Comorbidity rate 
Original version, with hierarchy and clinical judgement 17.6 26.1 
Without hierarchy 17.6 42.5 
Omission of clinical judgement 21.4 31.6 
 
 A more moderate increase was found when clinical judgement was 
omitted. As reported in chapter 8 on the clinical judgement of the SCAN, 
this increase was largely due to an increase in the prevalence rate of the 
three newly measured diagnostic categories. A reduction of the diagnostic 
range whereby the diagnostic categories lower in the hierarchy were 
omitted had a considerable effect on both the prevalence rate and the 
comorbidity rate (11.9% and 22.3%, respectively). 
 
xxvi In general, fully structured interviews generate higher diagnostic 
prevalence rates than do semi-structured interviews. Theoretically, when 
independence of the diagnostic categories is adopted as a premise, higher 
prevalence rates lead to a higher minimum comorbidity rate. When, as 
argued earlier, the diagnostic categories are not entirely separate, 
independent entities, the actual comorbidity rate rises above this 
theoretical minimum rate. Moreover, fully structured interviews rely on 
perceived morbidity of signs and symptoms without a clinical attribution to 
a certain diagnosis. This subjectivity may lead to the attribution of one and 
the same sign or symptom to more than one diagnosis and consequently it 
artificially increases the comorbidity rate. 
 
xxvii  Healthy subjects, patients seen by GPs in their surgery, outpatients and 
inpatients identified by mental health care 
 
xxviii Although Brugha et al. (1999b) reported data suggesting ‘progress in 
overcoming the persistent problem of lay rater bias identified in previous 
studies’ (Rodgers & Mann 1986), this pronouncement is exaggerated. 
These investigators did not use average, but highly experienced lay 
interviewers who followed a considerably extended training period in 
clinical evaluation. Furthermore, the positive cases were recruited from a 
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hospital site and consequently were too easy to identify because of the 
presence of obvious signs and symptoms. 
 
xxix  For the clinical practice situation, the Mini-SCAN, a completely 
computerised condensed version of SCAN, has been developed and 
should be the clinical interview instrument of choice for use in daily 
practice (Nienhuis & Giel 2006). 
 
xxx When the interviewer is convinced that the remaining part of the section 
will not yield any major symptoms relevant to the assessment of a possible 
diagnosis, the rest of the section is omitted.  
 
xxxi  For example, the items necessary for dysthymia are obtained by reviewing 
items on depression that were assessed earlier in the section. 
 
xxxii  At the conversion from SCAN to PSE-9, on this item the lower of the two 
possible scores has been chosen. Starting from SCAN, basically two 
scores (2 and 3) in PSE-9 are possible. Score “2” seems the most in 
accordance with the qualitative intention. 
 
xxxiii  Does not discriminate between PSE-9 question 47 and 48. For CATEGO 
this is not of importance according to WHO-committee. 
 
xxxiv Does not discriminate between PSE-9 question 47 and 48. For CATEGO 
this is not of importance according to WHO-committee. 
 
xxxv  The PSE-9 scores 1 and 2 are not separately convertible from SCAN. 
The highest PSE-9 score has been chosen for not losing positive signs in 
the conversion process. 
 
xxxvi The PSE-9 scores 1 and 2 are not separately convertible from SCAN. The 
highest PSE-9 score has been chosen for not losing positive signs in the 
conversion process. 
 
xxxvii Because de final version of Section 21 of SCAN-2.1 was not yet available 
at the time of the training and reliability study, the decision was made for 
the fieldwork to use the trained version of SCAN-2.1 of spring 1997, The 
item numbers of section 21 have been adjusted. 
